consumable
An aerosolisable formulation with nicotine and tobacco-derived compounds replicates the flavor and irritation of traditional cigarettes, addressing the shortcomings of existing non-combustible smoking articles and e-cigarettes by providing a more satisfying experience.
Patent Information
- Application Number
- PCT/GB2026/050796
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-10-15
- Filing Date
- 2026-05-11
- Publication Date
- 2026-11-12
AI Technical Summary
Existing non-combustible smoking articles and e-cigarettes fail to fully replicate the flavor and irritation sensations of traditional cigarettes, leading to a less satisfying experience for consumers.
An aerosolisable formulation comprising a carrier, nicotine in unprotonated and protonated forms, and a specific combination of compounds such as myosmine, p-cresol, and other flavor and irritation markers, which are derived from tobacco extracts, is used to create an inhalable aerosol that mimics the flavor and irritation of smoking a cigarette.
The formulation provides a more satisfying 'cigarette-like' experience by replicating the flavor and irritation dimensions of traditional cigarettes, enhancing the user experience in non-combustible smoking devices.
Smart Images

Figure IMGF000021_0001 
Figure IMGF000024_0001 
Figure IMGF000025_0001
Abstract
Description
[0001] CONSUMABLE
[0002] FIELD OF THE DISCLOSURE
[0003] The present disclosure relates to an aerosolisable formulation, containers in which are contained the aerosolisable formulation and to electronic vapour provision systems such as electronic nicotine delivery systems (e.g. e-cigarettes) incorporating said solution.
[0004] BACKGROUND
[0005] Smoking articles such as cigarettes, cigars, and the like, burn tobacco during use to create tobacco smoke. Alternatives to these types of articles release an inhalable aerosol or vapour by releasing compounds from a substrate material by heating without burning. These may be referred to as non-combustible smoking articles, aerosol-generating assemblies, or noncombustible aerosol provision systems. One example of such a product is a heating device which releases compounds by heating, but not burning, a solid aerosolisable material. This solid aerosolisable material may, in some cases, contain a tobacco material. The heating volatilises at least one component of the material, typically forming an inhalable aerosol. These products may be referred to as heat-not-burn devices, tobacco heating devices or tobacco heating products. Various different arrangements for volatilising at least one component of the solid aerosolisable material are known.
[0006] As another example, there are e-cigarette / tobacco heating product hybrid devices, also known as electronic tobacco hybrid devices. These hybrid devices contain a liquid source, which may or may not contain nicotine, which is vaporised by heating to produce an inhalable vapour or aerosol. The device additionally contains a solid aerosolisable material, which may or may not contain a tobacco material, and components of this material are entrained in the inhalable vapour or aerosol to produce the inhaled medium. A further alternative is vapour products which are handheld, battery-powered devices that heat a liquid to produce an inhalable aerosol, commonly known as vapour.
[0007] DRAWINGS
[0008] Figure 1 represents an aerosolisable formulation user study of sensorial impact.
[0009] Figure 2 represents an aerosolisable formulation user study of sensorial irritation.
[0010] Figure 3 is a bar chart showing the location of irritation across samples 1-3 as described in Example 8.
[0011] Figure 4 is a bar chart showing the location of irritation across samples 4-6 as described in Example 8.SUMMARY
[0012] In accordance with some aspects of the invention described herein, there is provided an aerosolisable formulation comprising: (a) a carrier; (b) nicotine in unprotonated form and in protonated form; (c) a composition comprising one or more compounds selected from: myosmine; p-cresol; pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; nicotyrine; propanoic acid, 2-oxo, methyl ester; propanoic acid, 2-methyl-; 2-cyclopenten-1-one, 3-methyl-; limonene (e.g. D-limonene); 6-ethyl-5,6-dihydro-2H-pyran-2-one; phenol; phenol, 4-ethyl-; propanoic acid; styrene; benzene, 1,3-dimethyl-; 3-pyridinol; 2,3-dimethoxyphenol; 2-pentadecanone, 6, 10, 14-trimethyl-; 2-cyclopenten-1-one, 3-ethyl-2-hydroxy-; methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; methylacetophenone; phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-Linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; terpineol; acetic acid; 2-furanmethanol; 2-furancarboxaldehyde, 5-methyl; benzyl alcohol; phenethylalcohol; 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl (e.g. 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl, (R)); n-hexadecanoicacid; octadecanoic acid; or a combination thereof.
[0013] In accordance with some aspects of the invention described herein, there is provided an aerosolisable formulation comprising: (a) a carrier; (b) nicotine in unprotonated form and in protonated form; (c) a composition comprising one or more compounds selected from: p-cresol; pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; propanoic acid, 2-oxo, methyl ester; propanoic acid, 2-methyl-; 2-cyclopenten-1-one, 3-methyl-; limonene (e.g. D-limonene); 6-ethyl-5,6-dihydro-2H-pyran-2-one; phenol; phenol, 4-ethyl-; propanoic acid; styrene; benzene, 1,3-dimethyl-; 3-pyridinol; 2,3-dimethoxyphenol; 2-pentadecanone, 6, 10, 14-trimethyl-; 2-cyclopenten-1-one, 3-ethyl-2- hydroxy-; methylbutyric acid; piperonal; indole; methylacetophenone; phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-Linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; terpineol; acetic acid; 2-furanmethanol; 2-furancarboxaldehyde, 5-methyl; benzyl alcohol; phenethylalcohol; 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl (e.g. 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl, (R)); n-hexadecanoic acid; octadecanoic acid; or a combination thereof.
[0014] In some examples, the composition is an extract composition. It should be understood that reference herein to “extract composition” is used interchangeably with “composition”; the present disclosure is not limited to an extract composition.
[0015] The skilled person will appreciate the nomenclature used herein includes INCI (InternationalNomenclature Cosmetic Ingredient).
[0016] In some examples, the extract composition comprises three or more compounds selected from: myosmine; p-cresol; pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; nicotyrine; propanoic acid, 2-oxo, methyl ester; propanoic acid, 2-methyl-; 2-cyclopenten-1-one, 3-methyl-; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; phenol; phenol, 4-ethyl-; propanoic acid; styrene; benzene, 1,3-dimethyl-; 3-pyridinol; 2,3-dimethoxyphenol; 2-pentadecanone, 6, 10, 14-trimethyl-; 2-cyclopenten-1-one, 3-ethyl-2-hydroxy-; methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; methylacetophenone; phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-Linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; terpineol; acetic acid; 2-furanmethanol; 2-furancarboxaldehyde, 5-methyl; benzyl alcohol; phenethylalcohol; 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl; n-hexadecanoic acid; octadecanoic acid; or a combination thereof.
[0017] In some examples, the extract composition comprises three or more compounds selected from: myosmine; p-cresol; pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; nicotyrine; propanoic acid, 2-oxo, methyl ester; propanoic acid, 2-methyl-; 2-cyclopenten-1-one, 3-methyl-; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; phenol; phenol, 4-ethyl-; propanoic acid; styrene; benzene, 1,3-dimethyl-; 3-pyridinol; 2,3-dimethoxyphenol; 2-pentadecanone, 6, 10,14-trimethyl-; 2-cyclopenten-1-one, 3-ethyl-2-hydroxy-; methylbutyric acid; piperonal; indole; methylacetophenone; phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-Linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; terpineol; acetic acid; 2-furanmethanol; 2-furancarboxaldehyde, 5-methyl; benzyl alcohol; phenethylalcohol; 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl; n-hexadecanoic acid; octadecanoic acid; or a combination thereof.
[0018] In some examples, the extract composition comprises compounds selected from the groups consisting of:
[0019] (I). myosmine; p-cresol; pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; nicotyrine; propanoic acid, 2-oxo, methyl ester; propanoic acid, 2-methyl-; 2-cyclopenten-1-one, 3-methyl-; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; phenol; phenol, 4-ethyl-; propanoic acid; styrene; benzene, 1,3-dimethyl-; 3-pyridinol; 2,3-dimethoxyphenol; 2-pentadecanone, 6, 10,14-trimethyl-; 2-cyclopenten-1-one, 3-ethyl-2-hydroxy-; ora combination thereof;(II) methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; methylacetophenone; phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-Linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; terpineol; or a combination thereof ;
[0020] (III) acetic acid; 2-furanmethanol; 2-furancarboxaldehyde, 5-methyl; benzyl alcohol; phenethylalcohol; 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl; n-hexadecanoic acid; octadecanoic acid; or a combination thereof.
[0021] In some examples, the extract composition comprises at least two compounds selected from: myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alphalinolenic acid; methoxyvinylphenol; and guaiacol.
[0022] In some examples, the extract composition comprises at least three compounds selected from: myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0023] In some examples, the extract composition comprises at least one compound selected from: indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol.
[0024] In some examples, the extract composition comprises at least three compounds selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; methylacetophenone; phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; and terpineol.
[0025] In some examples, the extract composition comprises at least one compound selected from: myosmine; p-cresol; pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1h-indole, 6-methyl-; nicotyrine; propanoic acid, 2-oxo, methyl ester; propanoic acid, 2-methyl-; 2-cyclopenten-1-one, 3-methyl-; limonene; 6-ethyl-5,6-dihydro-2h-pyran-2-one; phenol; phenol, 4-ethyl-; propanoic acid; styrene; benzene, 1,3-dimethyl-; 3-pyridinol; 2,3-dimethoxyphenol; 2-pentadecanone, 6, 10, 14-trimethyl-; and 2-cyclopenten-1-one, 3-ethyl-2-hydroxy-.
[0026] In some examples, the extract composition comprises at least alpha-linolenic acid.
[0027] In some examples, the extract composition further comprises 2-furancarboxyladehyde, 5-methyl-.
[0028] In some examples, the extract composition is obtained, derived or derivable from plants or portions of plants from tobacco.In some examples, the one or more organic acids (c) comprise one or more organic acids selected from the group consisting of acetic acid, lactic acid, formic acid, citric acid, benzoic acid, pyruvic acid, levulinic acid, succinic acid, tartaric acid, oleic acid, sorbic acid, propionic acid, phenylacetic acid, isobutyric acid, butyric acid, methylbutyric acid, 2-methylbutyric acid, 3-methylpentanoic acid, isovaleric acid, valeric acid, hexanoic acid, hepatanoic acid, octanoic acid, nonanoic acid, methylvaleric acid, decanoic acid, glycolic acid, 2-butenedioic acid (Z), 2-butenedioic acid (E), succinic acid, glyceric acid, malic acid, pyroglutamic acid, trihydroxybutanoic acid, tetrahydroxypentanoic acid, 2-keto-L-gluconic acid, quinic acid, gluconic acid, galactaric acid, hexadecanoic acid, caffeic acid, linoleic acid, linolenic acid, glucuronic acid, chlorogenic acid, fumaric acid, maleic acid, oxalic acid, oxaloacetic acid, acetoacetic acid, beta-hydroxybutyric acid, alpha-ketoglutaric acid, alpha-ketobutyric acid and mixtures thereof; preferably wherein the one or more acids (c) is benzoic acid.
[0029] In some examples, the total content of the one or more organic acids (c) present in the formulation is 1.0 mole equivalents based on the nicotine
[0030] In some examples, the nicotine is present in the material in an amount of 5mg / ml of aerosolisable material or more.
[0031] In some examples, the carrier comprises glycerol, propylene glycol, water and mixtures thereof; preferably wherein the carrier consists of a mixture of glycerol and propylene glycol.
[0032] In some examples, the carrier is present in an amount of at least 70%w / w based on the total weight of the aerosolisable material.
[0033] In some examples, based on the total amount of propylene glycol and glycerol in the aerosolisable material, the aerosolisable material comprises: 60 to 80%w / w propylene glycol; and 40 to 20%w / w glycerol.
[0034] In some examples, the pH of the aerosolisable formulation is of from about 4.5 to 7.5. In some examples, the pH of the aerosolisable formulation is of from about 4.5 to 6.0.
[0035] In some examples, the aerosolisable formulation and / or the extract composition is treated to selectively remove one or more components therefrom.
[0036] In accordance with some aspects of the invention described herein, there is provided an aerosolised formulation comprising: (a) a carrier; (b) nicotine in unprotonated form and in protonated form; (c) one or more organic acids; and (d) an extract composition as defined herein.In some examples, the aerosolised formulation is formed from the aerosolisable formulation as defined herein.
[0037] In accordance with some aspects of the invention described herein, there is provided an electronic aerosol provision system comprising: (i) an aerosoliser for aerosolising an aerosolisable product for inhalation by a user of the electronic aerosol provision system; (ii) a power supply comprising a cell or battery for supplying power to the aerosoliser; and (iii) an aerosolisable formulation as defined herein.
[0038] In accordance with some aspects of the invention described herein, there is provided a method of preparing the aerosolisable formulation as defined herein, wherein the method comprises combining nicotine, one or more organic acids with a carrier and extract composition.
[0039] In accordance with some aspects of the invention described herein, there is provided a process for forming an aerosol, the process comprising aerosolising an aerosolisable formulation as defined herein.
[0040] In accordance with some aspects of the invention described herein, there is provided the use of an extract composition as defined herein for improving sensory properties of an aerosol formulation.
[0041] In accordance with some aspects of the invention described herein, there is provided the use of an extract composition as defined herein for modulating irritation of an aerosol formulation.
[0042] These and other features, aspects and advantages of the disclosure will be apparent from the following detailed description and drawings. The invention includes any combination of two, three, four, or more of the above-noted examples as well as combinations of any two, three, four, or more features or elements set forth in this disclosure, regardless of whether such features or elements are expressly combined in a specific example description herein. This disclosure is intended to be read holistically such that any separable features or elements of the disclosed invention, in any of its various aspects and examples, should be viewed as intended to be combinable unless the context clearly dictates otherwise.
[0043] DETAILED DESCRIPTION
[0044] It is to be understood that this disclosure is not limited to the particular configurations, process steps, and materials disclosed herein as such configurations, process steps, and materials may vary somewhat. It is also to be understood that the terminology employed herein is used for the purpose of describing particular examples only and is not intended to be limiting since the scope will be limited only by the appended claims and equivalents thereof.As used in this specification and the claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Reference to "dry % by weight" or "dry weight basis" refers to weight on the basis of dry ingredients (i.e., all ingredients except water or carrier). Reference to "wet weight" refers to the weight of the formulation or composition including water or carrier. Unless otherwise indicated, reference to "% by weight" (or “% by weight”) of formulation or composition reflects the total wet weight of the formulation or composition (i.e., including water / carrier). Unless otherwise indicated, all % values are calculated on a weight basis, and are provided with reference to the total weight of the product in which the substance is present.
[0045] In this specification, unless otherwise stated, the term "about" modifying the quantity of an ingredient in the formulation or employed in the methods refers to variation in the numerical quantity that can occur, for example, through typical measuring and liquid handling procedures used for making concentrates or use solutions in the real world; through inadvertent error in these procedures; through differences in the manufacture, source, or purity of the ingredients employed to make the formulation, or to carry out the methods; and the like. The term “about” also encompasses amounts that differ due to different equilibrium conditions for a formulation or composition resulting from a particular initial mixture. Whether or not modified by the term "about", the claims include equivalents to the quantities.
[0046] The ranges provided herein relate to preferred amounts of each of the compound groups. Each of these ranges may be taken alone or combined with one or more other compound group range(s) to provide a preferred example of the invention.
[0047] As used herein, “substantially free” means no more than trace amounts, i.e. the amount of the substance(s) concerned is negligible. In various examples, “substantially free” means no more than 1000 ppm, preferably no more than 100 ppm, more preferably no more than 10 ppm, even more preferably no more than 1 ppm of the substance(s) concerned.
[0048] In all aspects of the present disclosure, the disclosure includes, where appropriate, all enantiomers and tautomers of the compounds disclosed herein. A person skilled in the art will recognise compounds that possess optical properties (one or more chiral carbon atoms) or tautomeric characteristics. The corresponding enantiomers and / or tautomers may be isolated / prepared by methods known in the art. Some of the compounds disclosed herein may exist as stereoisomers and / or geometric isomers - e.g. they may possess one or more asymmetric and / or geometric centres and so may exist in two or more stereoisomeric and / or geometric forms. The present disclosure contemplates the use of all the individualstereoisomers and geometric isomers of those compounds, and mixtures thereof. The terms used in the claims encompass these forms.
[0049] As used herein, an alkyl group can be a substituted or unsubstituted, linear or branched chain saturated radical. Examples of alkyl groups include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, dodecyl, hexadecyl, heptadecyl, octadecyl, nondecyl, eicosyl, and isomeric forms thereof. Cycloalkyl groups are derived from cycloalkanes by removal of a hydrogen atom from a ring carbon atom; they include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 2-methylcyclopentyl, 2,3-dimethyl-cyclobutyl, 4-methylcyclobutyl, 3-cyclopentylpropyl, and the like.
[0050] As used herein, an alkenyl group can be a substituted or unsubstituted, linear, branched or cyclic unsaturated radical. An alkenyl group thus contains one or more carbon-carbon double bonds. Examples of alkenyl groups include ethenyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, dodecenyl, hexadecenyl, heptadecenyl, octadecenyl, nondecenyl, eicosenyl, and isomeric forms thereof. Cycloalkenyl groups include cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctenyl, and the like, and isomeric forms thereof.
[0051] As used herein, an aromatic group is a substituted or unsubstituted group derived from arenes by removal of a hydrogen atom from a ring carbon atom. Aryl groups include phenyl, tolyl, xylyl, naphthyl, biphenylyl, and the like.
[0052] A cigarette, also known as a factory-made cigarette or ‘FMC’, gives rise to a cigarette-like or FMC-like experience when smoked by a consumer. Such an experience can have various dimensions, including sense, taste and flavour dimensions. By the ‘sense’ of a cigarette, is meant the overall feel of smoking a cigarette which includes attributes such as impact, irritation, harshness, mouth drying, and mouth coating or mouthfeel. By the “taste” of a cigarette is meant the overall taste of smoking a cigarette including hay-like, bread-like, smoky, tannin, resinous, musk, etc., and by the “flavour” of a cigarette is meant the overall flavour of smoking cigarette such as creamy, fruity, floral, green, spicy, savoury, roasted, woody, etc.
[0053] As noted above, there are several alternative means by which a consumer can replicate the smoking experience. These include e-cigarettes and tobacco heating devices which provide the consumer with an inhalable aerosol. One potential drawback with such devices is, however, that they may fail to completely replicate one or more of the dimensions associated with the FMC-like experience. Dimensions that are particularly critical for consumers are “flavour” and “sense”. With an inhalable aerosol, flavour is delivered primarily via aroma.Hence, when a consumer is seeking an “FMC-like experience” with a heating device (whether with a solid, liquid, gel or hybrid aerosolisable formulation(s)), it is desirable for the aroma to replicate that of smoking a cigarette, i.e. for the aroma to be tobacco-like and deliver a richness and complexity comparable to smoking a cigarette. It is also desirable for the “sensation” to be comparable to smoking a cigarette; in particular, for the inhaled aerosol to deliver irritation to the nose and / or throat of the consumer.
[0054] The present disclosure relates to a combination of ingredients which can be used in a consumable for a substance delivery system to replicate the ‘FMC’ flavour, sensation (particularly irritation), or a combination thereof. In particular, the inventors have identified a range of compounds (also called chemical markers) responsible for various flavour dimensions of smoking a cigarette, such as creamy, fruity, floral, green, spicy, savoury, roasted, woody, etc., and identified a combination of such compounds which is particularly beneficial for delivering the desired ‘FMC-like’ flavour experience termed “tobacco-flavour” herein. The inventors have further identified a range of compounds / chemical markers responsible for the irritation to the nose and / or throat experienced when smoking a cigarette. These compounds were identified by collecting and analysing a range of different tobacco extracts, as well as using machine learning and / or human sensory assessment. More information on the analysis is set out herein. It will be understood that the substance delivery system is not a combustible substance delivery system (e.g. a cigarette). Hence, the term “substance delivery system” in the present disclosure means non-combustible substance delivery system.
[0055] The compounds of the present disclosure can advantageously be used to prepare a composition for inclusion in a consumable for a substance delivery system, including a composition which can be used with or without a plant material (e.g. a tobacco extract) in order to replicate the ‘FMC’ flavour and / or irritation experience. Furthermore, the levels of the compounds can be adjusted in order to tailor the flavour and / or irritation intensity to consumer preference or, when present, the substrate material (for example, the tobacco-type from which the base, tobacco extract included with the compounds in some examples was derived).
[0056] In total, the inventors identified over 300 compounds across 9 different tobacco extracts, the extracts being obtained by a variety of extraction methods and from various tobacco sources (e.g. Virginia, Oriental, Burley, and combinations thereof). Four of the tobacco extracts were then identified as being particularly appealing to consumers seeking an ‘FMC-like’ experience, and the compounds present in these extracts further analysed for chemical markers providing tobacco flavour and / or irritation. Some chemical markers provide both tobacco flavour and irritation, others are limited to one or the other.With this assessment, the inventors have found a combination of chemical markers that is able to provide a tobacco aroma and / or irritation when used in a substance delivery system, without the need to smoke or burn a cigarette. This includes the ability to combine the combination of chemical markers with a substrate material, such as a tobacco or other plant extract, and thereby improve the ‘FMC-like’ sensorial experience provided by the substrate material when used in a substance delivery system. Furthermore, it is possible to create a composition for use in an aerosol-free delivery system, such as an oral product which is placed in the oral cavity of the consumer. This may allow for a more user-friendly and improved cigarette-like experience to be created. Several benefits are therefore associated with the composition of the present disclosure; many consumers who smoke traditional cigarettes may previously have been reluctant or unwilling to use non-combustible aerosol provision devices, e.g. heat-not-burn, hybrid or vapour devices, or oral compositions, because the experience of using these devices or compositions may differ from the experience of burning and smoking a cigarette. The composition of the present disclosure may, however, allow for consumers to get the same or similar experience to smoking a cigarette when using oral compositions and / or non-combustible aerosol provision systems. For example, when using the composition of the present disclosure in a non-combustible aerosol provision system, a more ‘cigarette-like’ experience and / or aerosol can be created compared to using a previously-known or commercially available composition for use in such devices.
[0057] For ease of reference, these and further aspects of the present invention are now discussed under appropriate section headings. However, the teachings under each section are not necessarily limited to each particular section. In other words, particular sections of the description are not to be read in isolation from other sections.
[0058] Carrier
[0059] The aerosolisable formulation may take various forms, provided that the formulation is capable of generating aerosol, for example when heated, irradiated or energized in any other way, including a semi-solid (such as a gel), a liquid or a solid, which may or may not contain a further active substance and / or flavourants as defined herein.
[0060] The carrier comprises one or more constituents capable of forming an aerosol, particularly when evaporated and allowed to condense. In some examples, the carrier may comprise one or more of glycerol, propylene glycol, water, diethylene glycol, triethylene glycol, tetraethylene glycol, 1,3-butylene glycol, erythritol, meso-Erythritol, ethyl vanillate, ethyl laurate, a diethyl suberate, triethyl citrate, triacetin, a diacetin mixture, benzyl benzoate, benzyl phenyl acetate,tributyrin, lauryl acetate, lauric acid, myristic acid, propylene carbonate, ethanol and benzyl alcohol.
[0061] In some examples, the carrier comprises at least water. In some examples, the carrier comprises at least propylene glycol. In some examples, the carrier comprises at least glycerol. In some examples, the carrier comprises at least water and glycerol. In some examples, the carrier comprises at least propylene glycol and glycerol. In some examples, the carrier comprises at least propylene glycol and water. In some examples, the carrier comprises at least propylene glycol, glycerol and water.
[0062] In some examples, the carrier comprises ethanol, benzyl alcohol and combinations thereof.
[0063] The carrier may be present in any suitable amount based on the total weight of the aerosolisable material. In some examples, the carrier constituent comprises at least 50 wt.% based on the total weight of the aerosolisable material. In some examples, the carrier constituent comprises at least 60 wt.% based on the total weight of the aerosolisable material. In some examples, the carrier constituent comprises at least 70 wt.% based on the total weight of the aerosolisable material. In some examples, the carrier constituent comprises at least 80 wt.% based on the total weight of the aerosolisable material. In some examples, the carrier constituent comprises at least 90 wt.% based on the total weight of the aerosolisable material.
[0064] In some examples, the carrier is selected from propylene glycol, glycerol, triethyl citrate, benzyl alcohol and mixtures thereof.
[0065] In one example, the aerosolisable material is a liquid at about 25°C.
[0066] The carrier of the aerosolisable formulation may be any suitable solvent such that the nicotine can be vaporised for use. In some examples the solvent is selected from glycerol, propylene glycol and combination thereof. In some examples the solvent is at least glycerol. In some examples the solvent consists essentially of glycerol. In some examples the solvent consists of glycerol. In some examples the solvent is at least propylene glycol. In some examples the solvent consists essentially of propylene glycol. In some examples the solvent consists of propylene glycol. In some examples the solvent is at least a mixture of propylene glycol and glycerol. In some examples the solvent consists essentially of a mixture of propylene glycol and glycerol. In some examples the solvent consists of a mixture of propylene glycol and glycerol.
[0067] The carrier of the aerosolisable formulation may be present in any suitable amount. In some examples the carrier is present in an amount of 1 to 98 wt% based on the aerosolisableformulation. In some examples the carrier is present in an amount of 5 to 98 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 10 to 98 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 20 to 98 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 30 to 98 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 40 to 98 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 50 to 98 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 60 to 98 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 70 to 98 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 80 to 98 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 90 to 98 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 1 to 90 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 5 to 90 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 10 to 90 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 20 to 90 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 30 to 90 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 40 to 90 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 50 to 90 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 60 to 90 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 70 to 90 wt% based on the aerosolisable formulation. In some examples the carrier is present in an amount of 80 to 90 wt% based on the aerosolisable formulation.
[0068] In some examples the aerosolisable formulation further comprises water. The water may be present in any suitable amount. In some examples water is present in an amount of 1 to 50 wt% based on the aerosolisable formulation. In some examples water is present in an amount of 5 to 50 wt% based on the aerosolisable formulation. In some examples water is present in an amount of 10 to 50 wt% based on the aerosolisable formulation. In some examples water is present in an amount of 20 to 50 wt% based on the aerosolisable formulation. In some examples water is present in an amount of 1 to 40 wt% based on the aerosolisable formulation. In some examples water is present in an amount of 5 to 40 wt% based on the aerosolisable formulation. In some examples water is present in an amount of 10 to 40 wt% based on the aerosolisable formulation. In some examples water is present in an amount of 20 to 40 wt% based on the aerosolisable formulation. In some examples water is present in an amount of 1to 30 wt% based on the aerosolisable formulation. In some examples water is present in an amount of 5 to 30 wt% based on the aerosolisable formulation. In some examples water is present in an amount of 10 to 30 wt% based on the aerosolisable formulation. In some examples water is present in an amount of 20 to 30 wt% based on the aerosolisable formulation.
[0069] In some examples the combined amount of carrier and water in the aerosolisable formulation is from 1 to 98 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 5 to 98 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 10 to 98 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 20 to 98 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 30 to 98 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 40 to 98 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 50 to 98 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 60 to 98 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 70 to 98 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 80 to 98 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 90 to 98 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 1 to 90 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 5 to 90 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 10 to 90 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 20 to 90 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 30 to 90 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 40 to 90 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 50 to 90 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 60 to 90 wt% based on the aerosolisable formulation. In some examples the combined amountof carrier and water in the aerosolisable formulation is 70 to 90 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 80 to 90 wt% based on the aerosolisable formulation. In some examples the combined amount of carrier and water in the aerosolisable formulation is 90 to 90 wt% based on the aerosolisable formulation.
[0070] In some examples the aerosolisable formulation may contain solvents which advantageously allow for the preparation of the formulation. In some examples, the aerosolisable formulation contains ethanol which improves the solubility of benzoic acid when incorporated into the formulation.
[0071] The components of the system may be present in the following amounts. The water may represent up to 30% w / w of the total aerosolisable formulation. The carrier may represent up to 98% w / w of the total aerosolisable formulation. The nicotine may represent from greater than 0% to 6% w / w of the total aerosolisable formulation.
[0072] In some examples, the aerosolisable formulation is a liquid. In some examples the aerosolisable formulation is a liquid and comprises about 1% to about 25% by weight of the extract composition, about 50 to about 99% by weight of the carrier. In some examples the aerosolisable formulation is a liquid and comprises about 5 wt% by weight to about 20% by weight of the extract composition, about 60% to about 98% by weight of the carrier. In some examples the aerosolisable formulation is a liquid and comprises about 10% by weight to about 15% by weight of the extract composition, about 70% to about 95% by weight of the carrier.
[0073] In some examples, the aerosolisable formulation or carrier / aerosol-generating material may be an extruded material or in the form of strands or strips. In some examples, the aerosolgenerating material comprises one or more, or all of the materials defined herein in relation to the carrier. In some examples there is provided a carrier / aerosol generating material / system comprising the extract composition as defined herein, a carrier / aerosol former material, one or more binders, and optionally a botanical material. Optionally a filler may also be present. Optionally, a solvent, such as water, is also present and one or more other components of the aerosol-generating material may or may not be soluble in the solvent.
[0074] The aerosol-generating material may comprise or be in the form of an aerosol-generating film. The aerosol-generating film may comprise a binder, such as a gelling agent, and an aerosol former. Optionally, a substance to be delivered and / or filler may also be present. The aerosolgenerating film may have a thickness of about 0.015 mm to about 1 mm. For example, thethickness may be in the range of about 0.05 mm, 0.1 mm or 0.15 mm to about 0.5 mm or 0.3 mm. The aerosol-generating film may be continuous. For example, the film may comprise or be a continuous sheet of material. The sheet may be in the form of a wrapper; it may be gathered to form a gathered sheet or it may be shredded to form a shredded sheet. The shredded sheet may comprise one or more strands or strips of aerosol-generating material.
[0075] The aerosol-generating film may be discontinuous. For example, the aerosol-generating film may comprise one or more discrete portions or regions of aerosol-generating material, such as dots, stripes or lines, which may be supported on a support. In such examples, the support may be planar or non-planar.
[0076] The aerosol-generating film may be formed by combining a binder, such as a gelling agent, with a solvent, such as water, an aerosol-former and one or more other components, such as one or more substances to be delivered, to form a slurry and then heating the slurry to volatilise at least some of the solvent to form the aerosol-generating film. The slurry may be heated to remove at least about 60 wt%, 70 wt%, 80 wt%, 85 wt% or 90 wt% of the solvent.
[0077] The aerosol-generating material may comprise or be an “amorphous solid”. In some examples, the aerosol-generating materiel comprises an aerosol-generating film that is an amorphous solid. The amorphous solid may be a “monolithic solid”. The amorphous solid may be substantially non-fibrous. In some examples, the amorphous solid may be a dried gel. The amorphous solid is a solid material that may retain some fluid, such as liquid, within it. In some examples, the amorphous solid may, for example, comprise from about 50wt%, 60wt% or 70wt% of amorphous solid, to about 90wt%, 95wt% or 100wt% of amorphous solid.
[0078] In some examples, the binder consists of one or more gelling agent(s). Suitably, the aerosolisable formulation or aerosol generating system comprises from about 2 wt% to about 80 wt% binder(s), for example from about 5 wt%, 7 wt%, 10 wt%, 15 wt%, 17 wt%, 20 wt%, or 25 wt% to about 70 wt%, 60 wt%, 50 wt%, 45 wt%, 40 wt%, 35 wt% or 30 wt% of one or more binders (all calculated on a dry weight basis). For example, the aerosolisable formulation or aerosol generating system may comprise about 5-70 wt%, 7-60 wt%, 10-50 wt%, 15-45 wt%, 17-40 wt%, 20-35 wt% or 25-30 wt% of the binder(s).
[0079] In some examples, the one or more binders comprises one or more gelling agent(s). In some examples, the one or more binders consist of one or more gelling agent(s). In some examples, the gelling agent comprises a hydrocolloid.
[0080] In some examples, the one or more binders comprises (or is) one or more compounds selected from polysaccharide gelling agents, such as alginate, pectin, starch or a derivativethereof, cellulose or a derivative thereof, pullulan, carrageenan, agar and agarose; gelatin; gums, such as xanthan gum, guar gum and acacia gum; silica or silicone compounds, such as PDMS and sodium silicate; clays, such as kaolin; and polyvinyl alcohol.
[0081] In some examples the one or more binders comprises (or is) one or more polysaccharide gelling agents. In some examples, the polysaccharide gelling agent is selected from alginate, pectin, starch or a derivative thereof, or cellulose or a derivative thereof. In some examples the polysaccharide gelling agent is selected from alginate and a cellulose derivative.
[0082] In some examples, the one or more binders is a polysaccharide gelling agent, optionally wherein the polysaccharide gelling agent is selected from alginate and a cellulose derivative. In some examples, the polysaccharide gelling agent is alginate. In some examples, the alginate is sodium alginate.
[0083] In some examples, the polysaccharide gelling agent is a cellulose derivative. Without wishing to be bound by theory, it is believed that such gelling agents do not react with calcium ions to form crosslinks. In some examples the binder is not crosslinked. The absence of crosslinks in the gelling agent may facilitate quicker delivery of the composition (and any optional additional active substances and / or flavours) from the aerosolisable formulation or aerosol generating system. Examples of cellulosic binders (also referred to herein as cellulosic gelling agents or cellulose derivatives) include, but are not limited to, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose (CMC), hydroxypropyl methylcellulose (HPMC), methyl cellulose, ethyl cellulose, cellulose acetate (CA), cellulose acetate butyrate (CAB), and cellulose acetate propionate (CAP). In some examples the cellulose or derivative thereof is selected from hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose (CMC), hydroxypropyl methylcellulose (HPMC), methyl cellulose, ethyl cellulose, cellulose acetate (CA), cellulose acetate butyrate (CAB), and cellulose acetate propionate (CAP). In some examples, the cellulose derivative is CMC. For example, in some examples, the binder comprises (or is) one or more of alginate, pectin, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose, pullulan, xanthan gum, guar gum, carrageenan, agarose, acacia gum, fumed silica, PDMS, sodium silicate, kaolin and polyvinyl alcohol.
[0084] In some examples, the binder comprises (or is) one or more of hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose, guar gum, acacia gum, alginate and / or pectin. In some cases, the binder comprises (or is) alginate and / or pectin, and may be combined with a setting agent (such as a calcium source) during formation of the aerosolisable formulation or aerosol generating system. In some cases, the binder may comprise a calcium-crosslinked alginate and / or a calcium-crosslinked pectin. In some examples, the binder comprises (or is) alginate, optionally wherein the alginate is present in the aerosolisable formulation in an amount of from about 5-70 wt%, 7-60 wt%, 10-50 wt%, or 15-45 wt%, of the aerosolisable formulation or aerosol generating system (calculated on a dry weight basis). In some examples, alginate is the only binder present in the aerosolisable formulation / aerosol generating system. In other examples, the binder comprises alginate and at least one further binder, such as pectin. In particular examples, the binder is carboxymethylcellulose, optionally wherein the carboxymethylcellulose (CMC) is present in an amount of about 2-80 wt%, for example about 5-70 wt%, 10-60 wt%, 15-50 wt%, 17-45 wt%, 20-40 wt% or about 30 wt%. In some examples, CMC is the only binder present in the aerosolisable formulation / aerosol generating system.
[0085] The aerosolisable formulation or carrier / aerosol generating material may further comprise a filler. Use of a filler may help to reduce tackiness of the aerosolisable formulation / carrier / aerosol generating material, for example if high levels of aerosol-former material are present. Suitably, the aerosolisable formulation / carrier / aerosol generating material comprises from about 2 wt% to about 60 wt% binder and any optional filler. In some examples, filler is present in an amount of less than about 50 wt% of a filler, such as from about 1 wt% to 50 wt%, or 5 wt% to 40 wt%, or 5 wt% to 30 wt%, or 10 wt% to 20 wt%. In other examples, filler is present in an amount of less than 20 wt%, suitably less than 10 wt% or less than 5 wt%. In some cases, the aerosolisable formulation comprises less than 1 wt% of a filler, and in some cases, comprises no filler. The filler, if present, may comprise one or more inorganic filler materials, such as calcium carbonate, perlite, vermiculite, diatomaceous earth, colloidal silica, magnesium oxide, magnesium sulphate, magnesium carbonate, and suitable inorganic sorbents, such as molecular sieves. The filler may comprise one or more organic filler materials such as wood pulp; tobacco pulp; hemp fibre; starch and starch derivatives, such as maltodextrin; chitosan; and cellulose and cellulose derivatives, such as ground cellulose, microcrystalline cellulose and nanocrystalline cellulose. In particular cases, the aerosolisable formulation comprises no calcium carbonate such as chalk.
[0086] In particular examples which include filler, the filler is fibrous. For example, the filler may be a fibrous organic filler material such as wood pulp, tobacco pulp, hemp fibre, cellulose or cellulose derivatives. In some examples, the fibrous organic filler material may be wood pulp, hemp fibre, cellulose or cellulose derivatives. In some examples, the fibrous filler is wood pulp. Without wishing to be bound by theory, it is believed that including fibrous filler in an aerosolisable formulation may increase the tensile strength of the material. This may be particularly advantageous in examples wherein the aerosolisable formulation orcarrier / aerosol generating material is provided as a sheet, such as when a sheet circumscribes a rod of carrier, aerosolisable or aerosol generating material.
[0087] The aerosol-former material may comprise one or more constituents capable of forming an aerosol. In some examples, the aerosol-former material may comprise one or more of glycerol, propylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, 1,3-butylene glycol, erythritol, meso-Erythritol, ethyl vanillate, ethyl laurate, a diethyl suberate, triethyl citrate, triacetin, a diacetin mixture, benzyl benzoate, benzyl phenyl acetate, tributyrin, lauryl acetate, lauric acid, myristic acid, and propylene carbonate. In heated products, the aerosol-former material can be present in an amount of greater than 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14% or 15% by weight of the aerosol-generating material.
[0088] When the aerosolisable formulation or a consumable comprises aerosol-generating material, the consumable may further comprise one or more other components, such as an aerosolgenerating section, an aerosol-generating material storage area, an aerosol-generating material transfer component, an aerosol generation area, a housing, a wrapper, a mouthpiece, a filter and / or an aerosol-modifying agent.
[0089] A consumable may also comprise an aerosol generator, such as a heater, that emits heat to cause the aerosol-generating material to generate aerosol in use. The heater may, for example, comprise combustible material, a material heatable by electrical conduction, or a susceptor. The aerosol-generating section and / or the aerosol-generating material may comprise a cavity for receiving an aerosol-generator, such as a blade or a pin, of a noncombustible aerosol provision device. A susceptor is a material that is heatable by penetration with a varying magnetic field, such as an alternating magnetic field. The susceptor may be an electrically-conductive material, so that penetration thereof with a varying magnetic field causes induction heating of the material. The material may be a magnetic material, so that penetration thereof with a varying magnetic field causes magnetic hysteresis heating of the heating material. The susceptor may be both electrically-conductive and magnetic, so that the susceptor is heatable by both mechanisms. A device or a consumable may comprise the susceptor. For example, the aerosol-generating section of a consumable may comprise aerosol-generating material and a susceptor.
[0090] A consumable may be in the form of a rod and may comprise a downstream mouth-end and an upstream end.
[0091] Consumables are often named according to their length: "regular" (typically in the range 68-75 mm, e.g. from about 68 mm to 25 about 72 mm), "short" or "mini" (68 mm or less), "king-size" (typically in the range 75-91 mm, e.g. from about 79 mm to about 88 mm), "long" or "super-king" (typically in the range 91-105 mm, e.g. from about 94 mm to about 101 mm) and "ultra-long" (typically in the range from about 110 mm to about 121 mm). Typical heating product consumable circumferences are: "regular" (about 23-25 mm), "wide" (greater than 25 mm), "slim" (about 22-23 mm), "demi-slim" (about 19-22 mm), "super-slim" (about 16-19 mm), and "micro-slim" (less than about 16 mm). Accordingly, for example, a consumable in demi-slim size will have a length of about 75 mm and a circumference of about 21 mm. A consumable in a king-size, super-slim format will have a length of about 83 mm and a circumference of about 17 mm, for example.
[0092] Articles may include an aerosol-generating material and a downstream portion downstream of the aerosol-generating material, and each format may be produced with downstream portions of different lengths. The downstream portion length will usually be from about 30 mm to 50 mm. A tipping paper connects the downstream portion to the carrier / aerosol generating material and will usually have a greater length than the downstream portion, for example from 3 to 10 mm longer, such that the tipping paper covers the downstream portion and overlaps the carrier / aerosol generating material, for instance in the form of a rod, to connect the downstream portion to the rod.
[0093] The consumable may comprise aerosol-generating material that is wrapped in a wrapper. The wrapper may, for example, be a paper or a paper-backed foil wrapper. The wrapper can be permeable, partially permeable or impermeable to gas.
[0094] An aerosol-modifying agent is a substance, typically located downstream of the aerosol generation area, that is configured to modify the aerosol generated, for example by changing the taste, flavour, acidity or another characteristic of the aerosol. The aerosol-modifying agent may be provided in an aerosol-modifying agent release component, that is operable to selectively release the aerosol-modifying agent. The aerosol-modifying agent may, for example, be an additive or a sorbent. The aerosol-modifying agent may, for example, comprise one or more of a flavourant, a colourant, water, and a carbon adsorbent. The aerosol-modifying agent may, for example, be a solid, a liquid, or a gel. The aerosol-modifying agent may be in powder, thread or granule form. The aerosol-modifying agent may be free from filtration material.
[0095] An aerosol generator is an apparatus configured to cause aerosol to be generated from the aerosol-generating material. In some examples, the aerosol generator is a heater configured to subject the aerosol-generating material to heat energy, so as to release one or more volatiles from the aerosol-generating material to form an aerosol. In some examples, theaerosol generator is configured to cause an aerosol to be generated from the aerosolgenerating material without heating. For example, the aerosol generator may be configured to subject the aerosol-generating material to one or more of vibration, increased pressure, or electrostatic energy. The aerosol generator may comprise a projection that is configured to subject the aerosol-generating material to heat energy, such as a blade or pin heater. The projection may be configured for insertion into the aerosol-generating section of a consumable. The aerosol generator may be configured to heat the aerosol-generating material to a temperature of up to about 500 °C, about 450 °C, or about 400 °C or about 350 °C.
[0096] Exemplary aerosol generator technologies include: for heater technologies: a resistive heater, an infrared heater, an induction heater, a laser heater, a plasma heater, a microfluidic heater, a convection heater, allotrope of carbon heater, carbon foam heater, a radio-frequency heater, an electro-resistive heater, a halogen heater; for non-heating technology: vibration vaporiser, surface acoustic wave vaporiser, increased pressure vaporiser, electrostatic energy vaporiser, an ultrasonic vaporiser.
[0097] Nicotine & Acid
[0098] As discussed herein the present disclosure provides a aerosolisable formulation comprising (i) a carrier; (ii) nicotine in unprotonated form and in protonated form; and (iii) one or more acids, wherein at least benzoic acid, levulinic acid or a mixture thereof is present; and wherein the total content of acid present in the solution is no greater than 0.6 mole equivalents based on the nicotine.
[0099] We have found that, in some examples, by protonating the nicotine present in the formulation, the formulation when vaporised and inhaled provide means of modulating flavour, impact, irritation, smoothness and / or nicotine reward for the user. This may further accentuate the affects of the extract composition comprised within the formulation. We have particularly found that the levels of acid addition required by the present disclosure, namely wherein the total content of acid present in the formulation is no less than 0.6 mole equivalents based on the nicotine and no greater than 1.4, may be used across a broad range of nicotine content solutions. At the levels of acid addition required by the present disclosure formulations may be provided having desirable properties of flavour, impact, irritation, smoothness and / or nicotine reward for the user both when the nicotine content is relatively low, such as 1.8 wt% nicotine or less and when the nicotine content is relatively high, such as greater than 1.8wt% nicotine.
[0100] As is understood by one skilled in the art, nicotine may exist in unprotonated form,monoprotonated form or diprotonated form. The structures of each of these forms are given below.
[0101]
[0102] Unprotonated nicotine monoprotonated nicotine diprotonated nicotine
[0103] Reference in the specification to protonated form means both monoprotonated nicotine and diprotonated nicotine. Reference in the present disclosure to amounts in the protonated form means the combined amount of monoprotonated nicotine and diprotonated nicotine. Furthermore, when reference is made to a fully protonated formulation it will be understood that at any one time there may be very minor amounts of unprotonated nicotine present, e.g. less than 1% unprotonated.
[0104] In some examples, we have found that protonating all or substantially all of the nicotine present in the aerosolisable formulation desirable characteristics in terms of flavour, impact, irritation, smoothness and / or nicotine reward for the user are observed. In some examples, all or substantially all of the nicotine present in the aerosolisable formulation is in protonated form when one or more acids are added to the aerosolisable formulation in an amount of 1.0 to 1.4 mole equivalents based on the nicotine. In some examples the aerosolisable formulation consists of nicotine in monoprotonated form. In some examples, it is envisaged that the aerosolisable formulation may comprise nicotine in monoprotonated form, but it may be that small amounts of diprotonated nicotine are also present. In some examples, the aerosolisable formulation comprises of or consists of nicotine in in monoprotonated form and in diprotonated form.
[0105] In some examples from 80 to 100 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 85 to 100 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 90 to 100 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 95 to 100 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 96 to 100 wt% of the nicotine present in the aerosolisable formulation isin protonated form. In some examples from 97 to 100 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 98 to 100 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 99 to 100 wt% of the nicotine present in the aerosolisable formulation is in protonated form.
[0106] In some examples from 80 to 99 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 85 to 99 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 90 to 99 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 95 to 99 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 96 to 99 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 97 to 99 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 98 to 99 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 80 to 98 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 85 to 98 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 90 to 98 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 95 to 98 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 96 to 98 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 97 to 98 wt% of the nicotine present in the aerosolisable formulation is in protonated form.
[0107] In the context of the present disclosure, reference to an aerosolisable formulation comprising nicotine in both protonated form and in unprotonated form generally means that the amount of nicotine in unprotonated form is not minimal. For example, the amount of non-protonated nicotine is typically greater than 1% w / w.
[0108] In some examples, the aerosolisable formulation comprises nicotine in unprotonated form and nicotine in protonated form. In some examples, the aerosolisable formulation comprises nicotine in unprotonated form and nicotine in protonated form. In some examples the aerosolisable formulation comprises nicotine in unprotonated form and nicotine in monoprotonated form. In some examples, it is envisaged that the aerosolisable formulation may comprise nicotine in unprotonated form and nicotine in monoprotonated form, it may be that small amounts of diprotonated nicotine are also present. In some examples, the aerosolisable formulation comprises nicotine in unprotonated form, nicotine in monoprotonated form and nicotine in diprotonated form.In some examples, we have found that by protonating a portion of the nicotine with additional acid and only a portion of the nicotine desirable characteristics are observed.
[0109] In some examples from 50 to 95 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 60 to 95 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 70 to 95 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 80 to 95 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 85 to 95 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 90 to 95 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 50 to 90 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 60 to 90 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 70 to 90 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 80 to 90 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 85 to 90 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 50 to 85 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 60 to 85 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 70 to 85 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 80 to 85 wt% of the nicotine present in the aerosolisable formulation is in protonated form.
[0110] In some examples from 1 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 2 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 3 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 4 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 10 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 15 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 20 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 25 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 30 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 35 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from40 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 45 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 50 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 55 to 80 wt% of the nicotine present in the aerosolisable formulation is in protonated form.
[0111] In some examples from 5 to 75 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 70 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 65 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 60 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 55 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 50 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 45 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 40 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 35 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 30 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 25 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 20 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 15 wt% of the nicotine present in the aerosolisable formulation is in protonated form. In some examples from 5 to 10 wt% of the nicotine present in the aerosolisable formulation is in protonated form.
[0112] The relevant amounts of nicotine which are present in the aerosolisable formulation in protonated form are specified herein. These amounts may be readily calculated by one skilled in the art. Nicotine, 3-(1-methylpyrrolidin-2-yl) pyridine, is a diprotic base with pKa of 3.12 for the pyridine ring and 8.02 for the pyrrolidine ring It can exist in pH-dependent protonated (mono- and di-) and non-protonated (free base) forms which have different bioavailability.
[0113] ^'ifssSsiSasis
[0114] fife fiXiS?
[0115]
[0116] ^3^3The distribution of protonated and non-protonated nicotine will vary at various pH increments.
[0117]
[0118] The fraction of non-protonated nicotine will be predominant at high pH levels whilst a decrease in the pH will see an increase of the fraction of protonated nicotine (mono- or di- depending on the pH). If the relative fraction of protonated nicotine and the total amount of nicotine in the sample are known, the absolute amount of protonated nicotine can be calculated.
[0119] The relative fraction of protonated nicotine in aerosolisable formulation can be calculated by using the Henderson-Hasselbalch equation, which describes the pH as a derivation of the acid dissociation constant equation, and it is extensively employed in chemical and biological systems. Consider the following equilibrium:
[0120] B
[0121]
[0122] + H" BH*
[0123] The Henderson-Hasselbalch equation for this equilibrium is:
[0124] pH = pKa + log
[0125]
[0126] Where [B] is the amount of non-protonated nicotine (i.e. free base), [BH+] the amount of protonated nicotine (i.e. conjugate acid) and pKa is the reference pKa value for the pyrrolidine ring nitrogen of nicotine (pKa=8.02). The relative fraction of protonated nicotine can be derived from the alpha value of the non-protonated nicotine calculated from the Henderson-Hasselbalch equation as:
[0127] [g]
[0128] ruu _I_1
[0129] % protonated nicotine = 100 — {- - — - * 100}
[0130] |1 +LgJ I
[0131]
[0132] I+[BH +]J
[0133] Determination of pKa values of aerosolisable formulations was carried out using the basic approach described in “Spectroscopic investigations into the acid-base properties of nicotineat different temperatures”, Peter M. Clayton, Carl A. Vas, Tam T. T. Bui, Alex F. Drake and Kevin McAdam, Anal. Methods, 2013,5, 81-88.
[0134] As will be understood by one skilled in the art, the protonated form of nicotine is prepared by reacting unprotonated nicotine with an added acid. As is clear from the present disclosure, one or more organic acids are added to the aerosolisable formulation in order to protonate nicotine. In some examples, the acids are one or more organic acids selected from the group consisting of acetic acid, lactic acid, formic acid, citric acid, benzoic acid, pyruvic acid, levulinic acid, succinic acid, tartaric acid, oleic acid, sorbic acid, propionic acid, phenylacetic acid, isobutyric acid, butyric acid, methylbutyric acid, 2-methylbutyric acid, 3-methylpentanoic acid, isovaleric acid, valeric acid, hexanoic acid, hepatanoic acid, octanoic acid, nonanoic acid, methylvaleric acid, decanoic acid, glycolic acid, 2-butenedioic acid (Z), 2-butenedioic acid (E), succinic acid, glyceric acid, malic acid, pyroglutamic acid, trihydroxybutanoic acid, tetrahydroxypentanoic acid, 2-keto-L-gluconic acid, quinic acid, gluconic acid, galactaric acid, hexadecanoic acid, caffeic acid, linoleic acid, linolenic acid, glucuronic acid, chlorogenic acid, fumaric acid, maleic acid, oxalic acid, oxaloacetic acid, acetoacetic acid, beta-hydroxybutyric acid, alpha-ketoglutaric acid, alpha-ketobutyric acid and combination thereof.
[0135] In some examples, the one or more organic acids are selected from the group consisting of acetic acid, heptanoic acid, isobutyric acid, isovaleric acid, methylbutyric acid, 3-methylpentanoic acid, methylvaleric acid, phenylacetic acid, valeric acid, butyric acid, decanoic acid and combinations thereof.
[0136] In some examples, the one or more organic acids are selected from the group consisting of acetic acid, isobutyric acid, isovaleric acid, methylbutyric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, heptanoic acid, 2-methylvaleric acid, and combinations thereof.
[0137] In some examples, the one or more organic acids are selected from the group consisting of acetic acid, isobutyric acid, isovaleric acid, methylbutyric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, and combinations thereof.
[0138] In some examples, the one or more organic acids are selected from the group consisting of isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, 2-methylbutyric acid, isobutyric acid, acetic acid and combinations thereof.
[0139] In some examples, the one or more organic acids consist of levulinic acid and one more organic acids selected from the group consisting of isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, 2-methylbutyric acid, isobutyric acid, acetic acid andcombinations thereof.
[0140] In some examples, the one or more organic acids are selected from the group consisting of isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, 2-methylbutyric acid, isobutyric acid, acetic acid, heptanoic acid, 2-methyl valeric acid, lactic acid, butyric acid and combinations thereof.
[0141] In some examples, the one or more organic acids consist of levulinic acid and one more organic acids selected from the group consisting of isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, 2-methylbutyric acid, isobutyric acid, acetic acid, heptanoic acid, 2-methyl valeric acid, lactic acid, butyric acid and combinations thereof.
[0142] In some examples, the one or more organic acids consist of benzoic acid and one more organic acids selected from the group consisting of isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, 2-methylbutyric acid, isobutyric acid, acetic acid, heptanoic acid, 2-methyl valeric acid, lactic acid, butyric acid, levulinic acid and combinations thereof.
[0143] In some examples, the one or more organic acids consist of benzoic acid and one more organic acids selected from the group consisting of acetic acid, heptanoic acid, isobutyric acid, isovaleric acid, methylbutyric acid, 3-methylpentanoic acid, methylvaleric acid, phenylacetic acid, valeric acid, butyric acid, decanoic acid and combinations thereof. In some examples, the one or more organic acids consist of levulinic acid and one more organic acids selected from the group consisting of acetic acid, heptanoic acid, isobutyric acid, isovaleric acid, methylbutyric acid, 3-methylpentanoic acid, methylvaleric acid, phenylacetic acid, valeric acid, butyric acid, decanoic acid and combinations thereof. In some examples, the one or more organic acids are selected from benzoic acid, levulinic acid, lactic acid and combinations thereof. In some examples, the one or more organic acids are selected from benzoic acid, levulinic acid and combination thereof. In some examples, the one or more organic acids are selected from benzoic acid, lactic acid and combination thereof. In some examples, the one or more organic acids are a combination of benzoic acid, levulinic acid and lactic acid. In some examples, the one or more organic acids are a combination of benzoic acid and levulinic acid. In some examples, the one or more organic acids are a combination of benzoic acid and lactic acid. In some examples, the organic acid is benzoic acid. In some examples, the organic acid is levulinic acid.
[0144] While the extract composition described herein may also comprise acids, for all intents and purposes of the present disclosure, the “one or more organic acids” described herein as being comprised within the aerosolisable formulation are in addition to any acid present in the extractcomposition. Reference to the molar equivalents of the “one or more organic acids” present in the aerosolisable formulation, with respect to the nicotine, is explicitly directed to the molar equivalence of the additional organic acids relevant to the nicotine content and not the acids derived from the extract composition.
[0145] According to the present disclosure, the total content of the one or more organic acids added to and present in the aerosolisable formulation is of from 0.6 to 1.4 mole equivalents based on the nicotine.
[0146] In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.7 to 1.4 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.7 to 1.3 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.8 to 1.3 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.8 to 1.2 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.9 to 1.2 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.9 to 1.1 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.8 to 1.4 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.9 to 1.4 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 1.0 to 1.4 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 1.1 to 1.4 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 1.2 to 1.4 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 1.3 to 1.4 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.6 to 1.3 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.6 to 1.2 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.6 to 1.1 mole equivalents based on the nicotine. In someexamples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.6 to 1.0 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.6 to 0.9 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.6 to 0.8 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is of from 0.6 to 0.7 mole equivalents based on the nicotine.
[0147] In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is 1.4 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is 1.0 mole equivalents based on the nicotine. In some examples, the total content of the one or more organic acids present in the aerosolisable formulation is 0.6 mole equivalents based on the nicotine.
[0148] In some examples, the amount of benzoic acid present in the aerosolisable formulation is of from 0.6 to 1.4 mole equivalents based on the nicotine. In some examples, the amount of benzoic acid present in the aerosolisable formulation is of from 0.7 to 1.4 mole equivalents based on the nicotine. In some examples, the amount of benzoic acid present in the aerosolisable formulation is of from 0.7 to 1.3 mole equivalents based on the nicotine. In some examples, the amount of benzoic acid present in the aerosolisable formulation is of from 0.8 to 1.3 mole equivalents based on the nicotine. In some examples, the amount of benzoic acid present in the aerosolisable formulation is of from 0.8 to 1.2 mole equivalents based on the nicotine. In some examples, the amount of benzoic acid present in the aerosolisable formulation is of from 0.9 to 1.2 mole equivalents based on the nicotine. In some examples, the amount of benzoic acid present in the aerosolisable formulation is of from 0.9 to 1.1 mole equivalents based on the nicotine. In some examples, the amount of benzoic acid present in the aerosolisable formulation is 1.4 mole equivalents based on the nicotine. In some examples, the amount of benzoic acid present in the aerosolisable formulation is 1.0 mole equivalents based on the nicotine. In some examples, the amount of benzoic acid present in the aerosolisable formulation is 0.6 mole equivalents based on the nicotine.
[0149] As discussed herein, we have found that the levels of acid addition required by the present disclosure may be used across a broad range of nicotine content aerosolisable formulations. Aerosolisable formulations may be provided having desirable properties of flavour, impact, irritation, smoothness and / or nicotine reward for the user both when the nicotine content is relatively low, such as 1.9 wt% or 1.8wt% nicotine or less and when the nicotine content isrelatively high, such as greater than 1.9 wt% or 1.8wt% nicotine. Thus in some examples the aerosolisable formulation comprises nicotine in an amount of no greater than 1.9 wt% or 1.8 wt% based on the total weight of the aerosolisable formulation. Thus in some examples the aerosolisable formulation comprises nicotine in an amount of greater than 1.9 wt% or 1.8 wt% based on the total weight of the aerosolisable formulation.
[0150] Nicotine may be provided at any suitable amount depending on the desired dosage when inhaled by the user. In some examples, nicotine is present in an amount of no greater than 20 wt% based on the total weight of the aerosolisable formulation. Nicotine may be provided at any suitable amount depending on the desired dosage when inhaled by the user. In some examples, nicotine is present in an amount of no greater than 15 wt% based on the total weight of the aerosolisable formulation. Nicotine may be provided at any suitable amount depending on the desired dosage when inhaled by the user. In some examples, nicotine is present in an amount of no greater than 10 wt% based on the total weight of the aerosolisable formulation. Nicotine may be provided at any suitable amount depending on the desired dosage when inhaled by the user. In some examples, nicotine is present in an amount of no greater than 6 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.01 to 6 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.1 to 6 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.2 to 6 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.3 to 6 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.4 to 6 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.6 to 6 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.8 to 6 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1 to 6 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1.8 to 6 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.01 to 5 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.1 to 5 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.2 to 5 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.3 to 5 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.4 to 5 wt% based on the total weight of the aerosolisable formulation. In someexamples, nicotine is present in an amount of from 0.6 to 5 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.8 to 5 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1 to 5 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1.8 to 5 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.01 to 4 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.1 to 4 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.2 to 4 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.3 to 4 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.4 to 4 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.6 to 4 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.8 to 4 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1 to 4 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1.8 to 4 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.01 to 3 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.1 to 3 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.2 to 3 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.3 to 3 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.4 to 3 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.6 to 3 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.8 to 3 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1 to 3 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1.8 to 3 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.01 to 2 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.1 to 2 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.2 to 2 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.3 to 2 wt% based on the totalweight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.4 to 2 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.6 to 2 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.8 to 2 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1 to 2 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1.2 to 2 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1.4 to 2 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1.4 to 2 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1.8 to 2 wt% based on the total weight of the aerosolisable formulation.
[0151] In some examples, nicotine is present in an amount of no greater than 1.9 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of no greater than 1.8 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.4 to 1.9 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.4 to 1.8 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.5 to 1.9 wt% based on the total weight of the aerosolisable formulation. In some examples nicotine is present in an amount of from 0.5 to 1.8 wt% based on the total weight of the aerosolisable formulation In some examples nicotine is present in an amount of from 0.8 to 1.9 wt% based on the total weight of the aerosolisable formulation.. In some examples, nicotine is present in an amount of from 0.8 to 1.8 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1 to 1.9 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1 to 1.8 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of less than 1.9 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of less than 1.8 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.4 to less than 1.9 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.4 to less than 1.8 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.5 to less than 1.9 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.5 to less than 1.8 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine ispresent in an amount of from 0.8 to less than 1.9 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 0.8 to less than 1.8 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1 to less than 1.9 wt% based on the total weight of the aerosolisable formulation. In some examples, nicotine is present in an amount of from 1 to less than 1.8 wt% based on the total weight of the aerosolisable formulation.
[0152] In some examples nicotine is present in an amount of less than 1.8 wt% and the acids present are only benzoic acid. Thus in some examples the present disclosure provides a aerosolisable formulation comprising (i) a carrier; (ii) nicotine in unprotonated form and in protonated form, wherein nicotine is present in an amount of less than 1.8 wt% based on the total weight of the aerosolisable formulation; and (iii) acid selected from the group consisting of benzoic acid; and wherein the total content of acid present in the aerosolisable formulation is no greater than 0.6 mole equivalents based on the nicotine. In this aspect the amount of benzoic acid present in the aerosolisable formulation may be from 0.1 to 0.6 mole equivalents based on the nicotine, such as from 0.1 to 0.5 mole equivalents based on the nicotine, such as from 0.2 to 0.6 mole equivalents based on the nicotine, such as from 0.1 to 0.4 mole equivalents based on the nicotine, such as from 0.3 to 0.6 mole equivalents based on the nicotine, such as from 0.2 to 0.5 mole equivalents based on the nicotine, such as from 0.3 to 0.5 mole equivalents based on the nicotine, such as from 0.2 to 0.4 mole equivalents based on the nicotine.
[0153] In one aspect the acid is present in an amount of no greater than 6 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.01 to 6 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.02 to 6 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.05 to 6 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.08 to 6 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.01 to 5 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.02 to 5 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.05 to 5 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.08 to 5 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of no greater than 4 wt% based on the aerosolisable formulation or based on the aerosol formulation. In oneaspect the acid is present in an amount of from 0.01 to 4 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.02 to 4 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.05 to 4 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.08 to 4 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of no greater than 3 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.01 to 3 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.02 to 3 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.05 to 3 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.08 to 3 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of no greater than 2 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.01 to 2 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.02 to 2 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.05 to 2 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.08 to 2 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of no greater than 1 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.01 to 1 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.02 to 1 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.05 to 1 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.08 to 1 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.1 to 1 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of no greater than 0.6 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.01 to 0.6 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.02 to 0.6 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid ispresent in an amount of from 0.05 to 0.6 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.08 to 0.6 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.1 to 0.6 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of no greater than 0.5 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.01 to 0.5 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.02 to 0.5 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.05 to 0.5 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.08 to 0.5 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of no greater than 0.2 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.01 to 0.2 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.02 to 0.2 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.05 to 0.2 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.08 to 0.2 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of no greater than 0.1 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.01 to 0.1 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.02 to 0.1 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.05 to 0.1 wt% based on the aerosolisable formulation or based on the aerosol formulation. In one aspect the acid is present in an amount of from 0.08 to 0.1 wt% based on the aerosolisable formulation or based on the aerosol formulation.
[0154] Extract Composition
[0155] There is provided herein a (extract) composition for use in an aerosolisable formulation to provide a tobacco aroma (flavour) and / or irritation to the mouth, nose and / or throat and thereby replicate the desired ‘FMC-like’ experience for a consumer. By the term “tobacco aroma” is meant an aroma that simulates the aroma from burning or smoking a cigarette containing tobacco. This aroma results from various volatile compounds naturally-present in the tobaccoand / or produced during curing, aging and / or processing of the tobacco leaves. Many of the compounds present in the extract composition of the present disclosure thus have a boiling point of less than 250°C and / or a molecular weight of about 50 to about 500 g / mol. The molecular weight is the ratio of the mass of a molecule to the unified atomic mass unit (as defined in the IIIPAC Gold Book); it is also referred to in the art as the relative molar mass. Hence, the compounds present in the extract composition of the present disclosure have the potential to be aerosolised when the extract composition is used in an aerosolisable formulation which is a non-combustible aerosol provision system or device, such as a heat-not-burn or vaping device or system.
[0156] As well as being used in a non-combustible substance delivery system, the composition of the present disclosure is not raw tobacco. As used herein, the term “raw tobacco” refers to any part of a plant of the Nicotiana species (e.g. leaf or stem) that has been harvested from the ground but not otherwise subjected to any processing steps.
[0157] This extract composition may be used in an aerosolisable formulation with or without a plant (e.g. tobacco) material. When used in combination with a tobacco material such as a tobacco extract, the extract may first be analysed for the presence of one or more of the compounds, and then supplemented with one or more compounds as disclosed herein - termed key tobacco flavour markers and key irritation markers - in order to improve the FMC-like flavour and / or sensation experience obtained when used in an aerosolisable formulation. That is, one or more of the compounds defined herein may be added to a tobacco extract, the tobacco extract optionally already containing one or more of the compounds defined herein.
[0158] It is also possible to add further compounds to the extract compositions. Such compounds may be absent from a tobacco extract, but present in smoke formed by burning the same tobacco used to form the extract, e.g. in a cigarette. These compounds are discussed further below and termed the ‘smoke markers’. Such compounds may also or alternatively, be absent from a tobacco extract, but present in aerosol formed by aerosolising the extract, by heat or another means. These compounds are discussed further below and termed the ‘aerosol markers’. This may, in some examples, further improve the cigarette-like experience provided by the extract composition of the present disclosure when used in an aerosolisable formulation.
[0159] Irritation Markers
[0160] In accordance with some aspects of the present disclosure, there is provided an extract composition for an aerosolisable formulation which comprises at least one compound (such as at least two or at least three compounds) selected from the list of key irritation markers setout above. This list is referred to herein as “the key irritation marker list”. These compounds are also shown in the table below together with their CAS No(s) and chemical structure. As noted above, in all aspects of the present disclosure, the disclosure includes, where appropriate, all enantiomers, tautomers, stereoisomers and geometric isomers of the compounds disclosed herein, as appropriate. Hence, where one enantiomer, tautomer, stereoisomer and / or geometric isomer is depicted or referenced herein, this is not to be construed as limiting. The table below also includes the compound class of each irritation marker.
[0161] Compound - Chemical Structure Compound CAS
[0162] Key Irritation Class No.
[0163] Markers _
[0164] myosmine; 3- C6 to C18 (4,5-Dihydro-1H- 1125- Substituted pyrrol-2- 96-8 Pyridine yl)pyridine and
[0165] 532- 12-7
[0166] p-cresol Me C7 to C18
[0167] 106- Substituted 44-5 Phenol HO'
[0168] Pyridine, 4- C6 to C18 ethenyl- Substituted Pyridine 100- 43-6
[0169] 2-cyclopenten-1- Ketone one, 2-hydroxy- 80-71- 3-methyl- 7
[0170] 1H-indole, 6- Indole methyl- 3420- Derivative 02-8
[0171]
[0172] Nicotyrine C6 to C18
[0173] Substituted Pyridine 487- 19-4
[0174] Propanoic acid, o Ketone 2-oxo, methyl
[0175] 600- ester
[0176] 22-6
[0177] o
[0178] Propanoic acid, o C3 to C24 2-methyl- Carboxylic acid 79-31- 2
[0179] 2-Cyclopenten-1- Ketone one, 3-methyl- 2758- 18-1
[0180] D- Limonene Monoterpene
[0181] 5989- 27-5
[0182] 6-Ethyl-5,6- C4 to C18 dihydro-2H- 19895- Lactone pyran-2-one 35-3
[0183] Phenol Phenol 108- 95-2
[0184] Phenol, 4-ethyl- C7 to C18
[0185] 123- Substituted 07-9 Phenol
[0186] Propanoic acid C3 to C24
[0187] 79-09- Carboxylic acid 4
[0188]
[0189] Styrene Substituted 100- Benzene 42-5
[0190] Benzene, 1,3- Substituted dimethyl- 108- Benzene 38-3
[0191] 3-Pyridinol .OH C6 to C18
[0192] Substituted 109- Pyridine 00-2
[0193] 2,3- 0 H C7 to C18 Dimethoxyphenol Substituted 5150- Phenol 42-5
[0194] 2- Ketone Pentadecanone, 502- 6,10,14- 69-2
[0195] tri methyl- 2-Cyclopenten-1- Ketone one, 3-ethyl-2- 21835- hydroxy- 01-8
[0196]
[0197] In some examples, the extract composition comprises at least four compounds selected from the key irritation marker list. In some examples, the extract composition comprises at least five compounds selected from the key irritation marker list. In some examples, the extract composition comprises at least six compounds selected from the key irritation marker list. In some examples, the extract composition comprises at least seven compounds selected from the key irritation marker list. In some examples the extract composition comprises at least eight compounds selected from the key irritation marker list. In some examples the extract composition comprises at least nine compounds selected from the key irritation marker list. In some examples the extract composition comprises at least ten compounds selected from the key irritation marker list.
[0198] In some examples, the extract composition comprises all of the compounds selected from the key irritation marker list.In some examples, the extract composition comprises limonene, and at least two compounds selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; and Nicotyrine.
[0199] In some examples, the extract composition comprises limonene, and at least two compounds selected from: Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; and Phenol.
[0200] In some examples, the extract composition comprises limonene, and at least two compounds selected from: Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; and 2,3-Dimethoxyphenol.
[0201] In some examples, the extract composition comprises limonene, and at least two compounds selected from: 2-Pentadecanone, 6, 10, 14-tri methyl-; 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-; myosmine; p-cresol; Pyridine, 4-ethenyl-; and 2-cyclopenten-1-one, 2-hydroxy-3-methyl-.
[0202] In some examples, the extract composition comprises limonene, and at least two compounds selected from: 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; and 2-Cyclopenten-1-one, 3-methyl-;.
[0203] In some examples, the extract composition comprises limonene, and at least two compounds selected from: 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; and Benzene, 1,3-dimethyl-.
[0204] In some examples, the extract composition comprises limonene, and at least two compounds selected from: 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; 2-Cyclopenten-1-one, 3-ethyl-2- hydroxy-; myosmine; and p-cresol.
[0205] In some examples, the extract composition comprises limonene, and at least two compounds selected from: Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; and Propanoic acid, 2-methyl-.
[0206] In some examples, the extract composition comprises limonene, and at least two compounds selected from: 2-Cyclopenten-1-one, 3-methyl-; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; and Propanoic acid.
[0207] In some examples, the extract composition comprises limonene, and at least two compounds selected from: Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-.In some examples, the extract composition comprises limonene, and at least two compounds selected from myosmine; nicotyrine; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol. In some examples, the extract composition comprises limonene; myosmine; and nicotyrine.
[0208] In some examples, the extract composition comprises at least two irritation markers selected from 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl-5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-, methyl ester. In some examples, the extract composition comprises at least three irritation markers selected from 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl-5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo, -methyl ester. In some examples, the extract composition comprises at least four irritation markers selected from 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl-5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-, methyl ester. In some examples, the extract composition comprises at least five irritation markers selected from 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl-5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-, methyl ester. In some examples, the extract composition comprises 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl-5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-, methyl ester. In all of the above examples, the extract composition may further comprise myosmine, nicotyrine, and / or phenol.
[0209] In some examples, the extract composition further comprises one or more compounds selected from 3-methyl Pentanoic acid, and cotinine. Such compounds may be considered as additional irritation markers. In some examples, the extract composition further comprises two or more compounds selected from 3-methyl Pentanoic acid, 2-pyrrolidinone and cotinine. In some examples the extract composition further comprises 3-methyl Pentanoic acid.
[0210] In some examples, the extract composition comprises limonene, and at least two compounds selected from myosmine; nicotyrine; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol, and one or more compounds selected from 3-methyl Pentanoic acid, and cotinine. In some examples, the extract composition comprises limonene, and at least two compounds selected from myosmine, nicotyrine, 6-ethyl-5,6-dihydro-2H-pyran-2-one, and phenol, and two or more compounds selected from 3-methyl Pentanoic acid, and cotinine. In some examples the extract composition comprises limonene, and at least two compounds selected from myosmine, nicotyrine, 6-ethyl-5,6-dihydro-2H-pyran-2-one, and phenol, and each of 3-methyl Pentanoic acid, and cotinine.In some examples, the extract composition comprises limonene, and at least three compounds selected from myosmine; nicotyrine; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol, and one or more compounds selected from 3-methyl Pentanoic acid, and cotinine. In some examples, the extract composition comprises limonene, and at least three compounds selected from myosmine, nicotyrine, 6-ethyl-5,6-dihydro-2H-pyran-2-one, and phenol, and two or more compounds selected from 3-methyl Pentanoic acid, 2-pyrrolidinone and cotinine. In some examples the extract composition comprises limonene, and at least three compounds selected from myosmine, nicotyrine, 6-ethyl-5,6-dihydro-2H-pyran-2-one, and phenol, and each of 3-methyl Pentanoic acid, and cotinine.
[0211] In some examples, the extract composition comprises myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol, and one or more compounds selected from 3-methyl Pentanoic acid, and cotinine. In some examples, the extract composition comprises myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol, and two or more compounds selected from 3-methyl Pentanoic acid, 2-pyrrolidinone and cotinine. In some examples, the extract composition comprises myosmine; nicotyrine; limonene; 6-ethyl- 5,6-dihydro-2H-pyran-2-one; phenol, 3-methyl Pentanoic acid, and cotinine.
[0212] In some examples, the extract composition comprises limonene; myosmine; and nicotyrine. In some examples, the extract composition comprises limonene; myosmine; nicotyrine, and one or more compounds selected from 3-methyl Pentanoic acid, and cotinine. In some examples, the extract composition comprises limonene; myosmine; nicotyrine, and two or more compounds selected from 3-methyl Pentanoic acid, 2-pyrrolidinone and cotinine. In some examples, the extract composition comprises limonene; myosmine; nicotyrine, and 3-methyl Pentanoic acid.
[0213] In some examples, the extract composition comprises at least two irritation markers selected from 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl- 5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-, methyl ester, and one or more compounds selected from 3-methyl pentanoic acid, 2-pyrrolidinone, and cotinine. In some examples, the extract composition comprises at least three irritation markers selected from 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl- 5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-methyl ester, and one or more compounds selected from 3-methyl pentanoic acid, 2-pyrrolidinone, and cotinine. In some examples, the extract composition comprises at least four irritation markers selected from 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl- 5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-methyl ester, and one or more compounds selected from 3-methyl pentanoic acid, 2-pyrrolidinone, and cotinine. Insome examples, the extract composition comprises at least five irritation markers selected from 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl-5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-methyl ester, and one or more compounds selected from 3-methyl pentanoic acid, 2-pyrrolidinone, and cotinine. In some examples, the extract composition comprises 2,3-dimethoxyphenol; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 3-pyridinol; 6-ethyl-5,6-dihydro-2H-pyran-2-one; propanoic acid; and propanoic acid, 2-oxo-methyl ester, and one or more compounds selected from 3-methyl pentanoic acid, 2-pyrrolidinone, and cotinine. In all of the above examples, the extract composition may further comprise myosmine, nicotyrine, and / or phenol.
[0214] In some examples, the concentration of each irritation marker defined herein in the extract composition is from about 1 ng / uL to about 300 ng / uL. In some examples, the concentration of each irritation marker defined herein in the extract composition is from about 5 ng / uL to about 300 ng / uL. In some examples the total concentration of irritation markers defined herein in the extract composition is from about 500 to about 2000 ng / uL.
[0215] In some examples, the concentration of limonene in the extract composition is from about 1 ng / uL to about 50 ng / uL. In some examples, the concentration of limonene in the extract composition is from about 1 ng / uL to about 25 ng / uL. In some examples, the concentration of limonene in the extract composition is from about 5 ng / uL to about 15 ng / uL.
[0216] In some examples, the extract composition comprises myosmine and the concentration of myosmine in the extract composition is from about 1 ng / uL to about 250 ng / uL. In some examples, the concentration of myosmine in the extract composition is from about 10 ng / uL to about 200 ng / uL. In some examples, the concentration of myosmine in the extract composition is from about 25 ng / uL to about 150 ng / uL.
[0217] In some examples, the extract composition comprises nicotyrine and the concentration of nicotyrine in the extract composition is from about 1 ng / uL to about 250 ng / uL. In some examples, the concentration of nicotyrine in the extract composition is from about 10 ng / uL to about 200 ng / uL. In some examples, the concentration of nicotyrine in the extract composition is from about 25 ng / uL to about 150 ng / uL.
[0218] In some examples, the extract composition comprises 6-ethyl-5,6-dihydro-2H-pyran-2-one and the concentration of 6-ethyl-5,6-dihydro-2H-pyran-2-one in the extract composition is from about 1 ng / uL to about 250 ng / uL. In some examples, the concentration of 6-ethyl-5,6-dihydro-2H-pyran-2-one in the extract composition is from about 10 ng / uL to about 200 ng / uL. In someexamples, the concentration of 6-ethyl-5,6-dihydro-2H-pyran-2-one in the extract composition is from about 25 ng / uL to about 150 ng / uL.
[0219] In some examples, the extract composition comprises phenol and the concentration of phenol in the extract composition is from about 1 ng / uL to about 150 ng / uL. In some examples, the concentration of phenol in the extract composition is from about 1 ng / uL to about 100 ng / uL. In some examples, the concentration of phenol in the extract composition is from about 5 ng / uL to about 50 ng / uL.
[0220] The skilled person will appreciate that the above concentrations may be combined when the extract composition includes the named compounds in combination with one another according to the above-described examples.
[0221] When incorporated into an aerosolisable formulation, the extract composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly relative to the total weight of the aerosolisable formulation. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. The concentration values ng / uL may be converted into wt%, based on the total weight of the aerosolisable formulation, as follows:
[0222] g / mL = ng / uL x 10-6
[0223] % w / w compound in extract composition = (g / mL / (extract composition density in g / mL) x 100)
[0224] % w / w compound in aerosolisable formulation = (% w / w of compound in extract composition) / wt% extract composition in aerosolisable formulation (e.g. 5, 8, 10, 15, 20, 25 and 30 wt%).
[0225] Tobacco Flavour Markers
[0226] In accordance with some aspects of the present disclosure, there is provided an extract composition for an aerosolisable formulation, which comprises at least two compounds or at least three compounds selected from the list of key tobacco flavour markers as set out above. These compounds are referred to herein as the key tobacco flavour marker list, and are shown in the table below together with their CAS No(s) and chemical structure. As noted above, in all aspects of the present disclosure, the disclosure includes, where appropriate, all enantiomers, tautomers, stereoisomers and geometric isomers of the compounds disclosed herein, as appropriate. Hence, where one enantiomer, tautomer, stereoisomer and / or geometric isomer is depicted or referenced herein, this is not to be construed as limiting. The table below also includes the compound class of each irritation marker.Compound - Chemical Structure Compound Class CAS
[0227] Tobacco Flavour
[0228] No.
[0229] Markers
[0230] C3 to C24 carboxylic acid 116- Methylbutyric acid
[0231] 53-0
[0232] C7 to C18 aromatic 120- aldehyde / acetal Piperonal
[0233] 57-0
[0234] Indole
[0235] 120- Indole
[0236] 72-9
[0237] C7 to C18 aromatic 121- aldehyde / substitute Ethyl vanillin
[0238] 32-4 d phenol
[0239] C7 to C18 aromatic 121- aldehyde / substitute Vanillin
[0240] 33-5 d phenol
[0241] Ketone Methylacetophenon 122- e 00-9
[0242] C7 to C18 aromatic 122- aldehyde Phenylacetaldehyde
[0243] 78-1
[0244] C7 to C18 aromatic 123- aldehyde Anisaldehyde
[0245] 11-5
[0246] 124- Aliphatic aldehyde Nonanal
[0247] 19-6
[0248] C7 to C18 2785 substituted phenol Ethylguaiacol
[0249] -89-9
[0250]
[0251]
[0252] In some examples, the extract composition comprises at least two compounds selected from the key tobacco flavour marker list. In some examples, the extract composition comprises at least three compounds selected from the key tobacco flavour marker list. In some examples, the extract composition comprises at least four compounds selected from the key tobacco flavour marker list. In some examples, the extract composition comprises at least five compounds selected from the key tobacco flavour marker list. In some examples, the extract composition comprises at least six compounds selected from the key tobacco flavour markerlist. In some examples, the extract composition comprises at least seven compounds selected from the key tobacco flavour marker list. In some examples the extract composition comprises at least eight compounds selected from the key tobacco flavour marker list. In some examples the extract composition comprises at least nine compounds selected from the key tobacco flavour marker list. In some examples the extract composition comprises at least ten compounds selected from the key tobacco flavour marker list.
[0253] In some examples, the extract composition comprises all of the compounds selected from the key tobacco flavour marker list.
[0254] In some examples, the extract composition comprises at least three compounds selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; and Methylacetophenone.
[0255] In some examples, the extract composition comprises at least three compounds selected from: Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; and Eucalyptol.
[0256] In some examples, the extract composition comprises at least three compounds selected from: Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; and Piperitone.
[0257] In some examples, the extract composition comprises at least three compounds selected from: Guaiacol; Terpineol; Methylbutyric acid; Piperonal; indole; and ethyl vanillin.
[0258] In some examples, the extract composition comprises at least three compounds selected from: vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; and Ethylguaiacol.
[0259] In some examples, the extract composition comprises at least three compounds selected from: alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; and Methoxyvinylphenol.
[0260] In some examples, the extract composition comprises at least three compounds selected from: Linalool; Piperitone; Guaiacol; Terpineol; methylbutyric acid; and Piperonal.
[0261] In some examples, the extract composition comprises at least three compounds selected from: indole; ethyl vanillin; vanillin; methylacetophenone; Phenylacetaldehyde; and anisaldehyde.In some examples, the extract composition comprises at least three compounds selected from Nonanal; Ethylguaiacol; alpha-linolenic acid; eucalyptol; isovaleric acid; and 2,3-pentanedione.
[0262] In some examples, the extract composition comprises at least three compounds selected from: Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol.
[0263] In some examples, the extract composition comprises guaiacol.
[0264] In some examples, the extract composition comprises at least three compounds selected from phenylacetaldehyde, methylbutyric acid, isovaleric acid, indole, and guaiacol.
[0265] In some examples, the extract composition comprises at least three compounds selected from methylbutyric acid, isovaleric acid, methylacetophenone, guaiacol, and linolenic acid. In some examples, the extract composition comprises at least four compounds selected from methylbutyric acid, isovaleric acid, methylacetophenone, guaiacol, and linolenic acid.
[0266] In some examples, the extract composition further comprises one or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-,, n-hexadecanoic acid, and octadecanoic acid. Such compounds may be considered as additional tobacco flavour markers. In some examples, the extract composition further comprises two or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples the extract composition further comprises three or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition further comprises four or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition further comprises five or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition further comprises six or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoicacid. In some examples, the extract composition further comprises seven or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition further comprises eight or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples the extract composition further comprises acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid.
[0267] In some examples, the extract composition comprises at least three compounds selected from indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol. In some examples, the extract composition comprises indole; alpha-linolenic acid and methoxyvinyl phenol. In some examples, the extract composition comprises indole; alpha-linolenic acid, and guaiacol. In some examples, the extract composition comprises alpha-linolenic acid, methoxyvinylphenol and guaiacol. In some examples, the extract composition comprises indole, methoxyvinylphenol, and guaiacol.
[0268] In some examples, the extract composition comprises at least three compounds selected from indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol and one or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition comprises at least three compounds selected from indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol and two or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition comprises at least three compounds selected from indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol and three or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition comprises at least three compounds selected from indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol and four or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl,benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone, 5,6,7, 7a-tetrahydro-4, 4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid.
[0269] In some examples, the extract composition comprises indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol and one or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition comprises indole; alphalinolenic acid; methoxyvinylphenol; and guaiacol and two or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition comprises indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol and three or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone, 5,6,7, 7a-tetrahydro-4, 4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition comprises indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol and four or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid.
[0270] In some examples, the extract composition comprises indole; alpha-linolenic acid; methoxyvinylphenol; guaiacol; acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone, 5,6,7, 7 a- tetra hydro-4,4, 7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid.
[0271] In some examples, the extract composition comprises guaiacol and one or more compounds selected from: acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition comprises guaiacol and two or more compounds selected from: acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition comprises guaiacol and three or more compounds selected from: acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone, 5,6,7, 7a-tetrahydro-4, 4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extractcomposition comprises guaiacol and four or more compounds selected from: acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition comprises guaiacol and five or more compounds selected from: acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone, 5,6,7, 7 a- tetra hydro-4,4, 7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid.
[0272] In some examples, the extract composition comprises acetic acid, 2-furanmethanol, 2-furancarboxyaldehyde, 5-methyl-, 2-methoxyphenol, n-hexadecanoic acid, octadecanoic acid, and guaiacol.
[0273] In some examples, the concentration of each tobacco flavour marker listed herein in the extract composition is from about 2 ng / uL to about 300 ng / uL. In some examples the total concentration of tobacco flavour markers in the extract composition is from about 500 to about 3000 ng / uL. When incorporated into an aerosolisable formulation, the extract composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly relative to the total weight of the aerosolisable formulation.
[0274] In some examples, the extract composition comprises alpha-linolenic acid. The concentration of alpha-linolenic acid may be about 2 ng / uL to about 300 ng / uL. In some examples, the concentration of alpha-linolenic acid is about 2 to about 10 ng / uL. When incorporated into a aerosolisable formulation, the extract composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly relative to the total weight of the aerosolisable formulation.
[0275] In some examples, the extract composition comprises 2-furancarboxyladehyde, 5-methyl-. The concentration of 2-furancarboxyladehyde, 5-methyl- may be about 2 ng / uL to about 300 ng / uL. In some examples, the concentration of 2-furancarboxyladehyde, 5-methyl- is about 10 to about 75 ng / uL.
[0276] When incorporated into a aerosolisable formulation, the extract composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly relative to the total weight of the aerosolisable formulation. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. The concentration values ng / uL may be converted into wt%, based on the total weight of the aerosolisable formulation, as follows:
[0277] g / mL = ng / uL x 10'6% w / w compound in extract composition = (g / mL / (extract composition density in g / mL) x 100)
[0278] % w / w compound in aerosolisable formulation = (% w / w of compound in extract composition) / wt% extract composition in aerosolisable formulation (e.g. 5, 8, 10, 15, 20, 25 and 30 wt%).
[0279] Plant Extracts
[0280] In some examples, one or more of the compounds are obtained by extraction from a natural source, e.g. a tobacco source. Also provided herein is a method for forming the extract composition, the method comprising contacting a tobacco material with a solvent, and extracting one or more of the compounds from the tobacco into the solvent.
[0281] The present disclosure is not, however, limited to obtaining one or more compounds via an extraction method. The present disclosure includes the formulation of a partially or totally synthetic or artificial extract composition. In some examples, at least one of the compounds may be a synthetic compound. In this manner, the extract composition may include one or more compounds which are naturally derived, e.g. from a tobacco source, and one or more compounds which are synthetic (e.g. obtained commercially or otherwise synthesised).
[0282] In some examples, the total number of chemical compounds present in the extract composition is less than about 800, such as less than about 600, or less than about 500. By total number of chemical compounds is meant the number of different chemical compounds present at a detectable level by e.g. GC-MS.
[0283] In some examples, the total content of any one of the tobacco-specific nitrosamines (TSNAs) in the extract composition, namely N-nitrosonornicotine (NNN), N’-nitrosoanatabine (NAT), N-nitrosoanabasine (NAB) and nicotine-derived nitrosamine ketone (NNK), is less than about 4 pg / g. This may be an indication that at least one compound is obtained from a tobacco extract.
[0284] In some examples, the extract composition may include formaldehyde and / or acetaldehyde. This may be an indication that at least one compound is obtained from a tobacco extract. The amount of formaldehyde and / or acetaldehyde is less than about 4 pg / g.
[0285] In some examples, the extract composition may include at least one plant material, optionally wherein the plant material is a tobacco extract. The tobacco extract may include one or more of the compounds defined above for the extract composition. The disclosures made herein in relation to the compounds thus apply equally to a tobacco extract comprising one or more of said compounds. In other examples, one or more of said compounds may be added to the tobacco extract to form a extract composition of the present disclosure. In some examples, the extract composition is a tobacco extract.When present or used to obtain one or more compounds of the composition, any tobacco extract may be used. In some examples, the tobacco extract may be an extract of Virginia tobacco, Burley tobacco, Oriental tobacco, Dark tobacco, or a combination thereof. In some examples, the tobacco extract comprises an extract of Virginia tobacco. The tobacco may be cured; in some examples, the tobacco is cured. Cured tobacco may be flue-cured, air-cured and / or sun-cured. In some examples, the tobacco extract comprises an extract of flue-cured Virginia tobacco.
[0286] In some examples, the tobacco from which one or more compounds may be extracted (referred to herein as raw tobacco) may include tobacco leaf. In some examples, the tobacco leaf may be defined by its nicotine content. In some examples, the nicotine content of the tobacco leaf may be from about 0.5 to about 8.0 wt%, based on the total weight of the leaf. In some examples, the nicotine content of the tobacco leaf may be from about 0.8 to about 7.5 wt%, based on the total weight of the leaf. In some examples, the nicotine content of the tobacco leaf may be from about 1.5 to about 7.5 wt%, based on the total weight of the leaf.
[0287] In some examples, the tobacco leaf may be defined by its sugar content. Exemplary nicotine and sugar contents for flue-cured Virginia tobacco are about 0.9 to about 5.5 wt% nicotine and about 4 to about 25 wt% sugar. Exemplary nicotine and sugar contents for air-cured Burley tobacco are about 1.5 to about 6.5 wt% nicotine and less than about 1 to about 2 wt% sugar. Exemplary nicotine and sugar contents for sun-cured Oriental tobacco are about 0.5 to about 3.0 wt% nicotine and about 8 to about 12 wt% sugar. Exemplary nicotine and sugar contents for fire-cured dark tobacco are about 2.5 to about 6 wt% nicotine and less than about 1 to about 2 wt% sugar.
[0288] In some examples, the tobacco extract is obtained from cured Virginia tobacco, cured Burley tobacco, cured Oriental tobacco, cured Dark tobacco, or a combination thereof. In some examples, the tobacco extract is obtained from flue-cured Virginia tobacco, air-cured Burley tobacco, sun-cured Oriental tobacco, fire-cured Dark tobacco, or a combination thereof. The solvent extraction method disclosed herein for forming the composition is not particularly limited. It may be a simultaneous distillation extraction method, a supercritical fluid extraction method or a combination thereof. Other extraction methods are also known including maceration, percolation or hot reflux or Soxhlet extraction, or microwave extraction. The method may also include further steps such as filtration, fractionation, pyrolysis, adsorption, distillation and / or purification. Extraction methods are provided in WO 2026 / 021165 A1, US 2026 / 0053181 A1, WO 2026 / 026620 A1, WO 2026 / 045589 A1, and WO 2026 / 045587 A1 which are herein incorporated by reference for such methods. Hot reflux and microwaveextraction are described in WO 2026 / 045589 A1 and WO 2026 / 045587 A1 (Shenzhen Smoore Technology LTD), which are herein incorporated by reference for such methods. For example, a hot reflux extraction method is disclosed using an SF-2L small-scale reflux apparatus. In this method, tobacco leaves are placed in a round-bottom flask which is heated by an electric heating mantle. Evaporated ethanol and water are passed into a condenser and refluxed. The extraction temperature is 95°C and the extraction time is 120 minutes. After extraction, a filtrate is collected and the extract is concentrated using a rotary evaporator. Further examples of hot reflux extraction can be found in WO 2026 / 045587 A1.
[0289] Simultaneous distillation extraction is a technique in which the steps of isolation and extraction of certain compounds from a sample can be achieved simultaneously. In some example, a simultaneous distillation extraction (SDE) process can be used for forming tobacco extracts in which process comprises (i) providing a tobacco material, (ii) subjecting the tobacco material to steam distillation, and (iii) extracting one or more volatile compounds of interest from the tobacco material with a solvent, wherein the distillation step (ii) and extraction step (iii) are carried out simultaneously.
[0290] The method may comprise mixing a quantity of tobacco (e.g. ground tobacco) with water. This solution may have a pH of from about 5 to about 7, such as from about 5.5 to about 6.5. Glass beads may be added to prevent bumping. The solution may then be heated, for example, to a temperature of from about 100°C to about 130°C.
[0291] The distillation step (ii) and extraction step (iii) being carried out simultaneously means that in some examples, the SDE method may be carried out in a single step. In some examples, an additional distillation and / or extraction step is excluded. In some examples, the SDE method is carried out in a single apparatus with no additional processing prior to removal of the extracted product from the apparatus.
[0292] In some examples the solvent used for extraction is a non-polar solvent. In some examples the solvent used for extraction is a polar solvent. As used herein, the term “polar” refers to a solvent having a dielectric constant of greater than or equal to 15. As used herein, the term “non-polar” refers to a solvent having a dielectric constant of less than 15.
[0293] In some examples, the solvent is immiscible with water. In some examples, the solvent comprises an organic solvent. The term “organic” is understood in the art; it is typically considered to be a solvent comprising carbon. In some examples, the solvent is selected from: n-butanol, cyclohexane, dichloromethane, ethyl acetate, heptane, hexane, methyl-t-butyl ether, 2-butanone, pentane, diisopropyl ether, diethyl ether, and mixtures thereof. The use ofa mixture of pentane and ether is non-toxic and may be easily replaced by ethanol after extraction of the volatile compounds of interest has been achieved.
[0294] In some examples, further processing of the extracted product may be carried out. The further processing may comprise a purifying step which comprises replacing the solvent used for extraction with another solvent suitable for use in a composition as described herein. In some examples, such a purifying step comprises replacing the solvent used for extraction with ethanol.
[0295] In some examples a supercritical fluid extraction (SFE) process used for forming tobacco extracts is employed. The process may comprise contacting tobacco with an extraction solvent under supercritical conditions. In some examples, the extraction solvent comprises, or is, supercritical carbon dioxide. In some examples, no co-solvent is present.
[0296] In some examples, the SFE process is performed at a pressure of from about 50 to about 500 bar. In some examples, the temperature during extraction may range from about 25°C to about 90°C. In some examples, supercritical extraction is performed using a flow rate of extraction solvent of from about 0.5 to about 5 kg / hr. In some examples, the pressure is varied during the SFE process, for example to collect fractions having varying volatility. In such examples, a lower pressure (e.g. about 50 to about 200 bar) may be used for a first period of time, followed by a higher pressure (e.g. from about 200 to about 500 bar) for a second period of time. The first period of time may be from about 0.5 to about 2 hours. The second period of time may be from about 0.5 to about 2 hours. In some examples, the two fractions or extracts are combined. In some examples the two fractions or extracts are collected separately and not combined. In some examples, only the extract from the second extraction is retained and / or used in the present disclosure.
[0297] In some examples, the SFE process involves placing ground tobacco into a vessel (e.g. 260 g of ground tobacco into a 1L vessel) and using supercritical carbon dioxide as the extraction solvent at 1 kg / h. No co-solvent may be used. The pressure of the system is set to 100 to 300 bar and the temperature maintained at 60 degrees. The extracts are collected in two containers: one for the volatile fraction, one for the non-volatile fraction. The volatile fraction is collected first, pressure at 100 bar and for a period of 1 hour. The non-volatile fraction is collected second, the pressure being increased to 300 bar and extraction conducted for a period of 1.5 hours. Only the non-volatile fraction is retained for the present disclosure.
[0298] In some examples, the SFE process involves placing ground tobacco in a container (e.g., 260 g of ground tobacco in a 1 L container) and using supercritical carbon dioxide as an extractionsolvent at 1 kg / h and ethanol as a co-solvent (30%). The pressure of the system is set to 250 bar and the temperature maintained at 75 degrees. The extracts are collected for a period of 2 hours.
[0299] In accordance with some aspects of the present disclosure, there is provided a extract composition for an aerosolisable formulation , wherein the extract composition comprises a plant extract as defined herein, and at least two compounds from the combined list of key irritation markers and key tobacco flavour markers; namely myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-; methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol.
[0300] In some examples, the extract composition comprises at least three of the listed compounds. In some examples, the extract composition comprises at least four of the listed compounds. In some examples, the extract composition comprises at least five of the listed compounds. In some examples, the extract composition comprises at least six of the listed compounds. In some examples, the extract composition comprises at least seven of the listed compounds. In some examples, the extract composition comprises at least eight of the listed compounds. In some examples, the extract composition comprises at least nine of the listed compounds. In some examples, the extract composition comprises at least ten of the listed compounds.
[0301] In some examples, the extract composition comprises the key irritation markers as defined above.
[0302] In some examples, the extract composition comprises the key tobacco flavour markers as defined above.
[0303] In some examples, the extract composition comprises at least two compounds selected from: myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alphalinolenic acid; methoxyvinylphenol; and guaiacol. In some examples, the extract composition comprises at least three compounds selected from: myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol. In some examples, the extract composition comprises at least four compoundsselected from: myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol. In some examples, the extract composition comprises at least five compounds selected from: myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol. In some examples, the extract composition comprises at least six compounds selected from: myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol. In some examples, the extract composition comprises at least seven compounds selected from: myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alphalinolenic acid; methoxyvinylphenol; and guaiacol. In some examples, the extract composition comprises at least eight compounds selected from: myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol. In some examples, the extract composition comprises myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol.
[0304] Further combinations of markers applicable for all extract compositions of the present disclosure are disclosed below.
[0305] The above-defined concentrations for each irritation marker and each tobacco flavour marker apply equally to the extract composition comprising a plant extract. The above-defined concentrations for the total amount of irritation markers and total amount of tobacco flavour markers apply equally to the extract composition comprising a plant extract.
[0306] Tobacco Particles
[0307] In some examples, the composition may further comprise a plurality of solid tobacco particles. In some examples, the solid tobacco particles remain as distinct entities within the composition, such that the composition can be considered to be in the form of a heterogeneous mixture. For example, the solid tobacco particles may be at least partially suspended in the composition. As used herein, the term “at least partially suspended” means that the solid tobacco particles are distributed within the composition (e.g. a liquid composition), wherein the distribution of said particles within the formulation is not necessarily even. For example, the spatial distribution of the particles may be biased towards one portion of the composition. In some examples, the suspension of the particles may be enhanced by agitation, for example shaking or inversion, such as when comprised in an article and / or in a non-combustible aerosol provision system, including in use.In some examples the solid tobacco particles are visible, for example to the naked eye. It will be understood that the term “visible” as used herein means that the solid tobacco particles can be seen, e.g. when present in a composition according to the present disclosure, such as by a user. Thus, the presence of the solid tobacco particles in the composition of the present disclosure can be readily apparent to a user (e.g. of a substance provision system), such as by the presence of distinct, visible particles in said composition. By “the naked eye”, the term will be understood to mean that the solid tobacco particles can be seen e.g. by a user without magnification or other visual enhancement. In various examples, the solid tobacco particles are visible under ambient conditions, for example normal temperature (e.g. from about 15 °C to about 25 °C) and pressure (e.g. about 1 atm). In various examples, the tobacco particles may be visible in one or more stages of use but not all. For example, the tobacco particles may be visible in the composition as such. In further examples, the tobacco particles may be visible when the composition is comprised in an article. For example, the article may be partially or completely transparent such that the presence of the tobacco particles in the formulation in the article may be determined by a user by viewing the article. In some examples, the article may comprise at least a transparent portion, wherein the transparent portion may be configured so that the solid tobacco particles are visible to the naked eye, e.g. to a user of the article. In further examples, the tobacco particles may be visible when the composition is comprised in a substance delivery system. For example, the article and substance delivery system may each comprise at least a transparent portion wherein said transparent portions are arranged such that the tobacco particles are visible to the naked eye, e.g. to a user of the substance delivery system.
[0308] The size of the solid tobacco particles is not necessarily limited. In some examples, the solid tobacco particles have a size of at least about 50 pm, at least about 0.1 mm or at least about 0.5 mm. In some examples, the solid tobacco particles have a size of up to about 15 mm, up to about 10 mm or up to about 2 mm. In further examples, the solid tobacco particles have a size of from about 50 pm to about 15 mm, from about 0.1 mm to about 10 mm or from about 0.5 mm to about 2 mm. The particle size may be determined by sieving. For example, a recited lower particle size limit means that the particles will not pass through a sieve with a mesh size of said limit, and an upper particle size limit means that the particles will pass through a sieve with a mesh size of said limit. Thus, a particle size of at least 50 pm means that the particles are retained on a sieve with a 50 pm mesh. In another example, a particle size of up to about 15 mm means that the particles are not retained on a sieve (i.e. the particles pass through the sieve) with a 15 mm mesh.In some examples, at least about 80%, at least about 90%, at least about 95% or at least about 99% by weight of the solid tobacco particles have a size according to any of the foregoing examples.
[0309] The tobacco material from which the tobacco particles according to the present disclosure are obtained or obtainable from is not necessarily limited. For example, the tobacco material may be as described in any of the examples of tobacco / tobacco material described herein. In some examples, the tobacco material from which the tobacco particles are obtained or obtainable from may include tobacco leaf. In further examples the tobacco leaf may be defined by its nicotine and / or sugar content as described herein.
[0310] In some examples, the tobacco particles are obtained or obtainable by grinding a tobacco material, such as tobacco leaf. The means by which the tobacco material may be ground is not limited and a person of skill in the art of the present disclosure will be able to select suitable apparatus and / or methods for grinding a tobacco material such as tobacco leaf as part of their common general knowledge. In some examples, the tobacco particles are obtained or obtainable by mill grinding a tobacco material. For instance, using a cutting mill, examples of which are commercially available and known to a person of skill in the art. For instance, a FRITSCH PULVERISETTE 19 cutting mill. In some examples, tobacco particles are obtained or obtainable by grinding, such as mill grinding, a tobacco material and sieving the ground tobacco material, e.g. to obtain a particle size such as those disclosed herein. In some examples the sieving may be integrated into the grinding process, e.g. the grinding apparatus such as a cutting mill may comprise a sieve.
[0311] In some examples, the tobacco material from which the tobacco particles are obtained may have been processed. In some examples, the tobacco particles may be obtained or obtainable from a tobacco material that has been extracted with at least one solvent. For example, a waste or by-product of an extraction process such as disclosed in further detail herein. In advantageous examples, the tobacco material may have been ground, e.g. to form solid tobacco particles, prior to the extraction process such that the solid tobacco particles may be used directly after the extraction process in the composition of the present disclosure.
[0312] Combinations of Irritation and Tobacco Flavour Markers
[0313] The extract compositions of the present disclosure may include a combination of one or more key irritation markers as defined above and one or more key tobacco flavour markers as defined above.In some examples, the extract compositions of the present disclosure include at least three compounds selected from the key irritation markers as defined above, and at least one compound selected from the key tobacco flavour markers, namely methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.
[0314] In some examples, the extract composition comprises at least four compounds selected from the key irritation marker list, and at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.
[0315] In some examples, the extract composition comprises at least five compounds selected from the key irritation marker list, and at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.
[0316] In some examples, the extract composition comprises at least six compounds selected from the key irritation marker list, and at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.
[0317] In some examples, the extract composition comprises at least seven compounds selected from the key irritation marker list, and at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. Insome examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.
[0318] In some examples the extract composition comprises at least eight compounds selected from the key irritation marker list, and at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.
[0319] In some examples the extract composition comprises at least nine compounds selected from the key irritation marker list, and at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.
[0320] In some examples the extract composition comprises at least ten compounds selected from the key irritation marker list, and at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.
[0321] In some examples, the extract composition comprises all of the compounds selected from the key irritation marker list, and at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.
[0322] In some examples, the extract composition comprises at least three compounds selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol, and at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin;Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.
[0323] In some examples, the extract composition comprises limonene; myosmine; and nicotyrine, and at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the at least one compound is selected from indole, alpha-linolenic acid, methoxyvinylphenol, and guaiacol.
[0324] In some examples, the extract compositions of the present disclosure include at least three compounds selected from the key tobacco flavour markers as defined above, and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6,10, 14-tri methyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0325] In some examples, the extract compositions of the present disclosure include at least four compounds selected from the key tobacco flavour markers as defined above, and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6,10, 14-tri methyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0326] In some examples, the extract compositions of the present disclosure include at least five compounds selected from the key tobacco flavour markers as defined above, and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6,10, 14-tri methyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0327] In some examples, the extract compositions of the present disclosure include at least six compounds selected from the key tobacco flavour markers as defined above, and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6,10, 14-tri methyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0328] In some examples, the extract compositions of the present disclosure include at least seven compounds selected from the key tobacco flavour markers as defined above, and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6,10, 14-tri methyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0329] In some examples, the extract compositions of the present disclosure include at least eight compounds selected from the key tobacco flavour markers as defined above, and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6,10, 14-tri methyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0330] In some examples, the extract compositions of the present disclosure include at least nine compounds selected from the key tobacco flavour markers as defined above, and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1 H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6,10, 14-tri methyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0331] In some examples, the extract compositions of the present disclosure include at least ten compounds selected from the key tobacco flavour markers as defined above, and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1 H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6,10, 14-tri methyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0332] In some examples, the extract compositions of the present disclosure include all of the compounds from the key tobacco flavour markers as defined above, and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1 H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6,10, 14-tri methyl-; and 2-Cyclopenten- 1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0333] In some examples, the extract composition comprises at least three compounds selected from: indole; alpha-linolenic acid; methoxyvinyl phenol; and guaiacol; and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1 H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.In some examples, the extract composition comprises alpha-linolenic acid; methoxyvinyl phenol; and guaiacol; and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0334] In some examples, the extract composition comprises alpha-linolenic acid; methoxyphenol; and guaiacol; and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0335] In some examples, the extract composition comprises alpha-linolenic acid; and guaiacol; and at least one compound selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the at least one compound is selected from myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.
[0336] In any of the above examples, the extract composition may further comprise one or more compounds selected from 3-methyl Pentanoic acid, 2-pyrrolidinone and cotinine. Such compounds may be considered as additional irritation markers. In some examples, the extract composition further comprises two or more compounds selected from 3-methyl Pentanoic acid, 2-pyrrolidinone and cotinine. In some examples the extract composition further comprises 3-methyl Pentanoic acid, and 2-pyrrolidinone.In any of the above examples, the extract composition may further comprise one or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone, 5,6,7, 7a-tetrahydro-4, 4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. Such compounds may be considered as additional tobacco flavour markers. In some examples, the extract composition further comprises two or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples the extract composition further comprises three or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition further comprises four or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition further comprises five or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition further comprises six or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition further comprises seven or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples, the extract composition further comprises eight or more compounds selected from acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid. In some examples the extract composition further comprises acetic acid, 2-furan methanol, 2-furancarboxyaldehyde, 5-methyl, benzyl alcohol, phenol, phenethylalcohol, 2(4H)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, n-hexadecanoic acid, and octadecanoic acid.
[0337] The above-defined concentrations for each irritation marker and each tobacco flavour marker apply equally to the combinations of markers. The above-defined concentrations for the totalamount of irritation markers and total amount of tobacco flavour markers apply equally to the combinations of markers.
[0338] In examples where myosmine and phenol are present, the weight ratio of these compounds in the extract compositions of the present disclosure may be from about 1:1 to about 10:1.
[0339] In examples where myosmine and nicotyrine are present, the weight ratio of these compounds in the extract compositions of the present disclosure may from about 1:1 to about 10:1.
[0340] In examples where myosmine and limonene are present, the weight ratio of these compounds in the extract compositions of the present disclosure may from about 5:1 to about 40:1.
[0341] In examples where myosmine and 6-ethyl-5,6-dihydro-2H-pyran-2-one are present, the weight ratio of these compounds in the extract compositions of the present disclosure may be from about 1:4 to about 2:1.
[0342] In examples where methoxyvinylphenol and alpha-linolenic acid are present, the weight ratio of these compounds in the extract compositions of the present disclosure may be from about 1:1 to about 10:1.
[0343] In examples where guaiacol and alpha-linolenic acid are present, the weight ratio of these compounds in the extract compositions of the present disclosure may be about 1:1 to about 10:1.
[0344] In examples where indole and alpha-linolenic acid are present, the weight ratio of these compounds may be from about 1:1 to about 10:1.
[0345] The skilled person will appreciate that these weight ratios may be combined with one another in examples of the present disclosure.
[0346] In some examples, the total acid content of the extract composition is no greater than 1.0 mole equivalents based on the nicotine. In some examples, the total acid content of the extract composition is no greater than 0.9 mole equivalents based on the nicotine. In some examples, the total acid content of the extract composition is no greater than 0.8 mole equivalents based on the nicotine. In some examples, the total acid content of the extract composition is no greater than 0.7 mole equivalents based on the nicotine. In some examples, the total acid content of the extract composition is no greater than 0.6 mole equivalents based on the nicotine. In some examples, the total acid content of the extract composition is no greater than 0.5 mole equivalents based on the nicotine. In some examples, the total acid content of the extract composition is no greater than 0.4 mole equivalents based on the nicotine. In someexamples, the total acid content of the extract composition is no greater than 0.3 mole equivalents based on the nicotine. In some examples, the total acid content of the extract composition is no greater than 0.2 mole equivalents based on the nicotine. In some examples, the total acid content of the extract composition is no greater than 0.1 mole equivalents based on the nicotine.
[0347] Other Compounds
[0348] The extract composition of the present disclosure may include one or more other compounds as defined below. These compounds are understood to be in addition to any compounds of the named classes present as tobacco flavour / irritation markers as defined herein.
[0349] In some examples, the extract composition includes at least one C6 to C18 substituted pyrazine. In some examples the C6 to C18 substituted pyrazine comprises substituents selected from alkyl groups, alkenyl groups, aryl groups, hydroxyl groups, carboxyl groups, alkoxy groups, sulfhydryl groups, thionyl groups, sulfide groups, and combinations thereof. The at least one C6 to C18 substituted pyrazine may be selected from pyrazine, trimethyl-(e.g. 2,3,5-trimethylpyrazine); pyrazine, 2,6-diethyl; pyrazine, tetramethyl- (e.g. 2, 3,5,6-tetramethylpyrazine); 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; isopropenylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2,3-diethylpyrazine, 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; and combinations thereof.
[0350] In some examples, the extract composition includes a terpene alcohol which may be selected from geranyl linalool, isophytol, menthol, dihydrolinalool, phytol, sclareol, 2-[(2r,5s)-5-methyl-5-vinyltetrahydro-2-furanyl]-2-propanol, and combinations thereof.
[0351] In some examples, the extract composition comprises at least one C7 to C18 aromatic acetal which may be present as a key tobacco flavour marker) optionally selected from veratraldehyde propylene glycol acetal, 2-phenyl,1,3-dioxan-5-ol, 4-methyl-2-phenyl-1,3-dioxolane, 2-(4-methoxyphenyl)-4-methyl-1,3-dioxolane, and combinations thereof.
[0352] In some examples, the extract composition comprises at least one C2 to C24 carboxylic acid which is optionally selected from benzoic acid, phenylacetic acid, acetic acid, and anhydrides thereof, or C5 to C24 fatty acids.
[0353] In some examples, the extract composition comprises one or more C6 to C24 aliphatic esters which are optionally fatty acid esters selected from: methyl hexanoate, ethyl octanoate, ethyl decanoate, ethyl laurate, ethyl tetradecanoate, methyl palmitate, ethyl pentadecanoate, ethylpalmitate, methyl linoleate, ethyl linolenate, ethyl linoleate, ethyl stearate, methyl linolenate, docosahexanoic acid methyl ester, and combinations thereof.
[0354] In some examples, the extract composition comprises at least one C4 to C18 lactone which is optionally selected from valerolactone, undecan-4-olide, sclareolide, butyrolactone, but-2-en-4-olide, caprolactone, dl-pantolactone, gamma-octanoic lactone, gamma-nonalactone, alpha-levantanolide, 6-pentyloxan-2-one, gamma-decanolactone, (2,6,6-trimethyl-2-hydroxycyclohexylidene)acetic acid lactone, dodecalactone, loliolide, 5-methoxypsoralen, 6-methoxyfuro[2,3-h]chromen-2-one, 3,4-dihydroisocoumarin, maltol (3-Hydroxy-2-methyl-4H-pyran-4-one), 2,3-dihydro-3,5-dihydroxy-6-methyl-4(h)-pyran-4-one, ethyl maltol (2-Ethyl-3-hydroxy-4H-pyran-4-one), coumarin, 3,4-dihydrocoumarin, 6-methylcoumarin, 6-hydroxy-4-methylcoumarin, 7-ethoxycoumarin, and combinations thereof.
[0355] In some examples, the extract composition may further comprise a bipyridine compound, optionally which is 2,3’-dipyridyl. In some examples, the extract composition may be substantially free from bipyridine compounds.
[0356] In some examples the extract composition may comprise at least one norisoprenoid. In some examples the at least one norisoprenoid is selected from damascenone, damascene, ionone, megastigmatrienone, n-methylionone, solanone, 3-hydroxy-beta-damascone, 3-buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl), or a combination thereof.
[0357] In some examples, the extract composition may comprise nicotine.
[0358] In some examples, the extract composition further comprises at least one norisoprenoid and nicotine, optionally wherein the weight ratio of norisoprenoid to nicotine is about 1:10 to 1:1.
[0359] In some examples, the extract composition may comprise at least one aromatic alcohol which is optionally a C7 to C18 monoalcohol, optionally selected from benzyl alcohol, phenylethanol, phenylmethylcarbinol, 1-phenylpropane-1,2-diol, 1-phenyl-2-butanol, and combinations thereof.
[0360] In some examples, the extract composition further comprises one or more carboxylate esters. In some examples, the carboxylate ester is selected from: ethyl acetate; isopropyl formate; methyl meth oxy acetate; methyl 2-methyl butyrate; propanoic acid, 2-hydroxy-, ethyl ester; ethyl isovalerate; mono-ethyl succinate; isoamyl isovalerate; 2-methylpentanoyl 2-methylpentanoate; triethyl citrate; 1,2,3-propanetriol,1-acetate; 2-hydroxypropylacetate; 1,1-ethanediol, diacetate; dibutyl phthalate; acetic acid, methyl ester; bis(2-ethylhexyl) benzene-1,3-dicarboxylate; and combinations thereof.In some examples, the extract composition further comprises at least one sesquiterpene which optionally may be selected from calamenene, alpha-muurolene, r-cadinene, viridiflorene, longifolene, nootkatone, beta-bisabolol, cedrol, nerolidol, santalol, beta-bisabolene, beta-cedrene, beta-humulene, alpha-cyperone, cyperotundone, 3,7-dimethyl-10-(propan-2-ylidene)cyclodeca-3,7-dienone, solavetivone, alantolactone, neophytadiene, guai-1(5)-en-11-okacetate, and combinations thereof.
[0361] In some examples, the extract composition further comprises one or more furan derivatives which are optionally selected from furfuryl alcohol, furfural, 5-methyl furfural, ethanone, 1-(2-furanyl)-, 2-pentylfuran, 2-(propan-2-ylsulfanylmethyl)furan, 1-(furan-2-yl)pentan-1-one, furfuryl methyl ether, 2-acetylfuran, 2-acetyl-5-methylfuran, linalooloxide, or a combination thereof.
[0362] Smoke Markers
[0363] In some examples the extract compositions of the present disclosure include compounds which may be absent from a tobacco extract, but present in smoke formed by burning the same tobacco used to form the extract, e.g. in a cigarette. As noted above, these compounds are termed ‘smoke markers’. These compounds may also be considered irritation and / or tobacco flavour markers.
[0364] The smoke markers may be one or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1-methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, 3-methylpentanoic acid, phenol, 5-ethenyl-2-methoxy-, tetradecanoic acid, and acetic acid.
[0365] In some examples, the extract composition may comprise one or more compounds selected from 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1- (acetyl oxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural. In some examples, the extract composition may comprise two or more compounds selected from 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1- (acetyl oxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural. In someexamples, the extract composition may comprise three or more compounds selected from 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1- (acetyl oxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural. In some examples, the extract composition may comprise four or more compounds selected from 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1- (acetyl oxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural. In some examples, the extract composition may comprise five or more compounds selected from 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1- (acetyl oxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural. In some examples, the extract composition may comprise six or more compounds selected from 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1- (acetyl oxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural. In some examples, the extract composition may comprise 3-Methyl-1H-pyrazole-4-carbaldehyde, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1- (acetyl oxy)-, 2-pyrrolidinone, methylcyclopentenolone, and furfural.
[0366] In some examples, the extract composition comprises one or more compounds selected from 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1-methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol. In some examples, the extract composition comprises two or more compounds selected from 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1 -methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol. In some examples, the extract composition comprises three or more compounds selected from 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1-methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol. In some examples, the extract composition comprises four or morecompounds selected from 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1 -methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6,10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1 ,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol. In some examples, the extract composition comprises five or more compounds selected from 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1-methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol. In some examples, the extract composition comprises six or more compounds selected from 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1-methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol. In some examples, the extract composition comprises 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, 1H-pyrrole-2-carboxyaldehyde, 1-methyl-, ethanone, 1-(2-furanyl)-, dimethylpyrazine, pyrazine, ethyl-, trimethylpyrazine, Ethylguaiacol, ethanone, 1-(3-pyridinyl)-, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, n-hexadecanoic acid, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, and 2-furanmethanol.
[0367] In some examples, the extract composition comprises one or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-. In some examples, the extract composition comprises two or more compounds selected from: 3-Methyl-1H-pyrazole- 4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-. In some examples, the extract composition comprises three or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-. In some examples, the extract composition comprises four or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-. In some examples, the extract composition comprises five or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-. In some examples, the extract composition comprises six or more compounds selected from: 3-Methyl-1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1 -(acetyloxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-. In some examples, the extract composition comprises 3-Methyl-1H-pyrazole-4-carbaldehyde, 3-methylpentanoic acid, benzene, 1-isocyano-3-methyl-, 4-vinylphenol, 2-propanone, 1- (acetyl oxy)-, 2-pyrrolidinone, methylcyclopentenolone, furfural, 3-methylpentanoic acid, and phenol, 5-ethenyl-2-methoxy-.
[0368] In some examples, the extract composition comprises one or more compounds selected from: 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, trimethylpyrazine, strawberry furanone, 2-pentadecanone, 6, 10, 14-tri methyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1 -(acetyloxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural. In some examples, the extract composition comprises two or more compounds selected from: 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1 -(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, trimethylpyrazine, strawberry furanone, 2-pentadecanone, 6,10,14-trimethyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1 -(acetyloxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural. In some examples, the extract composition comprises three or more compounds selected from: 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, trimethylpyrazine, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1- (acetyl oxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural. In some examples, the extract composition comprises four or more compounds selected from: 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, trimethylpyrazine, strawberry furanone, 2-pentadecanone, 6, 10, 14-trimethyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1- (acetyl oxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural. In some examples, the extract composition comprises five or more compounds selected from: 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, trimethylpyrazine, strawberry furanone, 2-pentadecanone, 6, 10,14-trimethyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1- (acetyl oxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural. In some examples, the extract composition comprises six or more compounds selected from: 1 H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, trimethylpyrazine, strawberry furanone, 2-pentadecanone, 6, 10,14-trimethyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1- (acetyl oxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural. In some examples, the extract composition comprises 1H-pyrrole-2-carboxaldehyde, benzyl alcohol, ethanone, 1-(1 H-pyrrol-2-yl)-, dimethylpyrazine, toluene, pentanal, pyridine, hexadecanoic acid, methyl ester, ethanone, 1-(2-furanyl)-, pyrazine, ethyl-, trimethylpyrazine, strawberry furanone, 2-pentadecanone, 6, 10,14-trimethyl-, tetradecanoic acid, n-hexadecanoic acid, 2-propanone, 1-(acetyloxy)-, phenethyl alcohol, 2-furancarboxaldehyde, 5-methyl-, acetic acid, 1,2-cyclopentanedione, 3-methyl-, butyrolactone, 2-furanmethanol, methylcyclopentenolone, and furfural.
[0369] When present, each of the smoke markers may be included in an amount of about 0.1 to about 20 ug / mL. The total amount of smoke markers in the extract composition may from about 100 to about 500 ug / mL.
[0370] When incorporated into an aerosolisable formulation, the extract composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordinglyrelative to the total weight of the aerosolisable formulation. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. The concentration values ug / mL may be converted into wt%, based on the total weight of the aerosolisable formulation, as follows:
[0371] g / mL = ug / mL x 10-6
[0372] % w / w compound in extract composition = (g / mL / (extract composition density in g / mL) x 100)
[0373] % w / w compound in aerosolisable formulation = (% w / w of compound in extract composition) / wt% extract composition in aerosolisable formulation (e.g. 5, 8, 10, 15, 20, 25 and 30 wt%).
[0374] Aerosol Markers
[0375] In some examples the extract compositions of the present disclosure include compounds which may be absent from a tobacco extract, but present in an aerosol formed by aerosolising the extract, by heat or another means. As noted above, these compounds are termed ‘aerosol markers’. These compounds may also be considered irritation and / or tobacco flavour markers.
[0376] The aerosol markers may be one or more compounds selected from: acetic acid, cotinine, butanal, 3-methyl-, and 1,6,10,14-hexadecatetraen-3-ol,3,7,11,15-tetramethyl-. In some examples, the extract composition may comprise two or more compounds selected from: acetic acid, cotinine, butanal, 3-methyl-, and 1,6,10,14-hexadecatetraen-3-ol,3,7,11,15-tetramethyl-. In some examples, the extract composition may comprise three or more compounds selected from: acetic acid, cotinine, butanal, 3-methyl-, and 1,6,10,14-hexadecatetraen-3-ol,3,7,11,15-tetramethyl-. In some examples, the extract composition may comprise acetic acid, cotinine, butanal, 3-methyl-, and 1,6,10,14-hexadecatetraen-3-ol,3,7,11,15-tetramethy I- .
[0377] When present, each of the aerosol markers may be included in an amount of about 0.1 to about 20 ug / mL. The total amount of aerosol markers in the extract composition may from about 100 to about 500 ug / mL. When incorporated into a aerosolisable formulation, the extract composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly relative to the total weight of the aerosolisable formulation. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. The concentration values ug / mL may be converted into wt%, based on the total weight of the aerosolisable formulation, as follows:
[0378] g / mL = ug / mL x 10'6% w / w compound in extract composition = (g / mL / (extract composition density in g / mL) x 100)
[0379] % w / w compound in aerosolisable formulation = (% w / w of compound in extract composition) / wt% extract composition in aerosolisable formulation (e.g. 5, 8, 10, 15, 20, 25 and 30 wt%).
[0380] Other Components
[0381] In some examples, the further constituent comprises a flavour. As used herein, the terms "flavour" and "flavourant" refer to materials which, where local regulations permit, may be used to create a desired taste, aroma, or other somatosensory sensation in a product for adult consumers. They may include naturally occurring flavour materials, botanicals, extracts of botanicals, synthetically obtained materials, or combinations thereof (e.g., tobacco, cannabis, licorice (liquorice), hydrangea, eugenol, Japanese white bark magnolia leaf, chamomile, fenugreek, clove, maple, matcha, menthol, Japanese mint, aniseed (anise), cinnamon, turmeric, Indian spices, Asian spices, herb, Wintergreen, cherry, berry, red berry, cranberry, peach, apple, orange, mango, clementine, lemon, lime, tropical fruit, papaya, rhubarb, grape, durian, dragon fruit, cucumber, blueberry, mulberry, citrus fruits, Drambuie, bourbon, scotch, whiskey, gin, tequila, rum, spearmint, peppermint, lavender, aloe Vera, cardamom, celery, cascarilla, nutmeg, sandalwood, bergamot, geranium, khat, naswar, betel, shisha, pine, honey essence, rose oil, vanilla, lemon oil, orange oil, orange blossom, cherry blossom, cassia, caraway, cognac, jasmine, ylang-ylang, sage, fennel, wasabi, piment, ginger, coriander, coffee, hemp, a mint oil from any species of the genus Mentha, eucalyptus, star anise, cocoa, lemongrass, rooibos (Aspalathus linearis), flax, ginkgo biloba, hazel, hibiscus, laurel, mate, orange skin, rose, tea such as green tea or black tea, thyme, juniper, elderflower, basil, bay leaves, cumin, oregano, paprika, rosemary, saffron, lemon peel, mint, beefsteak plant, curcuma, cilantro, myrtle, cassis, valerian, pimento, mace, damien, marjoram, olive, lemon balm, lemon basil, chive, carvi, verbena, tarragon, limonene, thymol, camphene), flavour enhancers, bitterness receptor site blockers, sensorial receptor site activators or stimulators, sugars and / or sugar substitutes (e.g., sucralose, acesulfame potassium, aspartame, saccharine, cyclamates, lactose, sucrose, glucose, fructose, sorbitol, or mannitol), and other additives such as charcoal, chlorophyll, minerals, botanicals, or breath freshening agents. They may be imitation, synthetic or natural ingredients or blends thereof. They may be in any suitable form, for example, liquid such as an oil, solid such as a powder, or gas.
[0382] The flavour may be added to the aerosolisable formulation as part of a so-called “flavour block”, where one or more flavours are blended together and then added to the substrate material. The terms “flavour”, "flavourant", “flavour component” or "flavour block” mentioned herein are to be used interchangeably and construed accordingly. For example, the terms “flavour”, "flavourant", “flavour component” or "flavour block” refer to one or more naturallyoccurring or synthetically obtained compounds used to create a desired taste, aroma, or other somatosensory sensation in a product for adult consumers. In the context of the present disclosure, the terms “flavour”, "flavourant", “flavour component” or "flavour block” are to be construed as a flavour component being separate or otherwise distinct from the extract composition as defined herein.
[0383] As described herein, the extract composition, such as a tobacco extract composition, can be combined with at least one flavour / flavour block._When used in combination with a flavour / flavour block, the extract composition may first be analysed for the presence of one or more of the compounds, as discussed above, and then supplemented with additional compounds, e.g. as part of a flavour block, in order to improve the FMC-like flavour experience obtained when used in a substance delivery system, e.g. an electronic aerosol provision system.
[0384] The flavour and / or flavour block may be a composition that can simulate specific aspects of tobacco’s aromatic profile, i.e. the flavour and / or flavour block composition can have a tobacco-like aroma. In this regard, the flavour and / or flavour block may be chosen to accentuate or otherwise promote the taste and / or aroma profile of the extract composition, such as a tobacco extract. The flavour and / or flavour block may also be chosen to reduce or ameliorate the taste and / or aroma profile of the extract composition, such as a tobacco extract.
[0385] In some examples, the flavour and / or flavour block is a synthetic flavour and / or flavour component. In the context of the present invention, the term “synthetic” refers to a composition which is produced by combining multiple individual and / or isolated compounds to form a composition, rather than via an extraction process whereby a starting composition containing multiple compounds is extracted and optionally purified or modified to reduce its constituent components. The individual and / or isolated compounds present in the flavour and / or flavour component may be naturally occurring or synthetically obtained.
[0386] In some examples, there is provided the use of a flavour component (such as a synthetic flavour component) to improve the tobacco flavour of an aerosolisable formulation, wherein the aerosolisable formulation comprises an extract composition comprising one or more compounds selected from: myosmine; p-cresol; pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; nicotyrine; propanoic acid, 2-oxo, methyl ester; propanoic acid, 2-methyl-; 2-cyclopenten-1-one, 3-methyl-; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; phenol; phenol, 4-ethyl-; propanoic acid; styrene; benzene, 1,3-dimethyl-; 3-pyridinol; 2,3-dimethoxyphenol; 2-pentadecanone, 6, 10, 14-tri methyl-; 2-cyclopenten-1-one, 3-ethyl-2- hydroxy-; methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin;methylacetophenone; phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-Linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; terpineol; acetic acid; 2-furanmethanol; 2-furancarboxaldehyde, 5-methyl; benzyl alcohol; phenethylalcohol; 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl; n-hexadecanoic acid; octadecanoic acid; or a combination thereof, where the compounds are obtained by extraction from a tobacco material.
[0387] In some examples, the flavour comprises menthol, spearmint and / or peppermint. In some examples, the flavour comprises flavour components of cucumber, blueberry, citrus fruits and / or redberry. In some examples, the flavour comprises eugenol. In some examples, the flavour comprises flavour components extracted from tobacco. In some examples, the flavour comprises flavour components extracted from cannabis.
[0388] In some examples, the flavour component may comprise one or more compounds as defined herein. In some examples, the flavour component may comprise one or more compounds selected from the group consisting of ketones (e.g. aliphatic, heteroaromatic and / or aromatic ketones), aldehydes (e.g. aliphatic and / or aromatic aldehydes), C6 to C18 substituted pyrazines, furan derivatives, C6 to C18 substituted pyridines, C7 to C18 substituted phenols, norisoprenoids, thio-ethers, or combinations thereof, in accordance with the compounds defined herein for the extract composition.
[0389] In some examples, the flavour component may comprise one or more compounds selected from the group consisting of C3 to C10 aliphatic aldehydes, C3 to C10 aromatic aldehydes, C3 to C10 aliphatic ketones, C3 to C10 heteroaromatic ketones or aromatic ketones, C6 to C18 substituted pyrazines, C6 to C18 substituted pyridines, C7 to C18 substituted phenols, C6 to C18 norisoprenoids, C3 to C10 furan derivatives, C2 to C10 thio-ethers or combinations thereof, in accordance with the compounds defined herein for the extract composition.
[0390] In some examples, the flavour component may comprise one or more compounds selected from aliphatic ketones, aliphatic aldehydes, C6 to C18 substituted pyridines, C6 to C18 substituted pyrazines, furan derivatives and combinations thereof.
[0391] In some examples, the flavour component may comprise at least one aliphatic ketone, at least one aliphatic aldehyde and at least one C6 to C18 substituted pyridine. In some examples, the flavour component may comprise one aliphatic ketone, one aliphatic aldehyde and one C6 to C18 substituted pyridine.
[0392] In some examples, the flavour component may comprise at least one aliphatic aldehyde, at least one C6 to C18 substituted pyridine, at least one C6 to C18 substituted pyrazine and atleast one furan derivative. In some examples, the flavour component may comprise one aliphatic aldehyde, one C6 to C18 substituted pyridine, one C6 to C18 substituted pyrazine and one furan derivative.
[0393] In some examples, the flavour component may comprise at least one aliphatic ketone, at least one aliphatic aldehyde, at least one C6 to C18 substituted pyrazine and at least one C7 to C18 substituted phenols. In some examples, the flavour component may comprise at least one aliphatic ketone, at least one aliphatic aldehyde, at least two C6 to C18 substituted pyrazines and at least one C7 to C18 substituted phenols. In some examples, the flavour component may comprise one aliphatic ketone, one aliphatic aldehyde, one C6 to C18 substituted pyrazine and one C7 to C18 substituted phenols. In some examples, the flavour component may comprise one aliphatic ketone, one aliphatic aldehyde, two C6 to C18 substituted pyrazines and one C7 to C18 substituted phenols.
[0394] In some examples, the flavour component may comprise at least one aliphatic ketone, at least one furan derivative, at least one C6 to C18 substituted pyrazine, at least one C7 to C18 substituted phenol and at least one norisoprenoid. In some examples, the flavour component may comprise at least two aliphatic ketones, at least one furan derivative, at least two C6 to C18 substituted pyrazines, at least two C7 to C18 substituted phenols and at least one norisoprenoid. In some examples, the flavour component may comprise one aliphatic ketone, one furan derivative, one C6 to C18 substituted pyrazine, one C7 to C18 substituted phenol and one norisoprenoid. In some examples, the flavour component may comprise two aliphatic ketones, one furan derivative, two C6 to C18 substituted pyrazines, two C7 to C18 substituted phenols and one norisoprenoid.
[0395] In some examples, the flavour component may comprise at least one aromatic aldehyde, at least one aliphatic ketone, at least one heteroaromatic ketone or aromatic ketone, at least one C6 to C18 substituted pyrazine and at least one furan derivative. In some examples, the flavour component may comprise one aromatic aldehyde, one aliphatic ketone, one heteroaromatic ketone or aromatic ketone, one C6 to C18 substituted pyrazine and one furan derivative. In some examples, the flavour component may comprise at least one aromatic aldehyde, at least one aliphatic ketone, at least one heteroaromatic ketone or aromatic ketone, at least four C6 to C18 substituted pyrazines and at least two furan derivatives. In some examples, the flavour component may comprise one aromatic aldehyde, one aliphatic ketone, one heteroaromatic ketone or aromatic ketone, four C6 to C18 substituted pyrazines and two furan derivatives.In some examples, the flavour component may comprise at least one aliphatic aldehyde and at least one thio-ether. In some examples, the flavour component may comprise one aliphatic aldehyde and one thio-ether.
[0396] In some examples, the flavour component may comprise at least one C7 to C18 substituted phenol. In some examples, the flavour component may comprise one C7 to C18 substituted phenol. In some examples, the flavour component may comprise at least two C7 to C18 substituted phenols. In some examples, the flavour component may comprise two C7 to C18 substituted phenols.
[0397] In some examples, the flavour component may comprise at least one aliphatic ketone, at least one aliphatic aldehyde, at least one C6 to C18 substituted pyrazine, at least one C7 to C18 substituted phenol, at least one furan derivative, at least one norisoprenoid and at least one thio-ether. In some examples, the flavour component may comprise at least four aliphatic ketones, at least one aliphatic aldehyde, at least four C6 to C18 substituted pyrazines, at least three C7 to C18 substituted phenols, at least one furan derivative, at least one norisoprenoid and at least one thio-ether.
[0398] In some examples, the flavour component may comprise at least one aliphatic ketone, at least one aliphatic aldehyde, at least one C6 to C18 substituted pyrazine, at least one C7 to C18 substituted phenol, at least one furan derivative and at least one norisoprenoid. In some examples, the flavour component may comprise at least three aliphatic ketones, at least one aliphatic aldehyde, at least four C6 to C18 substituted pyrazines, at least three C7 to C18 substituted phenols, at least one furan derivative and at least one norisoprenoid.
[0399] In some examples, the flavour component may comprise at least one aliphatic aldehyde, at least one aromatic aldehyde, at least one aliphatic ketone, at least one heteroaromatic ketone or aromatic ketone, at least one C6 to C18 substituted pyrazine, at least one furan derivative and at least one thio-ether. In some examples, the flavour component may comprise at least one aliphatic aldehyde, at least one aromatic aldehyde, at least one aliphatic ketone, at least one heteroaromatic ketone or aromatic ketone, at least four C6 to C18 substituted pyrazines, at least two furan derivatives and at least one thio-ether.
[0400] In some examples, the flavour component may comprise at least one aliphatic ketone, at least one aliphatic aldehyde, at least one C6 to C18 substituted pyridine and at least one thio-ether. In some examples, the flavour component may comprise at least one aliphatic ketone, at least two aliphatic aldehydes, at least one C6 to C18 substituted pyridine and at least one thioether.In some examples, the flavour component may comprise at least one aliphatic aldehyde, at least one C6 to C18 substituted pyridine, at least one C6 to C18 substituted pyrazine, at least one furan derivative and at least one thio-ether. In some examples, the flavour component may comprise at least two aliphatic aldehydes, at least one C6 to C18 substituted pyridine, at least one C6 to C18 substituted pyrazine, at least one furan derivative and at least one thioether.
[0401] In some examples, the flavour component may comprise at least one aromatic aldehyde, at least one aliphatic ketone, at least one heteroaromatic ketone or aromatic ketone, at least one C6 to C18 substituted pyrazine, at least one furan derivative and at least one C7 to C18 substituted phenol. In some examples, the flavour component may comprise at least one aromatic aldehyde, at least one aliphatic ketone, at least one heteroaromatic ketone or aromatic ketone, at least four C6 to C18 substituted pyrazines, at least two furan derivatives and at least two C7 to C18 substituted phenols.
[0402] In some examples, the flavour component comprises at least one aliphatic aldehyde selected from C3 to C10 aliphatic aldehydes. In some examples, the flavour component comprises at least one aliphatic aldehyde selected from C3 to C6 aliphatic aldehydes. In some examples, the flavour component comprises at least one aliphatic aldehyde selected from the group consisting of methional, methyl butyraldehyde (3-), valeraldehyde and combinations thereof.
[0403] In some examples, the flavour component comprises at least one aromatic aldehyde selected from C3 to C10 aromatic aldehydes. In some examples, the flavour component comprises at least one aromatic aldehyde selected from C6 to C8 aromatic aldehydes. In some examples, the flavour component comprises at least one aromatic aldehyde, which may comprise benzaldehyde.
[0404] In some examples, the flavour component comprises at least one aliphatic ketone selected from C3 to C10 aliphatic ketones. In some examples, the flavour component comprises at least one aliphatic ketone selected from C5 to C9 aliphatic ketones. In some examples, the flavour component comprises at least one aliphatic ketone selected from the group consisting of 5-methyl-2-hepten-4-one, dimethyl-1,2-cyclopentadione (3,4-), Methyl cyclopentenolone and combinations thereof.
[0405] In some examples, the flavour component comprises at least one heteroaromatic ketone or aromatic ketone selected from C3 to C10 heteroaromatic ketones or aromatic ketones. In some examples, the flavour component comprises at least one heteroaromatic ketone or aromatic ketone selected from C4 to C6 heteroaromatic ketones or aromatic ketones. In someexamples, the flavour component comprises at least one heteroaromatic ketone or aromatic ketone, which may comprise 2-acetyl thiazole.
[0406] In some examples, the flavour component comprises at least one C6 to C18 substituted pyrazine selected from the group consisting of 2-ethyl-3,5-dimethylpyrazine, ethyl-2-methyl pyrazine (3-), ethyl-3, (5 or 6)-dimethyl pyrazine (2-), methoxy-3-methyl pyrazine (2 or 5 or 6-), acetyl pyrazine and combinations thereof.
[0407] In some examples, the flavour component comprises at least one C6 to C18 substituted pyridine which may comprise 2-acetyl pyridine.
[0408] In some examples, the flavour component comprises at least one C7 to C18 substituted phenol selected from the group consisting of methoxy-4-methylphenol (2-), 2,4-xylenol, guaiacol and combinations thereof.
[0409] In some examples, the flavour component comprises at least one C7 to C18 furan derivative selected from the group consisting of furfuryl mercaptan, 2-ethylfuran, methyl furfural (5-), methyl tetrahydrofuran-3-one-(2-) and combinations thereof.
[0410] In some examples, the flavour component comprises at least one norisoprenoid. In some examples, the flavour component comprises at least one norisoprenoid selected from the group consisting of C6 to C18 norisoprenoids. In some examples, the flavour component comprises at least one norisoprenoid, which may comprise damascenone (beta-).
[0411] In some examples, the flavour component comprises at least one furan derivative. In some examples, the flavour component comprises at least one furan derivative selected from the group consisting of C3 to C10 furan derivatives. In some examples, the flavour component comprises at least one thio-ether, which may comprise methyl sulfide.
[0412] In some examples, the flavour component comprises one or more compounds selected from the group consisting of 2,4-xylenol, 2-acetyl pyridine, 2-acetyl pyridine, 2-acetyl thiazole, 2-ethyl-3,5-dimethylpyrazine, 2-ethylfuran, 5-methyl-2-hepten-4-one, acetyl pyrazine, benzaldehyde, damascenone (beta-), dimethyl- 1,2-cyclopentadione (3,4-), ethyl-2-methyl pyrazine (3-), ethyl-3, (5 or 6)-dimethyl pyrazine (2-), furfuryl mercaptan, guaiacol, methional, methoxy-3-methyl pyrazine (2 or 5 or 6-), methoxy-4-methylphenol (2-), methyl butyraldehyde (3-), methyl cyclopentenolone, methyl furfural (5-), methyl sulfide, methyl tetra hydrofuran- 3-one-(2-), valeraldehyde or combinations thereof.
[0413] In some examples, the flavour component comprises one or more compounds selected from the group consisting of 2-acetyl pyridine, acetyl pyrazine, dimethyl-1,2-cyclopentadione (3,4-), guaiacol, methoxy-3-methyl pyrazine (2 or 5 or 6-), methoxy-4-methylphenol (2-), valeraldehyde or combinations thereof.
[0414] In some examples, the flavour component comprises one or more compounds selected from the group consisting of 2-acetyl pyridine, dimethyl-1,2-cyclopentadione (3,4-), valeraldehyde or combinations thereof. In some examples, the flavour component comprises 2-acetyl pyridine, dimethyl- 1,2-cyclopentadione (3,4-), valeraldehyde.
[0415] In some examples, the flavour component comprises one or more compounds selected from the group consisting of 2-acetyl pyridine, ethyl-3,(5 or 6)-dimethyl pyrazine (2-), methyl butyraldehyde (3-), methyl furfural (5-) or combinations thereof. In some examples, the flavour component comprises 2-acetyl pyridine, ethyl-3,(5 or 6)-dimethyl pyrazine (2-), methyl butyraldehyde (3-), methyl furfural (5-).
[0416] In some examples, the flavour component comprises one or more compounds selected from the group consisting of acetyl pyrazine, dimethyl-1,2-cyclopentadione (3,4-), methoxy-3-methyl pyrazine (2 or 5 or 6-), methoxy-4-methylphenol (2-), valeraldehyde or combinations thereof. In some examples, the flavour component comprises acetyl pyrazine, dimethyl-1,2-cyclopentadione (3,4-), methoxy-3-methyl pyrazine (2 or 5 or 6-), methoxy-4-methylphenol (2-), valeraldehyde.
[0417] In some examples, the flavour component comprises one or more compounds selected from the group consisting of 2-acetyl thiazole, 2-ethyl-3,5-dimethylpyrazine, 2-ethylfuran, 5-methyl- 2-hepten-4-one, acetyl pyrazine, benzaldehyde, ethyl-2-methyl pyrazine (3-), methoxy-3-methyl pyrazine (2 or 5 or 6-), methyl tetrahydrofuran-3-one-(2-) or combinations thereof. In some examples, the flavour component comprises 2-acetyl thiazole, 2-ethyl-3,5-dimethylpyrazine, 2-ethylfuran, 5-methyl-2-hepten-4-one, acetyl pyrazine, benzaldehyde, ethyl-2-methyl pyrazine (3-), methoxy-3-methyl pyrazine (2 or 5 or 6-), methyl tetrahydrofuran- 3-one-(2-).
[0418] In some examples, the flavour component comprises one or more compounds selected from the group consisting of acetyl pyrazine, damascenone (beta-), dimethyl- 1,2-cyclopentadione (3,4-), furfuryl mercaptan, guaiacol, methoxy-3-methyl pyrazine (2 or 5 or 6-), methoxy-4-methylphenol (2-), methyl cyclopentenolone or combinations thereof. In some examples, the flavour component comprises acetyl pyrazine, damascenone (beta-), dimethyl-1,2-cyclopentadione (3,4-), furfuryl mercaptan, guaiacol, methoxy-3-methyl pyrazine (2 or 5 or 6-), methoxy-4-methylphenol (2-), methyl cyclopentenolone.In some examples, the flavour component comprises one or more compounds selected from the group consisting of methional, methyl sulfide or combinations thereof. In some examples, the flavour component comprises_methional and methyl sulfide.
[0419] In some examples, the flavour component comprises one or more compounds selected from the group consisting of 2,4-xylenol, guaiacol or combinations thereof. In some examples, the flavour component comprises 2,4-xylenol and guaiacol.
[0420] In some examples, the flavour component comprises one or more compounds selected from the group consisting of methional, methyl sulfide, 2-acetyl pyridine, dimethyl-1,2-cyclopentadione (3,4-), valeraldehyde or combinations thereof. In some examples, the flavour component comprises methional, methyl sulfide, 2-acetyl pyridine, dimethyl-1,2-cyclopentadione (3,4-), valeraldehyde.
[0421] In some examples, the flavour component comprises one or more compounds selected from the group consisting of methional, methyl sulfide, 2-acetyl pyridine, ethyl-3,(5 or 6)-dimethyl pyrazine (2-), methyl butyraldehyde (3-), methyl furfural (5-) or combinations thereof. In some examples, the flavour component comprises methional, methyl sulfide, 2-acetyl pyridine, ethyl-3,(5 or 6)-dimethyl pyrazine (2-), methyl butyraldehyde (3-), methyl furfural (5-).
[0422] In some examples, the flavour component comprises one or more compounds selected from the group consisting of damascenone (beta-), furfuryl mercaptan, guaiacol, methyl cyclopentenolone, acetyl pyrazine, dimethyl- 1,2-cyclopentadione (3,4-), methoxy-3-methyl pyrazine (2 or 5 or 6-), methoxy-4-methylphenol (2-), valeraldehyde or combinations thereof. In some examples, the flavour component comprises damascenone (beta-), furfuryl mercaptan, guaiacol, methyl cyclopentenolone, acetyl pyrazine, dimethyl-1,2-cyclopentadione (3,4-), methoxy-3-methyl pyrazine (2 or 5 or 6-), methoxy-4-methylphenol (2-), valeraldehyde.
[0423] In some examples, the flavour component comprises one or more compounds selected from the group consisting of methional, methyl sulfide, damascenone (beta-), furfuryl mercaptan, guaiacol, methyl cyclopentenolone, acetyl pyrazine, dimethyl-1,2-cyclopentadione (3,4-), methoxy-3-methyl pyrazine (2 or 5 or 6-), methoxy-4-methylphenol (2-), valeraldehyde or combinations thereof. In some examples, the flavour component comprises methional, methyl sulfide, damascenone (beta-), furfuryl mercaptan, guaiacol, methyl cyclopentenolone, acetyl pyrazine, dimethyl-1,2-cyclopentadione (3,4-), methoxy-3-methyl pyrazine (2 or 5 or 6-), methoxy-4-methylphenol (2-), valeraldehyde.
[0424] In some examples, the flavour component comprises one or more compounds selected from the group consisting of methional, methyl sulfide, 2-acetyl thiazole, 2-ethyl-3,5-dimethylpyrazine, 2-ethylfuran, 5-methyl-2-hepten-4-one, acetyl pyrazine, benzaldehyde, ethyl-2-methyl pyrazine (3-), methoxy-3-methyl pyrazine (2 or 5 or 6-), methyl tetrahydrofuran-3-one-(2-) or combinations thereof. In some examples, the flavour component comprises methional, methyl sulfide, 2-acetyl thiazole, 2-ethyl-3,5-dimethylpyrazine, 2-ethylfuran, 5-methyl-2-hepten-4-one, acetyl pyrazine, benzaldehyde, ethyl-2-methyl pyrazine (3-), methoxy-3-methyl pyrazine (2 or 5 or 6-), methyl tetrahydrofuran-3-one-(2-).
[0425] In some examples, the flavour component comprises one or more compounds selected from the group consisting of 2,4-xylenol, guaiacol, 2-acetyl thiazole, 2-ethyl-3,5-dimethylpyrazine, 2-ethylfuran, 5-methyl-2-hepten-4-one, acetyl pyrazine, benzaldehyde, ethyl-2-methyl pyrazine (3-), methoxy-3-methyl pyrazine (2 or 5 or 6-), methyl tetrahydrofuran-3-one-(2-) or combinations thereof. In some examples, the flavour component comprises 2,4-xylenol, guaiacol, 2-acetyl thiazole, 2-ethyl-3,5-dimethylpyrazine, 2-ethylfuran, 5-methyl-2-hepten-4-one, acetyl pyrazine, benzaldehyde, ethyl-2-methyl pyrazine (3-), methoxy-3-methyl pyrazine (2 or 5 or 6-), methyl tetrahydrofuran-3-one-(2-).
[0426] In some examples, the aforementioned components may be incorporated into an aerosolisable formulation according to the present disclosure in the following concentrations relative to the total weight of the aerosolisable formulation:
[0427] Component %w / w
[0428] dimethyl-1 ,2-cyclopentadione (3,4-) 0.01 - 0.1
[0429] valeraldehyde 0.005 - 0.5
[0430] 2-acetyl pyridine 0.01 - 0.1
[0431] ethyl-3,(5 or6)-dimethyl pyrazine (2-) 0.001 - 0.01
[0432] methyl butyraldehyde (3-) 0.005 - 0.1
[0433] 2-acetyl pyridine 0.001 - 0.01
[0434] methyl furfural (5-) 0.001-0.1
[0435] dimethyl-1 ,2-cyclopentadione (3,4-) 0.001 - 0.5
[0436] valeraldehyde 0.005 - 0.5
[0437] methoxy-3-methyl pyrazine (2 or 5 or 6-) 0.002 - 0.2
[0438] methoxy-4-methylphenol (2-) 0.001 - 0.1
[0439] acetyl pyrazine 0.001 - 0.1
[0440] 2-acetyl thiazole 0.0001 - 0.05
[0441] 2-ethyl-3,5-dimethylpyrazine 0.001 - 0.1
[0442] 2-ethylfuran 0.0001 - 0.1
[0443] 5-methyl-2-hepten-4-one (filbertone) 0.001 - 0.5
[0444] ethyl-2-methyl pyrazine (3-) 0.0001 - 0.05
[0445] methoxy-3-methyl pyrazine (2 or 5 or 6-) 0.002 - 0.2
[0446] methyl tetrahydrofuran-3-one-(2-) 0.001 - 0.1
[0447] acetyl pyrazine 0.001 - 0.1
[0448] benzaldehyde 0.05 - 1
[0449] dimethyl-1 ,2-cyclopentadione (3,4-) 0.001 - 0.1
[0450] furfuryl mercaptan 0.00005 - 0.005
[0451]
[0452] methoxy-3-methyl pyrazine (2 or 5 or 6-) 0.0001 - 0.01methoxy-4-methylphenol (2-) 0.0005 - 0.001
[0453] acetyl pyrazine 0.001 - 0.1
[0454] damascenone (beta-) 0.001 - 0.1
[0455] guaiacol 0.00005 - 0.001
[0456] methyl cyclopentenolone 0.001 - 0.1
[0457] methional 0.000001 - 0.001
[0458] methyl sulfide 0.0001 - 0.1
[0459] 2,4-xylenol 0.0001 - 0.1
[0460]
[0461] guaiacol 0.01 - 0.1
[0462] In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.1% w / w to about 30% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.1% w / w to about 25% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.5% w / w to about 25% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 1.0% w / w to about 25% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 1.5% w / w to about 25% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 1.5% w / w to about 22.5% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 1.5% w / w to about 20% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 1.5% w / w to about 15% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 1.5% w / w to about 10% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 1.5% w / w to about 7.5% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 2.0% w / w to about 7.5% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavourcomponent is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 2.0% w / w to about 6.0% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 2.5% w / w to about 6.0% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 3.0% w / w to about 6.0% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 3.0% w / w to about 5.5% w / w of the total weight of the aerosolisable formulation.
[0463] In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 2% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 1.8% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001 % w / w to about 1.6% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001 % w / w to about 1.5% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 1.4% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 1.3% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001 % w / w to about 1.2% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 1.1% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 1.0% w / w of the total weight of the aerosolisable formulation. In some examples,when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 0.9% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001 % w / w to about 0.8% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 0.7% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 0.6% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 0.5% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001 % w / w to about 0.4% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 0.3% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 0.2% w / w of the total weight of the aerosolisable formulation. In some examples, when the flavour component is incorporated into an aerosolisable formulation, the flavour component may be present in an amount of from about 0.0001% w / w to about 0.1% w / w of the total weight of the aerosolisable formulation.
[0464] In some examples, the flavour may comprise a sensate, which is intended to achieve a somatosensory sensation which are usually chemically induced and perceived by the stimulation of the fifth cranial nerve (trigeminal nerve), in addition to or in place of aroma or taste nerves, and these may include agents providing heating, cooling, tingling, numbing effect. A suitable heat effect agent may be, but is not limited to, vanillyl ethyl ether and a suitable cooling agent may be, but not limited to eucalyptol (if not already present in the composition), WS-3.
[0465] Where present, a flavouring agent may be included in the formulation in an amount up to about 10% by weight, such as up to about 5% by weight, such as up to about 1% by weight of the formulation. In some examples, a flavouring agent is present in an amount of from about0.01% to about 5% by weight, preferably in an amount of from about 0.1% to about 2.5% by weight of the formulation, and more preferably in an amount of from about 0.25% to about 1% by weight of the formulation.
[0466] The one or more other functional constituents may comprise one or more of colouring agents, pH regulators, preservatives, stabilizers, and / or antioxidants. A colouring agent may be employed in amounts sufficient to provide the desired physical attributes to the product. The colouring agent may, for example, alter the visual appearance of the formulation and further, may colour-match the formulation to other components of the aerosolisable formulation or other components of a aerosolisable formulation comprising the formulation. In some examples, the colouring agent may be included so as to confer the aerosolisable formulation with a brown appearance.
[0467] Aerosolisable Formulation
[0468] In some aspects of the present disclosure, the pH of the aerosolisable formulation is at least about 4.5. In some examples of the present disclosure, the pH of the aerosolisable formulation is at least about 5.0. In some examples of the present disclosure, the pH of the aerosolisable formulation is at least about 5.5. In some examples of the present disclosure, the pH of the aerosolisable formulation is at least about 6.0.
[0469] In some aspects of the present disclosure, the pH of the aerosolisable formulation is no greater than about 8.0. In some examples of the present disclosure, the pH of the aerosolisable formulation is at least about 7.5. In some examples of the present disclosure, the pH of the aerosolisable formulation is at least about 7.0. In some examples of the present disclosure, the pH of the aerosolisable formulation is at least about 6.5.
[0470] In some aspects of the present disclosure, the pH of the aerosolisable formulation is of from about 4.5 to 7.5. In some examples, the pH of the aerosolisable formulation is of from about 4.5 to 7.0. In some examples, the pH of the aerosolisable formulation is of from about 4.5 to 6.5. In some examples, the pH of the aerosolisable formulation is of from about 4.5 to 6.0. In some examples, the pH of the aerosolisable formulation is of from about 4.5 to 5.5. In some examples, the pH of the aerosolisable formulation is of from about 4.5 to 5.5.
[0471] In some examples, the turbidity of the aerosolisable material is about 10 NTU or less. In some examples, the turbidity of the aerosolisable material is about 9 NTU or less. In some examples, the turbidity of the aerosolisable material is about 8 NTU or less. In some examples, the turbidity of the aerosolisable material is about 7 NTU or less. In some examples, the turbidity of the aerosolisable material is about 6 NTU or less. In some examples, the turbidity of theaerosolisable material is about 5 NTU or less. In some examples, the turbidity of the aerosolisable material is about 4 NTU or less. In some examples, the turbidity of the aerosolisable material is about 3 NTU or less. In some examples, the turbidity of the aerosolisable material is about 2 NTU or less. In some examples, the turbidity of the aerosolisable material is about 1.5 NTU or less. In some examples, the turbidity of the aerosolisable material is about 1 NTU or less. In some examples, the turbidity of the aerosolisable material is about 0.9 NTU or less. In some examples, the turbidity of the aerosolisable material is about 0.8 NTU or less. In some examples, the turbidity of the aerosolisable material is about 0.7 NTU or less. In some examples, the turbidity of the aerosolisable material is about 0.6 NTU or less. In some examples, the turbidity of the aerosolisable material is about 0.5 NTU or less. In some examples, the turbidity of the aerosolisable material is about 0.4 NTU or less. In some examples, the turbidity of the aerosolisable material is about 0.3 NTU or less. In some examples, the turbidity of the aerosolisable material is about 0.2 NTU or less.
[0472] The turbidity of the aerosolisable material can be measured as is common in the art. For example, by using a TL2310 ISO Turbidimeter from Hach, Colorado, 80539-0389, United States.
[0473] Substance Delivery System
[0474] In another aspect of the present disclosure, there is provided a (non-combustible) substance delivery system comprising the aerosolisable formulation, consumable comprising the aerosolisable formulation or container comprising the aerosolisable formulation described herein. As used herein, the term “delivery system” is intended to encompass systems that deliver at least one substance to a user.
[0475] A non-combustible aerosol provision system is a system that releases compounds from an aerosol-generating material without combusting the aerosol-generating material, such as electronic cigarettes, tobacco heating products, and hybrid systems to generate aerosol using a combination of aerosol-generating materials.
[0476] According to the present disclosure, a “non-combustible” aerosol provision system is one where a constituent aerosol-generating material of the aerosol provision system (or component thereof) is not combusted or burned in order to facilitate delivery of at least one substance to a user. The aerosol provision system may also be referenced herein as an aerosol delivery system. In some examples, the delivery system is a non-combustible aerosol provision system, such as a powered non-combustible aerosol provision system. In someexamples, the non-combustible aerosol provision system is an electronic cigarette, also known as a vaping device or electronic nicotine delivery system (END), although it is noted that the presence of nicotine in the aerosol-generating material is not a requirement.
[0477] In some examples, the non-combustible aerosol provision system is an aerosol-generating material heating system, also known as a heat-not-burn system. An example of such a system is a tobacco heating system.
[0478] In some examples, the non-combustible aerosol provision system is a hybrid system to generate aerosol using a combination of aerosol-generating materials, one or a plurality of which may be heated. Each of the aerosol-generating materials may be, for example, in the form of a solid, liquid or gel and may or may not contain nicotine. In some examples, the hybrid system comprises a liquid or gel aerosol-generating material and a solid aerosolgenerating material. The solid aerosol-generating material may comprise, for example, tobacco or a non-tobacco product. Typically, the non-combustible aerosol provision system may comprise a non-combustible aerosol provision device and an article for use with or as the non-combustible aerosol provision device, which is also referred to as a consumable for use with the non-combustible aerosol provision device. The consumable being as defined herein, such as consumables comprising the aerosolisable formulations described herein. In some examples, the disclosure relates to consumables comprising aerosol-generating material and configured to be used with non-combustible aerosol provision devices. These consumables are sometimes referred to as articles throughout the disclosure.
[0479] In some examples, the non-combustible aerosol provision system, such as a non-combustible aerosol provision device thereof, may comprise a power source and a controller. The power source may, for example, be an electric power source or an exothermic power source. In some examples, the exothermic power source comprises a carbon substrate which may be energised so as to distribute power in the form of heat to an aerosol-generating material or to a heat transfer material in proximity to the exothermic power source.
[0480] In some examples, the non-combustible aerosol provision system may comprise an area for receiving the consumable, an aerosol generator, an aerosol generation area, a housing, a mouthpiece, a filter and / or an aerosol-modifying agent. In some examples, the consumable for use with the non-combustible aerosol provision device may comprise aerosol-generating material, an aerosol-generating material storage area, an aerosol-generating material transfer component, an aerosol generator, an aerosol generation area, a housing, a wrapper, a filter, a mouthpiece, and / or an aerosol-modifying agent.In some examples, the substance to be delivered may be an aerosol-generating material or a material that is not intended to be aerosolised. As appropriate, either material may comprise, in addition to the composition of the present disclosure, one or more active constituents, one or more flavours, one or more aerosol-former materials and / or one or more functional materials. More information is set out herein.
[0481] Process and Aerosol / Aerosolised Formulation
[0482] In another aspect there is provided a process for forming an aerosol, the process comprising aerosolising the aerosolisable formulation defined herein. The process may further comprise providing an aerosol generating system as defined herein or the aerosol provision system defined herein and aerosolising the aerosolisable formulation in the system.
[0483] In some examples the aerosol may be formed by a process performed at a temperature below about 60°C. In some examples the aerosol may be formed by a process performed at a temperature below about 50°C. In some examples the aerosol may be formed by a process performed at a temperature below about 40°C. In some examples the aerosol may be formed by a process performed at a temperature below about 30°C. In some examples the aerosol may be formed by a process performed at a temperature below about 25°C. In some examples the aerosol may be formed by a process which does not involve heating.
[0484] In some examples the aerosol may be formed by a process performed at a temperature of up to about 500 °C. In some examples the aerosol may be formed by a process performed at a temperature of up to about 450 °C. In some examples the aerosol may be formed by a process performed at a temperature of up to about 400 °C. In some examples the aerosol may be formed by a process performed at a temperature of up to about 350 °C.
[0485] In some examples, the aerosol may be formed by applying ultrasonic energy to the aerosolisable formulation. In some examples, the aerosol may be formed by applying heat energy to the aerosolisable formulation. In some examples, the aerosol may be formed by applying infra red energy to the aerosolisable formulation.
[0486] In some examples, the formulation may be contained or delivered by any means. In some examples, a contained aerosolisable formulation comprises (a) one or more containers; and (b) an aerosolisable formulation as defined herein. The container may be any suitable container, for example to allow for the storage or delivery of the formulation. In some examples, the container is configured for engagement with an electronic aerosol provision system. The container may be configured to become fluidly in communication with an electronic aerosol provision system so that formulation may be delivered to the electronicaerosol provision system. As described above, the present disclosure relates to container which may be used in an electronic aerosol provision system, such as an e-cigarette. Throughout the following description the term “e-cigarette” is used; however, this term may be used interchangeably with electronic aerosol provision system.
[0487] In some examples, the container is provided for the delivery of aerosolisable formulation to or within an e-cigarette. The aerosolisable formulation may be held within an e-cigarette or may be sold as a separate container for subsequent use with or in an e-cigarette. As understood by one skilled in the art, e-cigarettes may contain a unit known as a detachable cartomiser which typically comprises a reservoir of aerosolisable formulation, and an aerosoliser such as a wick material and a heating element for vaporising the aerosolisable formulation. In some e-cigarettes, the cartomiser is part of a single-piece device and is not detachable. In some examples, the container is a cartomiser or is part of a cartomiser. In some examples, the container is not a cartomiser or part of a cartomiser and is a container, such as a tank, which may be used to deliver nicotine formulation to or within an e-cigarette.
[0488] In some examples, the container is part of an e-cigarette. Therefore, in some examples, the an electronic aerosol provision system comprises: an aerosolisable formulation as defined herein; an aerosoliser for aerosolising formulation for inhalation by a user of the electronic aerosol provision system; and a power supply comprising a cell or battery for supplying power to the aerosoliser.
[0489] In some examples, the aerosol may be formed by applying ultrasonic energy to the aerosolisable formulation. In some examples, the aerosol may be formed by applying heat energy to the aerosolisable formulation. In some examples, the aerosol may be formed by applying infrared energy to the aerosolisable formulation.
[0490] In some examples, the aerosolised formulation comprises at least two compounds selected from phenethyl alcohol; acetic acid; cotinine; 6,8-nonadien-2-one; 2,3-dipyridyl; guaiacol; and 1,2-propanediol, 1-acetate; or cotinine, myosmine, and 1,6,10,14-hexadecatetraene-3-ol,3,7,11,15-tetramethyl-; optionally wherein the aerosolised formulation further comprises one or more compound selected from p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6,10, 14-trimethyl-; 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-; methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol.
[0491] In some examples, the aerosolised formulation may comprise one or more of the following compounds: cotinine, 1,6,10,14-hexadecatetraen-3-ol,3,7,11,15-tetramethyl-, acetic acid, butanal, 3-methyl-, or a combination thereof.
[0492] In some examples, an aerosolised formulation as defined herein has a particle size distribution of D50 of from 2 to 6pm. References in the present specification to particle size distribution, D50, D10 or D90 refer to values measured in accordance with British and European Pharmacopoeia, 2.9.31 Particle Size Analysis By Laser Light Diffraction (see BRITISH PHARMACOPOEIA COMMISSION. (2014), British Pharmacopoeia. London, England: Stationery Office and COUNCIL OF EUROPE. (2013). European Pharmacopoeia. Strasbourg, France: Council of Europe). The terms D50, Dv50 and Dx50 are interchangeable. The terms D10, Dv10 and Dx10 are interchangeable. The terms D90, Dv90 and Dx90 are interchangeable.
[0493] In some examples, the aerosolised formulation has a D50 of from 2.5 to 6pm. In some examples, the aerosolised formulation has a D50 of from 3 to 6pm. In some examples, the aerosolised formulation has a D50 of from 3.5 to 6pm. In some examples, the aerosolised formulation has a D50 of from 4 to 6pm. In some examples, the aerosolised formulation has a D50 of from 4.5 to 6pm. In some examples, the aerosolised formulation has a D50 of from 5 to 6pm. In some examples, the aerosolised formulation has a D50 of from 2.5 to 5.5pm. In some examples, the aerosolised formulation has a D50 of from 3 to 5.5pm. In some examples, the aerosolised formulation has a D50 of from 3.5 to 5.5pm. In some examples, the aerosolised formulation has a D50 of from 4 to 5.5pm. In some examples, the aerosolised formulation has a D50 of from 4.5 to 5.5pm. In some examples, the aerosolised formulation has a D50 of from 5 to 5.5pm. In some examples, the aerosolised formulation has a D50 of from 4 to 5.5pm. In some examples, the aerosolised formulation has a D50 of from 4 to 5pm. In some examples, the aerosolised formulation has a D50 of from 4 to 4.5pm. In some examples, the aerosolised formulation has a D50 of from 2.5 to 5pm. In some examples, the aerosolised formulation has a D50 of from 2.5 to 4.5pm.
[0494] In some examples, the aerosolised formulation has a D10 of at least 0.5pm. In some examples, the aerosolised formulation has a D10 of at least 1pm. In some examples, the aerosolised formulation has a D10 of at least 1.5pm. In some examples, the aerosolised formulation has a D10 of at least 2pm.In some examples, the aerosolised formulation has a D90 of no greater than 15pm. In some examples, the aerosolised formulation has a D90 of no greater than 12pm. In some examples, the aerosolised formulation has a D90 of no greater than 10pm.
[0495] Uses
[0496] In accordance with some aspects of the present disclosure, there is provided use of an extract composition to modify a tobacco flavour in an aerosolisable formulation as defined herein.
[0497] In some examples, the aerosolisable formulation is as defined in any of the above paragraphs. In this respect, the skilled person will appreciate that the disclosure relating to the aerosolisable formulations, consumable and substance delivery systems applies mutatis mutandis to the uses disclosed herein. The use of the extract composition to modify the tobacco flavour is, in some examples, relative to the aerosolisable formulation without the extract composition. In some examples, the extract composition increases the tobacco flavour of the aerosolisable formulation. In some examples, the extract composition increases the tobacco flavour intensity of the aerosolisable formulation.
[0498] In accordance with some aspects of the present disclosure, there is provided use of a extract composition to modify the tobacco flavour of a aerosolisable formulation in a substance delivery system, wherein the extract composition comprises one or more compounds selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the extract composition comprises two or more compounds selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10,14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. In some examples, the extract composition comprises three or more compounds selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; Limonene; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-.
[0499] In some examples, the extract composition and substance delivery system is as defined in any of the above paragraphs. In this respect, the skilled person will appreciate that the disclosure relating to the extract compositions, aerosolisable formulation and substance delivery system applies mutatis mutandis to the uses disclosed herein. The use of the extract composition to modify the tobacco flavour is, in some examples, relative to the aerosolisable formulation without the extract composition. In some examples, the extract composition increases the tobacco flavour of the aerosolisable formulation. In some examples, the extract composition increases the tobacco flavour intensity of the aerosolisable formulation.
[0500] In accordance with some aspects of the present disclosure, there is provided the use of a extract composition to modify the irritation of a aerosolisable formulation in a substance delivery system, wherein the extract composition comprises one or more compounds selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the extract composition comprises two or more compounds selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol. In some examples, the extract composition comprises three or more compounds selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol
[0501] In some examples; the extract composition and substance delivery system is as defined in any of the above paragraphs. In this respect, the skilled person will appreciate that the disclosure relating to the extract compositions, aerosolisable formulation and substance delivery system applies mutatis mutandis to the uses disclosed herein. The use of the extract composition to modify the irritation is, in some examples, relative to the aerosolisable formulation without the extract composition. In some examples, the extract composition increases the irritation of the aerosolisable formulation. In some examples, the extract composition increases the irritation intensity of the aerosolisable formulation.In accordance with some aspects of the present disclosure, there is provided the use of an aerosol formulation to improve nicotine satisfaction.
[0502] In accordance with some aspects of the present disclosure, there is provided the use of an aerosol formulation for improving the storage stability of an aerosolised nicotine formulation.
[0503] The use of the extract composition to modify the taste is, in some examples, relative to the aerosolisable formulation without the extract composition. In some examples, the extract composition increases the tobacco taste of the aerosolisable formulation. In some examples, the extract composition increases the tobacco taste intensity of the aerosolisable formulation.
[0504] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, components of an extract composition, e.g. a tobacco extract composition, were found to be augmented by a flavour component. In this regard, specific aspects are provided below.
[0505] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2,6,6-trimethyl-2-cyclohexene-1,4-dione, 2-acetyl-5-methylfuran, 2-methoxy-4-vinylphenol, 4-vinylphenol, benzaldehyde, 4-hydroxy-, benzeneacetic acid, benzenemethanol alpha-methyl-, ethanone, 1 -(1 h-pyrrol-2-yl)-, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, ethanone, 1-(3-pyridinyl)-, ethanone, 1-(4-methylphenyl)-, eugenol, hydrocinnamic acid, indole, maltol, methyl nicotinate, p-cresol, phenol, 2,4-dimethyl-, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, phytol, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, pyridine, 3-ethyl-, pyridine, 3-propyl-, resorcinol, tetradecanoic acid, tiglic acid; wherein the aerosolisable formulation further comprises a flavour component comprising one or more compounds selected from the group consisting of aromatic aldehydes, aliphatic ketones, aromatic ketones, C6 to C18 substituted pyrazines, furan derivatives and combinations thereof.
[0506] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2,6,6-trimethyl-2-cyclohexene-1,4-dione, 2-acetyl-5-methylfuran, 2-methoxy-4-vinylphenol, 4-vinylphenol, benzaldehyde, 4-hydroxy-, benzeneacetic acid, benzenemethanol alpha-methyl-, ethanone, 1 -(1 h-pyrrol-2-yl)-, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, ethanone, 1-(3-pyridinyl)-, ethanone, 1-(4-methylphenyl)-, eugenol, hydrocinnamic acid, indole, maltol, methyl nicotinate, p-cresol,phenol, 2,4-dimethyl-, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, phytol, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, pyridine, 3-ethyl-, pyridine, 3-propyl-, resorcinol, tetradecanoic acid, tiglic acid; wherein the aerosolisable formulation further comprises a flavour component comprising at least one aromatic aldehyde, at least one aliphatic ketone, at least one aromatic ketone, at least four C6 to C18 substituted pyrazines and at least two furan derivatives.
[0507] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2,6,6-trimethyl-2-cyclohexene-1,4-dione, 2-acetyl-5-methylfuran, 2-pentadecanone, 6, 10, 14-trimethyl-, 3-hexen-1-ol, (e)-, 5-hydroxymethylfurfural, methyl nicotinate, phenylethyl alcohol, phytol, pyridine, 2-ethyl-, ethanone, 1-(3-pyridinyl)-, tiglic acid, 2-furancarboxaldehyde, 5-methyl-, ethanone, 1-(1h-pyrrol-2-yl)-, maltol; wherein the aerosolisable formulation further comprises a flavour component comprising one or more compounds selected from the group consisting of aliphatic ketones, aliphatic aldehydes, C6 to C18 substituted pyridines and combinations thereof.
[0508] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2,6,6-trimethyl-2-cyclohexene-1,4-dione, 2-acetyl-5-methylfuran, 2-pentadecanone, 6, 10, 14-trimethyl-, 3-hexen-1-ol, (e)-, 5-hydroxymethylfurfural, methyl nicotinate, phenylethyl alcohol, phytol, pyridine, 2-ethyl-, ethanone, 1-(3-pyridinyl)-, tiglic acid, 2-furancarboxaldehyde, 5-methyl-, ethanone, 1-(1h-pyrrol-2-yl)-, maltol; wherein the aerosolisable formulation further comprises a flavour component comprising at least one aliphatic ketone, at least one aliphatic aldehyde and at least one C6 to C18 substituted pyridine.
[0509] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of (cyclohexylmethyl)pyrazine, 2,6,6-trimethyl-2-cyclohexene-1, 4-dione, 2-furancarboxaldehyde, 5-methyl-, 2-furoic acid, 2-methoxy-4-vinylphenol, 5-hydroxymethylfurfural, acetophenone, benzaldehyde, benzaldehyde, 4-hydroxy-, benzeneacetic acid methyl ester, benzenemethanol alpha-methyl-, benzoic acid, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, eugenol, hydrocinnamic acid, methyl nicotinate, pentanoic acid, 4-oxo-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 3,4-dimethyl-, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, 3-ethyl-, pyridine, 3-methyl-, tiglic acid; wherein the aerosolisable formulation further comprises a flavour componentcomprising one or more compounds selected from the group consisting of aliphatic aldehydes, C6 to C18 substituted pyridines, C6 to C18 substituted pyrazines, furan derivatives and combinations thereof.
[0510] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of (cyclohexylmethyl)pyrazine, 2,6,6-trimethyl-2-cyclohexene-1, 4-dione, 2-furancarboxaldehyde, 5-methyl-, 2-furoic acid, 2-methoxy-4-vinylphenol, 5-hydroxymethylfurfural, acetophenone, benzaldehyde, benzaldehyde, 4-hydroxy-, benzeneacetic acid methyl ester, benzenemethanol alpha-methyl-, benzoic acid, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, eugenol, hydrocinnamic acid, methyl nicotinate, pentanoic acid, 4-oxo-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 3,4-dimethyl-, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, 3-ethyl-, pyridine, 3-methyl-, tiglic acid; wherein the aerosolisable formulation further comprises a flavour component comprising at least one aliphatic aldehyde, at least one C6 to C18 substituted pyridine, at least one C6 to C18 substituted pyrazine and at least one furan derivative.
[0511] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of (cyclohexylmethyl)pyrazine, 2,6,6-trimethyl-2-cyclohexene-1, 4-dione, 2-furancarboxaldehyde, 5-methyl-, 2-furoic acid, 2-methoxy-4-vinylphenol, 5-hydroxymethylfurfural, acetophenone, benzaldehyde, benzaldehyde, 4-hydroxy-, benzeneacetic acid methyl ester, benzenemethanol alpha-methyl-, benzoic acid, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, eugenol, hydrocinnamic acid, methyl nicotinate, pentanoic acid, 4-oxo-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 3,4-dimethyl-, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, 3-ethyl-, pyridine, 3-methyl-, tiglic acid; wherein the aerosolisable formulation further comprises a flavour component comprising one or more compounds selected from the group consisting of aliphatic ketones, furan derivatives, C6 to C18 substituted pyrazines, C7 to C18 substituted phenols, norisoprenoids and combinations thereof.
[0512] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of (cyclohexylmethyl)pyrazine, 2,6,6-trimethyl-2-cyclohexene-1, 4-dione, 2-furancarboxaldehyde, 5-methyl-, 2-furoic acid, 2-methoxy-4-vinylphenol, 5-hydroxymethylfurfural, acetophenone, benzaldehyde, benzaldehyde, 4-hydroxy-, benzeneacetic acid methyl ester, benzenemethanol alpha-methyl-, benzoic acid, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, eugenol, hydrocinnamic acid, methylnicotinate, pentanoic acid, 4-oxo-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 3,4-dimethyl-, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, 3-ethyl-, pyridine, 3-methyl-, tiglic acid; wherein the aerosolisable formulation further comprises a flavour component comprising at least one aliphatic ketone, at least one furan derivative, at least one C6 to C18 substituted pyrazine, at least one C7 to C18 substituted phenol and at least one norisoprenoid.
[0513] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2-cyclopenten-1-one, 2-hydroxy-3-methyl-, 2-furancarboxaldehyde, 5-methyl-, 4-vinylphenol, benzeneacetic acid, butanoic acid, butanoic acid, 2-methyl-, butanoic acid, 3-methyl-, dimethyl sulfoxide, eugenol, heptanoic acid, indole, octanoic acid, oleic acid, pentanoic acid, pentanoic acid, 3-methyl-, pentanoic acid, 4-methyl-, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, propanoic acid, 2-methyl-, pyridine; wherein the aerosolisable formulation further comprises a flavour component comprising one or more compounds selected from the group consisting of aliphatic aldehydes, thio-ethers and combinations thereof.
[0514] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2-cyclopenten-1-one, 2-hydroxy-3-methyl-, 2-furancarboxaldehyde, 5-methyl-, 4-vinylphenol, benzeneacetic acid, butanoic acid, butanoic acid, 2-methyl-, butanoic acid, 3-methyl-, dimethyl sulfoxide, eugenol, heptanoic acid, indole, octanoic acid, oleic acid, pentanoic acid, pentanoic acid, 3-methyl-, pentanoic acid, 4-methyl, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, propanoic acid, 2-methyl-, pyridine; wherein the aerosolisable formulation further comprises a flavour component comprising at least one aliphatic aldehyde and at least one thio-ether.
[0515] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of (cyclohexylmethyl)pyrazine, 2-acetyl-5-methylfuran, 2-propanone, 1- (acetyl oxy)-, acetophenone, benzaldehyde, benzaldehyde, 4-hydroxy-, 5,9-undecadien-2-one, 6,10-dimethyl-, (e)-, ethanone, 1-(1 h-pyrrol-2-yl)-, ethanone, 1-(2-furanyl), ethanone, 1-(2-methylphenyl)-, ethanone, 1 -(3-pyridinyl)-, furaneol, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, 3-ethyl-, pyridine, 3-methyl-, resorcinol, benzenemethanol, alpha-methyl-, benzyl alcohol, maltol; wherein the aerosolisable formulation further comprises a flavour component comprising one or more compounds selected from the group consisting of aliphatic ketones, aliphatic aldehydes, C6 to C18 substituted pyrazines, C7 to C18 substituted phenols and combinations thereof.In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of (cyclohexylmethyl)pyrazine, 2-acetyl-5-methylfuran, 2-propanone, 1- (acetyl oxy)-, acetophenone, benzaldehyde, benzaldehyde, 4-hydroxy-, 5,9-undecadien-2-one, 6,10-dimethyl-, ethanone, 1-(1 h-pyrrol-2-yl)-, ethanone, 1-(2-furanyl), ethanone, 1-(2-methylphenyl)-, ethanone, 1 -(3-pyridinyl)-, furaneol, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, 3-ethyl-, pyridine, 3-methyl-, resorcinol, benzenemethanol, alpha-methyl-, benzyl alcohol, maltol; wherein the aerosolisable formulation further comprises a flavour component comprising at least one aliphatic ketone, at least one aliphatic aldehyde, at least one C6 to C18 substituted pyrazine and at least one C7 to C18 substituted phenol.
[0516] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2,6,6-trimethyl-2-cyclohexene-1,4-dione, 2-acetyl-5-methylfuran, 2-methoxy-4-vinylphenol, 4-vinylphenol, benzaldehyde, 4-hydroxy-, benzeneacetic acid, benzenemethanol, alpha-methyl-, ethanone, 1-(1 h-pyrrol-2-yl)-, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-ethylphenyl)-, ethanone, 1 -(3-pyridinyl)-, ethanone, 1-(4-methylphenyl)-, eugenol, hydrocinnamic acid, indole, maltol, methyl nicotinate, p-cresol, phenol, 2,4-dimethyl-, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, phytol, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, pyridine, 3-ethyl-, pyridine, 3-propyl-, resorcinol, tetradecanoic acid, tiglic acid; wherein the aerosolisable formulation further comprises a flavour component comprising at least one C7 to C18 substituted phenol.
[0517] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of (cyclohexylmethyl)pyrazine, 2,6,6-trimethyl-2-cyclohexene-1, 4-dione, 2-furancarboxaldehyde, 5-methyl-, 2-furoic acid, 2-methoxy-4-vinylphenol, 5-hydroxymethylfurfural, benzaldehyde, benzaldehyde, 4-hydroxy-, benzeneacetic acid methyl ester, benzenemethanol alpha-methyl-, benzoic acid, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, eugenol, hydrocinnamic acid, methyl nicotinate, pentanoic acid, 4-oxo-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 3,4-dimethyl-, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, 3-ethyl-, pyridine, 3-methyl-, tiglic acid, 2-acetyl-5-methylfuran, 2-propanone, 1 -(acetyloxy)-, acetophenone, 5,9-undecadien-2-one, 6,10-dimethyl-, (e)-, ethanone, 1-(1 h-pyrrol-2-yl)-, ethanone, 1-(3-pyridinyl)-, furaneol, resorcinol, benzyl alcohol, maltol; wherein the aerosolisable formulation further comprises a flavour component comprising one or more compounds selected from the group consisting ofaliphatic ketones, furan derivatives, aliphatic aldehydes, C6 to C18 substituted pyrazines, C7 to C18 substituted phenols, norisoprenoids and combinations thereof.
[0518] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of (cyclohexylmethyl)pyrazine, 2,6,6-trimethyl-2-cyclohexene-1, 4-dione, 2-furancarboxaldehyde, 5-methyl-, 2-furoic acid, 2-methoxy-4-vinylphenol, 5-hydroxymethylfurfural, benzaldehyde, benzaldehyde, 4-hydroxy-, benzeneacetic acid methyl ester, benzenemethanol alpha-methyl-, benzoic acid, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, eugenol, hydrocinnamic acid, methyl nicotinate, pentanoic acid, 4-oxo-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 3,4-dimethyl-, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, 3-ethyl-, pyridine, 3-methyl-, tiglic acid, 2-acetyl-5-methylfuran, 2-propanone, 1 -(acetyloxy)-, acetophenone, 5,9-undecadien-2-one, 6,10-dimethyl-, (e)-, ethanone, 1-(1 h-pyrrol-2-yl)-, ethanone, 1-(3-pyridinyl)-, furaneol, resorcinol, benzyl alcohol, maltol; wherein the aerosolisable formulation further comprises a flavour component comprising at least two aliphatic ketones, at least one furan derivative, at least one aliphatic aldehyde, at least two C6 to C18 substituted pyrazines, at least two C7 to C18 substituted phenols and at least one norisoprenoid.
[0519] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of (cyclohexylmethyl)pyrazine, 2,6,6-trimethyl-2-cyclohexene-1, 4-dione, 2-furancarboxaldehyde, 5-methyl-, 2-furoic acid, 2-methoxy-4-vinylphenol, 5-hydroxymethylfurfural, benzaldehyde, benzaldehyde, 4-hydroxy-, benzeneacetic acid methyl ester, benzenemethanol alpha-methyl-, benzoic acid, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, eugenol, hydrocinnamic acid, methyl nicotinate, pentanoic acid, 4-oxo-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 3,4-dimethyl-, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, 3-ethyl-, pyridine, 3-methyl-, tiglic acid, 2-acetyl-5-methylfuran, 2-propanone, 1 -(acetyloxy)-, acetophenone, 5,9-undecadien-2-one, 6,10-dimethyl-, (e)-, ethanone, 1-(1 h-pyrrol-2-yl)-, ethanone, 1-(3-pyridinyl)-, furaneol, resorcinol, benzyl alcohol, maltol, 2-cyclopenten-1-one, 2-hydroxy-3-methyl-, 2-furancarboxaldehyde, 5-methyl-, 4-vinylphenol, benzeneacetic acid, butanoic acid, butanoic acid, 2-methyl-, butanoic acid, 3-methyl-, dimethyl sulfoxide, eugenol, heptanoic acid, indole, octanoic acid, oleic acid, pentanoic acid, pentanoic acid, 3-methyl-, pentanoic acid, 4-methyl, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, propanoic acid, 2-methyl-, pyridine; wherein the aerosolisable formulation further comprises a flavour component comprising one or more compounds selected from the group consisting ofaliphatic ketones, furan derivatives, aliphatic aldehydes, C6 to C18 substituted pyrazines, C7 to C18 substituted phenols, norisoprenoids, thio-ethers and combinations thereof.
[0520] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of (cyclohexylmethyl)pyrazine, 2,6,6-trimethyl-2-cyclohexene-1, 4-dione, 2-furancarboxaldehyde, 5-methyl-, 2-furoic acid, 2-methoxy-4-vinylphenol, 5-hydroxymethylfurfural, benzaldehyde, benzaldehyde, 4-hydroxy-, benzeneacetic acid methyl ester, benzenemethanol alpha-methyl-, benzoic acid, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, eugenol, hydrocinnamic acid, methyl nicotinate, pentanoic acid, 4-oxo-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 3,4-dimethyl-, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, 3-ethyl-, pyridine, 3-methyl-, tiglic acid, 2-acetyl-5-methylfuran, 2-propanone, 1 -(acetyloxy)-, acetophenone, 5,9-undecadien-2-one, 6,10-dimethyl-, ethanone, 1-(1 h-pyrrol-2-yl)-, ethanone, 1 -(3-pyridinyl)-, furaneol, resorcinol, benzyl alcohol, maltol, 2-cyclopenten-1-one, 2-hydroxy-3-methyl-, 2-furancarboxaldehyde, 5-methyl-, 4-vinylphenol, benzeneacetic acid, butanoic acid, butanoic acid, 2-methyl-, butanoic acid, 3-methyl-, dimethyl sulfoxide, eugenol, heptanoic acid, indole, octanoic acid, oleic acid, pentanoic acid, pentanoic acid, 3-methyl-, pentanoic acid, 4-methyl, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, propanoic acid, 2-methyl-, pyridine; wherein the aerosolisable formulation further comprises a flavour component comprising at least two aliphatic ketones, at least one furan derivative, at least two aliphatic aldehydes, at least two C6 to C18 substituted pyrazines, at least two C7 to C18 substituted phenols, at least one norisoprenoid and at least one thio-ether.
[0521] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2,6,6-trimethyl-2-cyclohexene-1,4-dione, 2-acetyl-5-methylfuran, 2-methoxy-4-vinylphenol, 4-vinylphenol, benzaldehyde, 4-hydroxy-, benzeneacetic acid, benzenemethanol alpha-methyl-, ethanone, 1 -(1 h-pyrrol-2-yl)-, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, ethanone, 1-(3-pyridinyl)-, ethanone, 1-(4-methylphenyl)-, eugenol, hydrocinnamic acid, indole, maltol, methyl nicotinate, p-cresol, phenol, 2,4-dimethyl-, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, phytol, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, pyridine, 3-ethyl-, pyridine, 3-propyl-, resorcinol, tetradecanoic acid, tiglic acid, 2-cyclopenten-1-one, 2-hydroxy-3-methyl-, 2-furancarboxaldehyde, 5-methyl-, 4-vinylphenol, benzeneacetic acid, butanoic acid, butanoic acid, 2-methyl-, butanoic acid, 3-methyl-, dimethyl sulfoxide, eugenol, heptanoic acid, indole,octanoic acid, oleic acid, pentanoic acid, pentanoic acid, 3-methyl-, pentanoic acid, 4-methyl, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, propanoic acid, 2-methyl-, pyridine; wherein the aerosolisable formulation further comprises a flavour component comprising one or more compounds selected from the group consisting of aliphatic aldehydes, aromatic aldehydes, aliphatic ketones, aromatic ketones, C6 to C18 substituted pyrazines, thio-ethers, furan derivatives and combinations thereof.
[0522] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2,6,6-trimethyl-2-cyclohexene-1,4-dione, 2-acetyl-5-methylfuran, 2-methoxy-4-vinylphenol, 4-vinylphenol, benzaldehyde, 4-hydroxy-, benzeneacetic acid, benzenemethanol alpha-methyl-, ethanone, 1 -(1 h-pyrrol-2-yl)-, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, ethanone, 1-(3-pyridinyl)-, ethanone, 1-(4-methylphenyl)-, eugenol, hydrocinnamic acid, indole, maltol, methyl nicotinate, p-cresol, phenol, 2,4-dimethyl-, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, phytol, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, pyridine, 3-ethyl-, pyridine, 3-propyl-, resorcinol, tetradecanoic acid, tiglic acid, 2-cyclopenten-1-one, 2-hydroxy-3-methyl-, 2-furancarboxaldehyde, 5-methyl-, 4-vinylphenol, benzeneacetic acid, butanoic acid, butanoic acid, 2-methyl-, butanoic acid, 3-methyl-, dimethyl sulfoxide, eugenol, heptanoic acid, indole, octanoic acid, oleic acid, pentanoic acid, pentanoic acid, 3-methyl-, pentanoic acid, 4-methyl, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, propanoic acid, 2-methyl-, pyridine; wherein the aerosolisable formulation further comprises a flavour component comprising at least one aliphatic aldehyde, at least one aromatic aldehyde, at least one aliphatic ketone, at least one aromatic ketone, at least four C6 to C18 substituted pyrazines, at least one thio-ether and at least two furan derivatives.
[0523] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2,6,6-trimethyl-2-cyclohexene-1,4-dione, 2-acetyl-5-methylfuran, 2-methoxy-4-vinylphenol, 4-vinylphenol, benzaldehyde, 4-hydroxy-, benzeneacetic acid, benzenemethanol alpha-methyl-, ethanone, 1 -(1 h-pyrrol-2-yl)-, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, ethanone, 1-(3-pyridinyl)-, ethanone, 1-(4-methylphenyl)-, eugenol, hydrocinnamic acid, indole, maltol, methyl nicotinate, p-cresol, phenol, 2,4-dimethyl-, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, phytol, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, pyridine, 3-ethyl-, pyridine, 3-propyl-, resorcinol,tetradecanoic acid, tiglic acid, (cyclohexylmethyl)pyrazine, 2-propanone, 1- (acetyl oxy)-, acetophenone, benzaldehyde, 5,9-undecadien-2-one, 6,10-dimethyl-, (e)-, furaneol, pyridine, 3-methyl-, benzyl alcohol, maltol; wherein the aerosolisable formulation further comprises a flavour component comprising one or more compounds selected from the group consisting of aromatic aldehydes, aliphatic ketones, aliphatic aldehydes, aromatic ketones, C6 to C18 substituted pyrazines, C7 to C18 substituted phenols, furan derivatives and combinations thereof.
[0524] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2,6,6-trimethyl-2-cyclohexene-1,4-dione, 2-acetyl-5-methylfuran, 2-methoxy-4-vinylphenol, 4-vinylphenol, benzaldehyde, 4-hydroxy-, benzeneacetic acid, benzenemethanol alpha-methyl-, ethanone, 1 -(1 h-pyrrol-2-yl)-, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, ethanone, 1-(3-pyridinyl)-, ethanone, 1-(4-methylphenyl)-, eugenol, hydrocinnamic acid, indole, maltol, methyl nicotinate, p-cresol, phenol, 2,4-dimethyl-, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, phytol, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, pyridine, 3-ethyl-, pyridine, 3-propyl-, resorcinol, tetradecanoic acid, tiglic acid, (cyclohexylmethyl)pyrazine, 2-propanone, 1- (acetyl oxy)-, acetophenone, benzaldehyde, 5,9-undecadien-2-one, 6,10-dimethyl-, (e)-, furaneol, pyridine, 3-methyl-, benzyl alcohol, maltol; wherein the aerosolisable formulation further comprises a flavour component comprising at least one aromatic aldehyde, at least two aliphatic ketones, at least one aliphatic aldehyde, at least one aromatic ketone, at least five C6 to C18 substituted pyrazines, at least one C7 to C18 substituted phenols and at least two furan derivatives.
[0525] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2-cyclopenten-1-one, 2-hydroxy-3-methyl-, 2-furancarboxaldehyde, 5-methyl-, 4-vinylphenol, benzeneacetic acid, butanoic acid, butanoic acid, 2-methyl-, butanoic acid, 3-methyl-, dimethyl sulfoxide, eugenol, heptanoic acid, indole, octanoic acid, oleic acid, pentanoic acid, pentanoic acid, 3-methyl-, pentanoic acid, 4-methyl-, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, propanoic acid, 2-methyl-, pyridine, 2,6,6-trimethyl-2-cyclohexene-1,4-dione, 2-acetyl-5-methylfuran, 2-pentadecanone, 6, 10, 14-trimethyl-, 3-hexen-1-ol, (e)-, 5-hydroxymethylfurfural, methyl nicotinate, phenylethyl alcohol, phytol, pyridine, 2-ethyl-, ethanone, 1 -(3-pyridinyl)-, tiglic acid, ethanone, 1 -(1 h-pyrrol-2-yl)-, maltol; wherein the aerosolisable formulation further comprises a flavour component comprising one or morecompounds selected from the group consisting of aliphatic aldehydes, aliphatic ketones, C6 to C18 substituted pyridines, thio-ether and combinations thereof.
[0526] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2-cyclopenten-1-one, 2-hydroxy-3-methyl-, 2-furancarboxaldehyde, 5-methyl-, 4-vinylphenol, benzeneacetic acid, butanoic acid, butanoic acid, 2-methyl-, butanoic acid, 3-methyl-, dimethyl sulfoxide, eugenol, heptanoic acid, indole, octanoic acid, oleic acid, pentanoic acid, pentanoic acid, 3-methyl-, pentanoic acid, 4-methyl, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, propanoic acid, 2-methyl-, pyridine, 2,6,6-trimethyl-2-cyclohexene-1,4-dione, 2-acetyl-5-methylfuran, 2-pentadecanone, 6, 10, 14-trimethyl-, 3-hexen-1-ol, (e)-, 5-hydroxymethylfurfural, methyl nicotinate, phenylethyl alcohol, phytol, pyridine, 2-ethyl-, ethanone, 1 -(3-pyridinyl)-, tiglic acid, ethanone, 1 -(1 h-pyrrol-2-yl)-, maltol; wherein the aerosolisable formulation further comprises a flavour component comprising at least two aliphatic aldehydes, at least one aliphatic ketone, at least one C6 to C18 substituted pyridine and at least one thio-ether.
[0527] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compounds selected from the group consisting of 2-cyclopenten-1-one, 2-hydroxy-3-methyl-, 2-furancarboxaldehyde, 5-methyl-, 4-vinylphenol, benzeneacetic acid, butanoic acid, butanoic acid, 2-methyl-, butanoic acid, 3-methyl-, dimethyl sulfoxide, eugenol, heptanoic acid, indole, octanoic acid, oleic acid, pentanoic acid, pentanoic acid, 3-methyl-, pentanoic acid, 4-methyl-, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, propanoic acid, 2-methyl-, pyridine, (cyclohexylmethyl)pyrazine, 2,6,6-trimethyl-2-cyclohexene-1, 4-dione, 2-furoic acid, 2-methoxy-4-vinylphenol, 5-hydroxymethylfurfural, acetophenone, benzaldehyde, benzaldehyde, 4-hydroxy-, benzeneacetic acid methyl ester, benzenemethanol alpha-methyl-, benzoic acid, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, hydrocinnamic acid, methyl nicotinate, pentanoic acid, 4-oxo-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 3,4-dimethyl-, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, 3-ethyl-, pyridine, 3-methyl-, tiglic acid; wherein the aerosolisable formulation further comprises a flavour component comprising one or more compounds selected from the group consisting of aliphatic aldehydes, C6 to C18 substituted pyridines, C6 to C18 substituted pyrazines, furan derivatives, thio-ethers and combinations thereof.
[0528] In accordance with other aspects of the present disclosure, relating to the aerosolisable formulations defined herein, there is provided an extract composition comprising compoundsselected from the group consisting of 2-cyclopenten-1-one, 2-hydroxy-3-methyl-, 2-furancarboxaldehyde, 5-methyl-, 4-vinylphenol, benzeneacetic acid, butanoic acid, butanoic acid, 2-methyl-, butanoic acid, 3-methyl-, dimethyl sulfoxide, eugenol, heptanoic acid, indole, octanoic acid, oleic acid, pentanoic acid, pentanoic acid, 3-methyl-, pentanoic acid, 4-methyl, phenol, 2,6-dimethoxy-, phenol, 2-methoxy-, phenol, 4-ethyl-, phenol, 4-ethyl-2-methoxy-, propanoic acid, 2-methyl-, pyridine, (cyclohexylmethyl)pyrazine, 2,6,6-trimethyl-2-cyclohexene-1, 4-dione, 2-furoic acid, 2-methoxy-4-vinylphenol, 5-hydroxymethylfurfural, acetophenone, benzaldehyde, benzaldehyde, 4-hydroxy-, benzeneacetic acid methyl ester, benzenemethanol alpha-methyl-, benzoic acid, ethanone, 1-(2-furanyl)-, ethanone, 1-(2-methylphenyl)-, hydrocinnamic acid, methyl nicotinate, pentanoic acid, 4-oxo-, phenol, 2-methoxy-4-(2-propenyl)-, acetate, phenol, 3,4-dimethyl-, pyrazine, 2,6-dimethyl-, pyrazine, methyl-, pyridine, 3-ethyl-, pyridine, 3-methyl-, tiglic acid; wherein the aerosolisable formulation further comprises a flavour component comprising at least two aliphatic aldehydes, at least one C6 to C18 substituted pyridine, at least one C6 to C18 substituted pyrazine, at least one furan derivative and at least one thio-ether.
[0529] The skilled person will understand that the teachings herein that relate to the extract composition of the present disclosure apply mutatis mutandis to the aerosol provision system and consumable as described above.
[0530] Other Broad Concepts
[0531] Other broad concepts encompassed by the present disclosure include an aerosolisable formulation comprising (a) a carrier, (b) nicotine in unprotonated form and in protonated form, (c) one or more organic acids, the total content of the one or more organic acids (c) present in the formulation being from 0.6 to 1.4 mole equivalents based on the nicotine, and a composition comprising limonene and / or 3,4-dihydrocoumarin, and at least two compounds selected from: myosmine; p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Nicotyrine; Propanoic acid, 2-oxo, methyl ester; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10, 14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-; or at least two compounds selected from: p-cresol; Pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; Propanoic acid, 2-methyl-; 2-Cyclopenten-1-one, 3-methyl-; 6-Ethyl-5,6-dihydro-2H-pyran-2-one; Phenol; Phenol, 4-ethyl-; Propanoic acid; Styrene; Benzene, 1,3-dimethyl-; 3-Pyridinol; 2,3-Dimethoxyphenol; 2-Pentadecanone, 6, 10,14-trimethyl-; and 2-Cyclopenten-1-one, 3-ethyl-2-hydroxy-. The remainder of the present disclosure applies to this composition mutatis mutandis. Forexample, the composition may further comprise at least one compound selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; Methylacetophenone; Phenylacetaldehyde; Anisaldehyde; Nonanal; Ethylguaiacol; alpha-Linolenic acid; Eucalyptol; Isovaleric acid; 2,3-Pentanedione; Hexanal; Methoxyvinylphenol; Linalool; Piperitone; Guaiacol; and Terpineol.
[0532] In all of the concepts disclosed herein, the composition may further comprise one or more compound selected from: 3-ethylpyridine, indole, guaiacol, syringol, 4-methylguaicol, betacaryophyllene, 3-methyl indole, triethylamine, tabanone, methylamine, m-cresol, sclareol, cis-abienol, and combinations thereof.
[0533] The present invention will now be described with reference to the following non-limiting examples.
[0534] Examples
[0535] Example 1
[0536] The inventors have identified a range of compounds responsible for the tobacco flavour and / or irritation experience of smoking a traditional cigarette (sometimes called a factory made cigarette or FMC). The compounds were identified by collecting and analysing the smoke produced from burning cigarettes. Analysis was performed using HTS-HRMS (High Throughput Screening coupled with High Resolution Mass Spectroscopy) and GC-MS data. Specifically, compounds could be identified based on exact monoisotopic mass and isotopic patterns from HTS-HRMS data and from GC-MS data, as compared to reference MS libraries and reference compounds. Human sensory assessment was also used to identify compounds that provided irritation and tobacco flavour.
[0537] A machine learning model was created, trained and validated using more than 1,000 samples that were previously assessed by human sensory panels and GC-MS chemosensory analysis, to determine for each compound whether it would enhance or decrease one or more categories or dimensions associated with providing an ‘FMC-like’ experience, namely sense, taste, and flavour. Using partial least squares regression models, compounds were identified that noticeably enhanced tobacco flavour / aroma and / or irritation. The compounds having a VIP (Variable Importance of Projection) higher than 1 for irritation and tobacco flavour were then identified. These compounds were termed irritation and / or tobacco flavour markers. The twenty compounds with the highest VIP for irritation are listed in the table below.To further refine those compounds acting as key markers for tobacco flavour, the compounds identified in the above assessment were assigned an odour threshold value with reference to compound libraries. An odour threshold value or OTV represents the lowest concentration of a substance that can be detected by the human sense of smell. The twenty compounds that enhanced tobacco flavour with the lowest OTVs, i.e. those easily detected by the human sense of smell, are listed in the table below.
[0538] Table 1: Chemical Markers for Irritation and Tobacco Flavour
[0539] Tobacco Flavour
[0540] Irritation Markers CAS No. CAS No.
[0541] Markers
[0542] Myosmine 1125-96-8 Methylbutyric acid* 116-53-0 p-cresol 106-44-5 Piperonal 120-57-0 Pyridine, 4-ethenyl- 100-43-6 Indole 120-72-9 2-cyclopenten-1- one, 2-hydroxy-3- 80-71-7 Ethyl vanillin 121-32-4 methyl-**
[0543] 1H-indole, 6-methyl- 3420-02-8 Vanillin* 121-33-5 Nicotyrine 487-19-4 Methylacetophenone 122-00-9 Propanoic acid, 2- 600-22-6 Phenylacetaldehyde 122-78-1 oxo, methyl ester
[0544] Propanoic acid, 2- 79-31-2 Anisaldehyde 123-11-5 methyl- 2-Cyclopenten-1- 2758-18-1 Nonanal 124-19-6 one, 3-methyl- D- Limonene 5989-27-5 Ethylguaiacol 2785-89-9 6-Ethyl-5,6-dihydro- 19895-35-3 alpha-Linolenic acid 463-40-1 2H-pyran-2-one
[0545] Phenol 108-95-2 Eucalyptol 470-82-6 Phenol, 4-ethyl- 123-07-9 Isovaleric acid 503-74-2 Propanoic acid 79-09-4 2,3-Pentanedione 600-14-6 Styrene 100-42-5 Hexanal 66-25-1 Benzene, 1,3- 108-38-3 Methoxyvinylphenol 7786-61-0 dimethyl- 3-Pyridinol 109-00-2 Linalool 78-70-6
[0546] 2,3- 5150-42-5 Piperitone 89-81-6 Dimethoxyphenol
[0547] 2-Pentadecanone,
[0548] 502-69-2 Guaiacol 90-05-1 6, 10, 14- trimethyl- 2-Cyclopenten-1- one, 3-ethyl-2- 21835-01-8 Terpineol 98-55-5
[0549]
[0550] hydroxy-**
[0551] *compound also identified as enhancing irritation but with a VIP of less than 1.
[0552] **compound also identified as enhancing tobacco flavour but with no ...
Claims
CLAIMS1). An aerosolisable formulation comprising:(a) a carrier;(b) nicotine in unprotonated form and in protonated form;(c) one or more organic acids, the total content of the one or more organic acids (c) present in the formulation is of from 0.6 to 1.4 mole equivalents based on the nicotine; and(d) a composition comprising three or more compounds selected from: myosmine; p- cresol; pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6- methyl-; nicotyrine; propanoic acid, 2-oxo, methyl ester; propanoic acid, 2-methyl-; 2- cyclopenten-1-one, 3-methyl-; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; phenol; phenol, 4-ethyl-; propanoic acid; styrene; benzene, 1,3-dimethyl-; 3-pyridinol; 2.3-dimethoxyphenol; 2-pentadecanone, 6, 10, 14-trimethyl-; 2-cyclopenten-1-one, 3- ethyl-2-hydroxy-; methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; methylacetophenone; phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-Linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; terpineol; acetic acid; 2- furanmethanol; 2-furancarboxaldehyde, 5-methyl; benzyl alcohol; phenethylalcohol; 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl; n-hexadecanoic acid; octadecanoic acid; or a combination thereof; or a composition comprising one or more compounds selected from: p-cresol; pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; propanoic acid, 2-oxo, methyl ester; propanoic acid, 2-methyl-; 2-cyclopenten-1-one, 3-methyl-; limonene; 6-ethyl-5,6- dihydro-2H-pyran-2-one; phenol; phenol, 4-ethyl-; propanoic acid; styrene; benzene, 1.3-dimethyl-; 3-pyridinol; 2,3-dimethoxyphenol; 2-pentadecanone, 6, 10, 14- trimethyl-; 2-cyclopenten-1-one, 3-ethyl-2-hydroxy-; methylbutyric acid; piperonal; indole; methylacetophenone; phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-Linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; terpineol; acetic acid; 2- furanmethanol; 2-furancarboxaldehyde, 5-methyl; benzyl alcohol; phenethylalcohol; 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl; n-hexadecanoic acid; octadecanoic acid; or a combination thereof; optionally wherein the composition is an extract composition.2). The aerosolisable formulation according to claim 1, wherein the extract composition comprises three or more compounds selected from: myosmine; p-cresol; pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1H-indole, 6-methyl-; nicotyrine; propanoic acid, 2-oxo, methyl ester; propanoic acid, 2-methyl-; 2-cyclopenten-1-one, 3- methyl-; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; phenol; phenol, 4-ethyl-; propanoic acid; styrene; benzene, 1,3-dimethyl-; 3-pyridinol; 2,3-dimethoxyphenol; 2- pentadecanone, 6, 10, 14-trimethyl-; 2-cyclopenten-1-one, 3-ethyl-2-hydroxy-; methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; methylacetophenone; phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-Linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; terpineol; acetic acid; 2-furanmethanol; 2-furancarboxaldehyde, 5- methyl; benzyl alcohol; phenethylalcohol; 2(4H)-benzofuranone, 5, 6, 7, 7a-tetra hydro- 4,4, 7a-trimethyl; n-hexadecanoic acid; octadecanoic acid; or a combination thereof; preferably the three or more compounds are selected from any one of the groups consisting of:(I) myosmine; p-cresol; pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3- methyl-; 1H-indole, 6-methyl-; nicotyrine; propanoic acid, 2-oxo, methyl ester; propanoic acid, 2-methyl-; 2-cyclopenten-1-one, 3-methyl-; limonene; 6-ethyl-5,6- dihydro-2H-pyran-2-one; phenol; phenol, 4-ethyl-; propanoic acid; styrene; benzene, 1,3-dimethyl-; 3-pyridinol; 2,3-dimethoxyphenol; 2-pentadecanone, 6,10, 14-trimethyl-; 2-cyclopenten-1-one, 3-ethyl-2-hydroxy-; or a combination thereof;(II) methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; methylacetophenone;phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-Linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; terpineol; or a combination thereof;(III) acetic acid; 2-furanmethanol; 2-furancarboxaldehyde, 5-methyl; benzyl alcohol;phenethylalcohol; 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl; n- hexadecanoic acid; octadecanoic acid; or a combination thereof.3). The aerosolisable formulation according to claim 1 or claim 2, wherein the extract composition comprises at least two compounds selected from: myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one, phenol; indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol.4). The aerosolisable formulation according to any one of claims 1 to 3, wherein the extract composition comprises at least three compounds selected from: myosmine; nicotyrine; limonene; 6-ethyl-5,6-dihydro-2H-pyran-2-one; and phenol.5). The aerosolisable formulation according to any one of claims 1 to 4, wherein the extract composition comprises at least one compound selected from: indole; alpha-linolenic acid; methoxyvinylphenol; and guaiacol.6). The aerosolisable formulation according to any one of claims 1 to 5, wherein the extract composition comprises at least three compounds selected from: methylbutyric acid; piperonal; indole; ethyl vanillin; vanillin; methylacetophenone; phenylacetaldehyde; anisaldehyde; nonanal; ethylguaiacol; alpha-linolenic acid; eucalyptol; isovaleric acid; 2,3-pentanedione; hexanal; methoxyvinylphenol; linalool; piperitone; guaiacol; and terpineol.7). The aerosolisable formulation according to any one of claims 1 to 6, wherein the extract composition comprises at least one compound selected from: myosmine; p-cresol; pyridine, 4-ethenyl-; 2-cyclopenten-1-one, 2-hydroxy-3-methyl-; 1h-indole, 6-methyl-; nicotyrine; propanoic acid, 2-oxo, methyl ester; propanoic acid, 2-methyl-; 2-cyclopenten-1-one, 3-methyl-; limonene; 6-ethyl-5,6-dihydro-2h-pyran-2-one; phenol; phenol, 4-ethyl-; propanoic acid; styrene; benzene, 1,3-dimethyl-; 3-pyridinol; 2,3-dimethoxyphenol; 2-pentadecanone, 6, 10, 14-tri methyl-; and 2-cyclopenten-1-one, 3-ethyl-2-hydroxy-.8). The aerosolisable formulation according to any one of claims 1 to 7, wherein the extract composition comprises at least alpha-linolenic acid.9). The aerosolisable formulation according to any one of claims 1 to 8, wherein the extract composition further comprises 2-furancarboxyladehyde, 5-methyl-.10). The aerosolisable formulation according to any one of claims 1 to 9, wherein the extract composition is obtained, derived or derivable from plants or portions of plants from tobacco.11). The aerosolisable formulation according to any one of claims 1 to 10, wherein the one or more organic acids (c) comprise one or more organic acids selected from the group consisting of acetic acid, lactic acid, formic acid, citric acid, benzoic acid, pyruvic acid, levulinic acid, succinic acid, tartaric acid, oleic acid, sorbic acid, propionic acid, phenylacetic acid, isobutyric acid, butyric acid, methylbutyric acid, 2-methylbutyric acid, 3-methylpentanoic acid, isovaleric acid, valeric acid, hexanoic acid, hepatanoic acid, octanoic acid, nonanoic acid, methylvaleric acid, decanoic acid, glycolic acid, 2-butenedioic acid (Z), 2-butenedioic acid (E), succinic acid, glyceric acid, malic acid, pyroglutamic acid, trihydroxybutanoic acid,tetrahydroxypentanoic acid, 2-keto-L-gluconic acid, quinic acid, gluconic acid, galactaric acid, hexadecanoic acid, caffeic acid, linoleic acid, linolenic acid, glucuronic acid, chlorogenic acid, fumaric acid, maleic acid, oxalic acid, oxaloacetic acid, acetoacetic acid, beta-hydroxybutyric acid, alpha-ketoglutaric acid, alpha-ketobutyric acid and mixtures thereof; preferably wherein the one or more acids (c) is benzoic acid.12). The aerosolisable formulation according to any one of claims 1 to 11 , wherein the total content of the one or more organic acids (c) present in the formulation is 1.0 mole equivalents based on the nicotine13). The aerosolisable material according to any one of claims 1 to 12, wherein the nicotine is present in the material in an amount of 0.01 wt% of the aerosolisable material or more.14). The aerosolisable formulation according to any one of claims 1 to 13, wherein the carrier comprises glycerol, propylene glycol, water and mixtures thereof; preferably wherein the carrier consists of a mixture of glycerol and propylene glycol, such as wherein, based on the total amount of propylene glycol and glycerol in the aerosolisable material, the aerosolisable material comprises: 60 to 80%w / w propylene glycol; and 40 to 20%w / w glycerol.15). The aerosolisable material according to any one of claims 1 to 14, wherein the carrier is present in an amount of at least 70%w / w based on the total weight of the aerosolisable material.16). The aerosolisable formulation according to any one of claims 1 to 15, wherein the pH of the aerosolisable formulation is of from about 4.5 to 7.5; preferably wherein the pH of the aerosolisable formulation is of from about 4.5 to 6.0.17). The aerosolisable formulation according to any one of claims 1 to 16, wherein the aerosolisable formulation and / or the extract composition is treated to selectively remove one or more components therefrom.18). An aerosolised formulation comprising: (a) a carrier; (b) nicotine in unprotonated form and in protonated form; (c) one or more organic acids; and (d) an extract composition as defined according to claims 1 to 10.19). The aerosolised formulation of claim 19, wherein the aerosolised formulation is formed from the aerosolisable formulation of any one of claims 1 to 17.20). An electronic aerosol provision system comprising:(i) an aerosoliser for aerosolising an aerosolisable product for inhalation by a user of the electronic aerosol provision system;(ii) a power supply comprising a cell or battery for supplying power to the aerosoliser; and(iii) an aerosolisable formulation as defined in any one of claims 1 to 17.21). Method of preparing the aerosolisable formulation according to any one of claims 1 to 17, wherein the method comprises combining nicotine, one or more organic acids with a carrier and extract composition.22). A process for forming an aerosol, the process comprising aerosolising an aerosolisable formulation according to any one of claims 1 to 17.23). Use of an extract composition according to any one of claims 1 to 10 for improving sensory properties of an aerosol formulation.24). Use of an extract composition according to any one of claims 1 to 10 for modulating irritation of an aerosol formulation.25). An aerosolisable formulation according to any one of claims 1 to 17, wherein the aerosolisable formulation further comprises a flavour component comprising compounds selected from the groups consisting of:a. at least one aliphatic ketone, at least one aliphatic aldehyde and at least one C6 to C18 substituted pyridine;b. at least one aliphatic aldehyde, at least one C6 to C18 substituted pyridine, at least one C6 to C18 substituted pyrazine and at least one furan derivative;c. at least one aliphatic ketone, at least one aliphatic aldehyde, at least one C6 to C18 substituted pyrazine and at least one C7 to C18 substituted phenols;d. at least one aliphatic ketone, at least one furan derivative, at least one C6 to C18 substituted pyrazine, at least one C7 to C18 substituted phenol and at least one norisoprenoid;e. at least one aromatic aldehyde, at least one aliphatic ketone, at least one heteroaromatic ketone or aromatic ketone, at least one C6 to C18 substituted pyrazine and at least one furan derivative;f. at least one aliphatic aldehyde and at least one thio-ether; org. at least one C7 to C18 substituted phenol.
